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Abstract 1 
 
 
Abstract 
Imidazole glycerol phosphate synthase (ImGPS) is a bi-enzyme complex that consists of 
the glutaminase subunit HisH and the cyclase subunit HisF. HisH hydrolyzes glutamine to 
glutamate and ammonia, which is transported through a channel to the active site of HisF 
where it reacts with N´-[(5´-phosphoribulosyl)formimino]-5-aminoimidazole-4-
carboxamide-ribonucleotide (PRFAR) to imidazole glycerol phosphate (ImGP) and 5-
aminoimidazole-4-carboxamide ribotide (AICAR). ImGP and AICAR are further used in 
histidine and de novo purine biosynthesis, rendering ImGPS a key metabolic enzyme. The 
sequential HisH and HisF reactions are tightly coupled: glutaminase HisH activity is 
allosterically induced by the binding of PRFAR to the active site of HisF. The structural 
bases for complex formation between HisH and HisF and for the coupling of their catalytic 
activities are poorly understood. Thus, HisF:HisH is a paradigm for the study of protein-
protein interactions and allosteric regulation. Moreover, only plants, fungi, bacteria, and 
archaea are able to synthesize histidine. Thus, the inhibiton of ImGPS might be a potential 
therapeutic strategy to fight pathogenic microorganisms. In this context, recently, a peptide 
was identified that impedes the glutaminase activity in ImGPS from Thermotoga maritima 
(tm). It has been hypothesized that the peptide inhibits the catalytic activity of HisF:HisH 
by binding to tmHisF in the complex interface, however, the exact HisF:peptide interaction 
sites and the mode of inhibition remained elusive.  
Within the first part of this thesis, nuclear magnetic resonance (NMR) titration 
experiments demonstrated that the inhibitory peptide mainly interacts with structural 
elements and residues around positions 71-77 and 90-99 in HisF. Parts of this set of 
residues belong to the HisF:HisH interface and are thought to be involved in allosteric 
signal transduction, based on previous NMR and molecular dynamics data. This suggests 
that the peptide inhibits glutaminase activity by perturbing the interaction and allosteric 
communication between the HisF and HisH subunits.  
Within the second part of this thesis, residues of HisF that are crucial for its 
structural and functional interaction with HisH should be identified. For this purpose, it was 
planned to analyze the interaction of various combinations of HisF and HisH enzymes. 
However, these experiments could not be performed due to the insolubility of most of the 
tested proteins. In order to produce proteins that can be characterized, the primordial HisF 
and HisH enzymes from the last universal common ancestor (LUCA) were resurrected by 
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ancestral sequence reconstruction (ASR). LUCA-HisF and LUCA-HisH formed a high-
affinity complex; however, LUCA-HisH was catalytically inactive, probably due to 
inaccuracies of ASR. In contrast, LUCA-HisF was catalytically active and could be used 
for further analysis, which was performed as follows: Initial experiments showed that HisH 
from Zymomonas mobilis (zmHisH) tightly binds to LUCA-HisF but not to the present-day 
HisF from Pyrobaculum arsenaticum (paHisF), which are separated by 103 residues. 
Following the characterization of a reconstructed evolutionary intermediate linking LUCA-
HisF and paHisF and the inspection of the ImGPS interface, the number of candidate HisF 
residues crucial for binding to zmHisH could be narrowed to nine. Subsequent in silico 
mutagenesis based on homology modeling indicated that a single phenylalanine at position 
74 in HisF was most important for binding to zmHisH. The decisive role of this “hot spot” 
residue for complex formation between HisF and zmHisH was confirmed by extensive 
experimental site-directed mutagenesis. Subsequently, primordial HisF proteins were also 
utilized to disentangle mechanistic principles of allosteric communication with HisH. In 
this context, no glutaminase activity was observed for tmHisH when bound to LUCA-HisF 
with PRFAR. However, the crystal structure of LUCA-HisF:tmHisH with bound glutamine 
revealed no significant differences compared to the catalytically active tmHisF:tmHisH 
complex. LUCA-HisF and tmHisF are separated by 79 residues. Although the number of 
potentially important residue differences could be reduced to 69 with the help of a 
primordial enzyme that links LUCA-HisF and tmHisF and by means of computational 
analysis, residues that are decisive for allostery could not be identified by this approach.  
Taken together, the results of this thesis show that peptides interrupting allosteric 
inter-subunit communication and molecular fossils being resurrected by ASR can 
contribute to unraveling the structure-function relationship of multi-enzyme complexes 
such as ImGPS. 
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Zusammenfassung 
Die Imidazolglycerolphosphat-Synthase (ImGPS) ist ein Bienzymkomplex, der aus der 
Glutaminase-Untereinheit HisH und der Zyklase-Untereinheit HisF besteht. HisH 
hydrolisiert Glutamin zu Glutamat und Ammoniak, das durch einen intermolekularen Kanal 
zum aktiven Zentrum von HisF diffundiert und dort mit [(5‘Phosphoribulosyl)formimino]-
5-aminoimidazol-4-carboxamid-Ribonukleotid (PRFAR) zu Imidazolglycerolphosphat 
(ImGP) und 5‘-Aminoimidazol-4-carboxamid-Ribonucleotid reagiert. ImGP und AICAR 
fließen in die Histidin- und de novo Purinbiosynthese, was die ImGPS zu einem 
Schlüsselenzym des Metabolismus macht. Die Reaktionen, die von HisH und HisF 
katalysiert werden, sind eng aneinander gekoppelt: Die Glutaminaseaktivität von HisH wird 
durch die Bindung von PRFAR an das aktive Zentrum von HisF allosterisch induziert. Die 
strukturellen Grundlagen der HisF:HisH Interaktion und der Kopplung ihrer enzymatischen 
Aktivitäten ist bisher noch weitestgehend ungeklärt. Deshalb stellt der HisF:HisH Komplex 
ein Musterbeispiel zur Untersuchung von Protein-Protein Interaktionen und allosterischer 
Regulation dar. Außerdem sind nur Pflanzen, Pilze, Bakterien und Archaeen in der Lage 
Histidin herzustellen. Deshalb stellt die Inhibition der ImGPS eine potentielle Strategie zur 
Bekämpfung pathogener Mikroorganismen dar. In diesem Zusammmenhang wurde vor 
Kurzem ein Peptid identifiziert, das die Glutaminaseaktivität der ImGPS von Thermotoga 
maritima (tm) hemmt. Es wurde angenommen, dass das Peptid die katalytische Aktivität 
inhibiert, indem es in der Kontaktfläche der tmImGPS an die HisF Untereinheit bindet, 
jedoch blieb unklar wo genau das Peptid an HisF bindet und wodurch die Inhibition speziell 
zustande kommt.  
Im ersten Teil dieser Arbeit, konnte mit Hilfe von Kernspinresonanzspektroskopie 
(nuclear magnetic resonance, NMR) gezeigt werden, dass das inhibitorische Peptid vor 
allem mit Strukturelementen und Aminosäuren im Bereich der Positionen 71-77 und 90-99 
in der HisF-Untereinheit interagiert. Einige dieser Reste befinden sich in der HisF:HisH-
Interaktionsfläche und aufgrund vorheriger Studien, die auf NMR und Moleküldynamik 
beruhen, wird angenommen, dass diese an der Weiterleitung des allosterischen Signals 
beteiligt sind. Dies legt nahe, dass das Peptid die Glutaminaseaktivität hemmt, indem es die 
Interaktion und allosterische Kommunikation zwischen HisF und HisH stört.  
Im zweiten Teil der Arbeit sollten Reste von HisF, die sowohl für die strukturelle 
als auch für die funktionelle Interaktion von Bedeutung sind, identifiziert werden. Zu 
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diesem Zweck sollte die Interaktion verschiedenster Kombinationen von HisF- und HisH-
Enzymen untersucht werden. Da jedoch die meisten der ausgewählten Proteine nicht löslich 
exprimierbar waren, konnten diese Experimente nicht durchgeführt werden. Um Proteine 
herzustellen, die charakterisiert werden können, wurden HisF und HisH aus dem letzten 
gemeinsamen Vorläufer der zellulären Organismen (last universal common ancestor, 
LUCA), mittels Sequenzrekonstruktion „auferweckt“. LUCA-HisF und LUCA-HisH 
bildeten zwar einen hoch affinen Komplex aus, jedoch war LUCA-HisH katalytisch inaktiv, 
was möglicherweise auf Ungenauigkeiten bei der Sequenzrekonstruktion zurückzuführen 
ist. Im Gegensatz dazu war LUCA-HisF katalytisch aktiv und konnte für weitere Analysen 
herangezogen werden. Diese erfolgten folgendermaßen: Erste Untersuchungen zeigten, 
dass die HisH-Untereinheit aus Zymomonas mobilis (zmHisH) stark an LUCA-HisF, jedoch 
nicht an das rezente HisF aus Pyrobaculum arsenaticum (paHisF) bindet. Beide HisF-
Proteine unterscheiden sich an 103 Positionen. Die Reste in HisF, die für das 
unterschiedliche Bindeverhalten an zmHisH verantwortlich sind, konnten mit Hilfe der 
Charakterisierung eines HisF-Vorläuferproteins, das auf dem phylogenetischen Pfad 
zwischen LUCA-HisF und paHisF liegt, und mit Hilfe der Analyse der ImGPS 
Kontaktfläche, auf neun Aminosäuren eingeschränkt werden. In anschließenden in silico 
Mutagenesestudien, basierend auf Homologiemodellen, zeigte sich, dass vor allem ein 
einzelnes Phenylalanin an Position 74 in HisF entscheidend für die Bindung an zmHisH ist. 
Die herausragende Bedeutung dieses „hot spots“ für die Komplexbildung von HisF und 
zmHisH wurde in einer umfassenden gerichteten Mutagenese experimentell bestätigt. 
Rekonstruierte HisF-Proteine wurden anschließend ebenfalls verwendet um den 
Mechanismus der allosterischen Kommunikation mit HisH näher zu beleuchten. In diesem 
Zusammenhang konnte in Aktivitätsmessungen keine Glutaminaseaktivität für tmHisH, das 
mit LUCA-HisF mit gebundenem PRFAR interagiert, beobachtet werden. Die 
Kristallstruktur des LUCA-HisF:tmHisH Komplexes mit gebundenem Glutamin wies 
jedoch keine signifikanten Unterschiede zum katalytisch aktiven tmHisF:tmHisH Komplex 
auf. LUCA-HisF und tmHisF unterscheiden sich an 79 Positionen. Obwohl mit der Hilfe 
eines rekonstruierten HisF-Vorläuferenzyms, das auf dem phylogenetischen Pfad zwischen 
LUCA-HisF und tmHisF liegt und bioinformatischer Analyse die potentiell bedeutenden 
Unterschiede auf 69 Reste reduziert werden konnten, konnten keine Reste identifiziert 
werden, die eine wichtige Rolle für die Allosterie spielen. 
Zusammengefasst zeigen die Ergebnisse dieser Arbeit, dass Peptide, die die 
Kommunikation zwischen Komplexuntereinheiten stören, sowie molekulare Fossilien, die 
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durch Sequenzrekonstruktion „zum Leben erweckt“ wurden hilfreich sein können bei der 
Untersuchung von Struktur-Funktions-Beziehungen von Multienzymkomplexen wie der 
ImGPS.
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1 Introduction 
1.1 Protein-protein interactions 
Nowadays, it is generally accepted that the complexity of an organism is not defined by the 
total number of its genes but by the number of interactions between its cellular compounds. 
For example, while for Saccharomyces cerevisiae about 18000-30000 binary interactions 
were determined, for humans about 600000 were estimated (Merkl, 2015). Among these 
interactions, protein-protein interactions are of great importance as they are involved in 
many biological processes such as metabolic pathways and signal transduction cascades. 
This makes clear how important the understanding of protein-protein interactions and 
complexes is in order to understand biological systems in general.  
Protein complexes can be grouped on the basis of different features. They can be 
categorized into homo-oligomers and hetero-oligomers according to the polypeptide chains 
that form the subunits. In a homo-oligomer the polypeptide chains are identical, while the 
polypeptide chains in a hetero-oligomer are different (Zhang et al., 2013). Apart from that, 
complexes can be distinguished according to the duration of protein-protein interaction. In 
permanent complexes interactions are tight and stable once the complex has formed, 
whereas in transient complexes interactions can be broken by external influences. The first 
category involves, for example, antigen-antibody complexes, for which a permanent 
interaction is of great biological importance. The second category comprises proteins that 
regulate signaling pathways and that are required to bind to their partners only at a certain 
time (La et al., 2013). The assembly of proteins to oligomers has various biological 
functions. For example, it is often observed that oligomerization increases thermal stability 
(Jaenicke & Böhm, 1998; Sterner & Liebl, 2001; Vieille & Zeikus, 2001; Walden et al., 
2001; Schwab et al., 2008). Moreover, the assembly of proteins to complexes enables the 
transport of highly reactive and volatile substances under separation from the environment 
between two or more active sites that are located at different subunits (Miles et al., 1999; 
Huang et al., 2001; Raushel et al., 2003). Finally, oligomerization allows for regulative 
coupling of enzymatic functionalities via an allosteric mechanism (Perica et al., 2012).  
The stability of a complex is determined as the difference in Gibbs free energy G 
between the isolated monomers and the monomer assembly. This difference ΔG at the 
temperature T is defined as follows (Equation 1): 
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Equation 1: Calculation of Gibbs free energy. 
 
The free energy has two components: ΔH and ΔS. ΔH describes the change in enthalpy that 
is linked to the change in intermolecular, non-covalent interactions during complexation 
such as Van der Waals interactions, hydrogen bonds or Coulomb interactions. ΔS is the 
entropy term that either contributes to a destabilization during complex formation through 
desolvatation of polar groups at the protein surface or results in a stabilization in the form 
of an increase of the hydrophobic effect (Hilser et al., 1996; Chandler, 2005). In general, 
the hydrophobic effect makes the largest contribution to complex stability (Chothia & 
Janin, 1975; Young et al., 1994). Complex formation and stabilization results in a ΔG value 
< 0. Destabilization of the complex is accompanied by an increase in ΔG.  
Most often, protein-protein interfaces (PPIs) exhibit geometric and electrostatic 
complementarity and are densely packed. Although they are commonly large and expand 
from 700-1500 Å2 (Reichmann et al., 2007), not all residues in the interface contribute 
equally to binding affinity. In fact, complex stability critically depends on few residues in 
the interface, so called hot spots (Clackson & Wells, 1995). The replacement of such hot 
spots by alanines significantly destabilizes the free energy of complex formation 
(ΔΔG > 2 kcal/mol) (Bogan & Thorn, 1998). Hot spots are commonly located in the center 
of the interface, are enriched in Trp, Arg, and Tyr and often show a higher level of 
conservation compared to other interface residues (Zhang et al., 2013).  
The identification of hot spots is essential for the mechanistic understanding of 
protein-protein interactions. For example, abnormal protein-protein interactions are often 
associated with diseases like cancer. Thus, for medicinal science, protein-protein interfaces 
are attractive drug targets. As the restoration of protein-protein interactions is often difficult 
to realize (Fry & Vassilev, 2005), the disruption of abnormal protein-protein interactions 
with the help of small molecules has achieved much success during the last years 
(Watanabe & Osada, 2016). As protein-protein interfaces are large in size and rather flat, 
the identification of small molecules that tightly bind to the interface is often difficult. 
However, the knowledge of interface hot spots allows for the selective inhibition of key 
interactions in the interfaces (Fry & Vassilev, 2005). For example, an interesting target for 
cancer therapy is the interaction face of the complex of the tumor suppressor p53 and the 
MDM2 protein. The assembly of both proteins results in an inhibition of the transcription 
activation of p53 and promotes p53 degregation. As MDM2 is overexpressed in many 
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tumor cells, the inhibition of p53-MDM2 complex formation is a potential therapeutic 
strategy. In this context, small organic molecules (nutlins) were identified that effectively 
mimic specific hydrophobic key interactions that are essential for p53-MDM2 binding 
(Vassilev et al., 2004; Fry & Vassilev, 2005). Moreover, protein-protein interactions have 
been blocked with the help of peptides that were directly derived from epitopes of the 
corresponding interaction face. This strategy was, for example, successfully applied to the 
herpesvirus ribonucleotide reductase (Cohen et al., 1986). 
Various methods can be used for the systematic identification and analysis of 
protein-protein interactions. For example, PPIs can be identified by means of crystal 
structure analysis. However, PPIs deduced from crystal packing contacts may be artifacts 
and the interactions may not be of biological relevance (Janin & Rodier, 1995). Alanine 
scanning mutagenesis, which is the replacement of particular residues by alanines, is a 
common way to experimentally test the energetic contribution of interface residues to 
complex stability. This approach, however, is often laborious and expensive (Moreira et al., 
2007). Thus, various computer algorithms have been developed that predict PPIs, identify 
hot spots or asses the energetic contribution of particular residues to protein-protein 
interaction by in silico mutagenesis (Moreira et al., 2007; Aumentado-Armstrong et al., 
2015). These algorithms are based on empirical functions or force fields. The KFC2 server 
(Zhu & Mitchell, 2011), for example, identifies hot spots by means of geometric and 
biochemical features. Another example is FoldX, which is a force field that predicts the 
effect of mutations on the stability of proteins with known 3D structure. Moreover, this 
program was successfully applied to calculate ΔΔG-values, which are a measure for the 
effect of mutations on complex stability. 
Another computational method which allows for the analysis of PPI is residue 
coevolution. Coevolution describes the evolutionary interdependency of two or more 
positions in protein chains. This interdependency implies that a mutation at one position in 
the protein results in selective pressure on another position leading to a compensatory 
amino acid change and vice versa (Lovell & Robertson, 2010). Intermolecular coevolution 
is a crucial phenomenon in the evolution of protein complex interfaces as it guarantees the 
maintenance of the biological functionality of the complex by mutual adaptation of the 
subunit interfaces (Zhang et al., 2013). Along these lines, Aakre and co-workers (2015) 
successfully utilized GREMLIN (Generative Regularized ModeLs of proteINs) 
(Balakrishnan et al., 2011) for the identification of interaction hot spots in the toxin-
antitoxin system. GREMLIN is a method that learns a global statistical model of the amino 
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acid compositions in an MSA. The model accounts for conservation and correlated 
mutation statistics between sequential and long-range pairs of residues, and thus allows for 
the determination of residue contacts in a complex interface. 
1.2 Allostery 
Often, the binding of a ligand to a certain site in a protein induces functional, structural 
and/or dynamic modifications at another site, which can be even 20 to 30 Å apart from the 
initial binding site. This regulatory mechanism has been named allostery (Monod et al., 
1963) and the act of conveying these modifications between the two binding sites has been 
denoted as allosteric communication. More general, allostery can also be induced by other 
factors such as mutations or light (Nussinov et al., 2013). Two types of allostery can be 
distinguished depending on the parameter that is modified during the allosteric mechanism. 
While, in K-type allostery the binding of substrate to the active site is affected, V-type 
allostery describes an alteration of reaction velocity (Manley et al., 2013).  
The view on the mechanistic principles of this phenomenon has changed during the 
past 50 years (Motlagh et al., 2014) and is still under debate (Nussinov & Tsai, 2015). In 
the infancies of allosteric studies, allosteric regulation has been described for oligomeric 
proteins. The binding of a ligand, often denoted as effector, to the oligomer resulted in a 
shift from one discrete conformational state into another (Monod et al., 1965) or in a 
sequential conformational rearrangement (Koshland et al., 1966). These models allow, for 
example, the description of principles of cooperativity in hemoglobin (Perutz et al., 1998). 
Improvement of experimental technologies and the emergence of data from nuclear 
magnetic resonance (NMR) spectroscopy and computational methods like molecular 
dynamics (MD) simulations have attracted notice to intrinsic protein flexibility and thus the 
notion of allostery has been revised. The new view assumes that proteins populate a 
continuous conformational and dynamic ensemble. The effector may bind to more than one 
state and the binding results in a shift of the population distribution via multiple 
conformational and/or dynamic pathways throughout the protein (Goodey & Benkovic, 
2008; del Sol et al., 2009; Perica et al., 2012; Motlagh et al., 2014). These structural 
pathways that energetically couple two binding sites are often denoted as allosteric 
pathways (Perica et al., 2012). The new view implies that allostery must not be necessarily 
accompanied by conformational changes but can only be of dynamic nature (Cooper & 
Dryden, 1984). This was observed for the catabolite activator protein (CAP). CAP is a 
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transcriptional activator which forms a homodimer in solution. Each subunit comprises a 
cAMP binding site. Two cAMP molecules bind with negative cooperativity to CAP. The 
binding of cAMP results in an enhanced affinity of CAP to DNA. Studies on changes in 
CAP structure and dynamics, based on NMR and ITC measurements, revealed that the 
binding of the first cAMP does not affect the conformation at the second cAMP binding 
site. Instead, negative cooperativity is solely driven by changes in protein motions between 
the two binding sites (Popovych et al., 2006). This dynamically mediated allostery is, 
however, still subject of discussion (Nussinov & Tsai, 2015). Interestingly, many 
allosterically controlled systems are protein assemblies. Actually, oligomerization allows 
for the communication between subunits via additional, novel concerted motions, thus 
enabling highly sophisticated regulation (Perica et al., 2012). 
According to the current view, intra- and inter-molecular allosteric communication 
is based on various protein motions and conformational changes from atomic fluctuations 
and loop motions in the picosecond (ps) to nanosecond (ns) range, domain motions in the 
ns to microsecond (µs) range and larger conformational rearrangements to which a whole 
network of amino acids contributes and that occur in the µs to millisecond (ms) range 
(Goodey & Benkovic, 2008; Manley et al., 2013).  
Analogous to protein-protein interactions, allostery can be modulated with small 
molecules. Thus, the allosteric mechanism of an enzyme is, beside PPIs, a further target for 
therapeutic drugs (Nussinov & Tsai, 2013). Allosteric drugs bind to a site at the enzyme 
that is distal to the active site. Therefore, the use of allosteric drugs in therapy can have 
advantages in contrast to drugs that target the active site: For example, they are often more 
specific due to the fact that allosteric sites generally exhibit a lower degree of conservation 
than active sites. Moreover, allosteric drugs allow for an optimal regulation of the 
pharmacological effect. As they do not compete with the substrate the enzyme cannot only 
be simply switched on and off by it, but can variously be modified (Conn et al., 2009; 
Nussinov et al., 2011).  
An example of eligible targets for allosteric drugs are G-protein coupled receptors 
(Conn et al., 2009), as they are allosterically regulated and often involved in a multitude of 
human diseases. In this context, allosteric drugs have been used in the therapy of AIDS: 
Maraviroc (Selzentry), for example, is an allosteric modulator of the chemokine receptor 
CCR 5, which is used by HI-virus to enter and infect host cells (He et al., 1997). Maraviroc 
stabilizes a conformation of the CCR5 receptor that has a lower affinity to the virus and 
thus prevents its entry into the cell (Conn et al., 2009). 
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Other examples demonstrated that the design of allosteric modulators can also fail. For 
example, allosteric drugs that were designed for the suppression of proteinkinase C, an 
essential regulatory enzyme in cell signaling pathways, rather led to an activation 
(Nussinov et al., 2011). This makes clear that a detailed mechanistic understanding of an 
allosteric mechanism is needed in order to develop effective allosteric modulators. 
Various approaches help to strengthen this understanding: Mutational studies led to 
the identification of residues that are involved in allosteric pathways. For example, double 
mutant cycles are an experimental approach to determine the energetic coupling of two 
distal residues and thus to estimate the degree to which they are functionally coupled 
(Horovitz & Fersht, 1990; Sadovsky & Yifrach, 2007). Furthermore, X-ray crystallography 
was successful in capturing structural rearrangements upon ligand binding in the case of 
hemoglobin (Perutz et al., 1998) or ferric citrate membrane transporter FecA (Ferguson & 
Deisenhofer, 2004). Moreover, a detailed understanding of allosteric signal transduction 
with fast time scales requires sophisticated methods that allow for the observation of 
motions and dynamic fluctuations at atomic scales such as NMR spectroscopy and MD 
simulations. While NMR techniques cover all time scales that play a role in allosteric 
mechanisms, transitions on the ps to ns range can be studied with standard MD simulations. 
In particular, analyses of correlated motions in MD simulations allow for the identification 
of allosteric transitions of that kind (Manley et al., 2013). 
1.3 The imidazole glycerol phosphate synthase 
The imidazole glycerol phosphate synthase (ImGPS) belongs to the family of glutamine 
amido-transferases (GATases), which are the most widespread enzymatic ammonia donors 
in the biosynthesis of nucleotides, amino acids and coenzymes (Zalkin & Smith, 1998). 
GATases consist of glutaminase and synthase domains. The glutaminase hydrolyzes 
glutamine to glutamate and ammonia, which is added to a specific substrate by the synthase 
subunit. While synthase subunits markedly differ in their topology and catalytic 
mechanisms, GATases can be divided into two unrelated classes according to the active site 
residues of the glutaminase subunit (Massiere & Badet-Denisot, 1998; Zalkin & Smith, 
1998). Class I glutaminases adopt an α/β-hydrolase fold and are characterized by a catalytic 
triad in their active site (Ollis et al., 1992). Class II glutaminases are N-terminal nucleophile 
(Ntn)-type GATases, which have an N-terminal catalytic cysteine (Brannigan et al., 1995). 
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Figure 1: Structure and reaction of the ImGP synthase from Thermotoga maritima (HisF:HisH 
complex).  
The catalytic residues in the active site of HisF and HisH are depicted as spheres. The conformational 
transition that is induced by binding of PRFAR to the active site of HisF is illustrated as a red arrow. The blue 
arrow indicates the way of nascent ammonia through the tunnel in HisF. Details of the catalytic mechanism 
are outlined in the text. The crystal structure is taken from the pdb (1gpw) (Douangamath et al., 2002). 
 
ImGPS is a class I GAT that consists of the glutaminase domain HisH and the 
synthase domain HisF (Klem & Davisson, 1993) (Figure 1). In plants and fungi, the 
glutaminase and synthase active sites are located on a single polypeptide chain (Chittur et 
al., 2000), whereas in bacteria and archaea HisF and HisH are two separate subunits. 
ImGPS is, however, not present in mammals (Chaudhuri et al., 2001) . Structures of the 
ImGPS complex or of isolated HisF from Saccharomyces cerevisiae (Chaudhuri et al., 
2001; Chaudhuri et al., 2003), Pyrobaculum aerophilum (Banfield et al., 2001), Thermus 
thermophilus (Omi et al., 2002) and Thermotoga maritima (Douangamath et al., 2002; 
Korolev et al., 2002; List et al., 2012) show that HisF adopts a (βα)8-barrel fold, which 
consists of eight parallel β-sheets, which are surrounded by eight α-helices thus forming a 
tunnel along the central barrel axis. The (βα)8-barrel belongs to the most ancient observed 
folds (Caetano-Anolles et al., 2007). The C-terminal face of the barrel bears the cyclase 
catalytic site and the N-terminal face forms the complex interface with HisH.  
ImGPS from T. maritima (tmHisF:tmHisH or tmImGPS) is a hetero-obligomer, 
which is an obligatory permanently interacting bi-enzyme complex (Ofran & Rost, 2003). 
In tmHisF:tmHisH the interface has a dimension of 1100 Å2 and is characterized by 
electrostatic and shape complementarity, ensuring a tight docking of the subunits to each 
other (Douangamath et al., 2002; Amaro et al., 2005). 
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The active site of HisH (catalytic triad Cys84, His178, Glu180, numbering according to 
tmImGPS, Figure 1), which provides ammonia, is located in the interface near the opening 
of the tunnel in HisF. This opening is framed by four invariant residues that form a salt 
bridge cluster [Arg5(HisF), Glu46(HisF), Lys99(HisF), Glu167(HisF)]. From here, nascent 
ammonia is channeled over a distance of 25 Å to the active site of HisF (Figure 1) where it 
is added to N´-[(5´-phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamide-
ribonucleotide (PRFAR). Thus, ammonia is sequestered from the solvent and not 
protonated to nonreactive ammonium ions. In a cyclization reaction PRFAR is cleaved into 
imidazole glycerol phosphate (ImGP) and 5-aminoimidazole-4-carboxamide ribotide 
(AICAR), which are essential components of histidine and de novo purine biosynthesis 
(Figure 1) (Beismann-Driemeyer & Sterner, 2001). By linking amino acid and nucleotide 
metabolism, ImGPS serves as a metabolic key enzyme. Noteworthy, glutaminase activity of 
HisH is contingent upon the binding of a ligand to the active site of HisF. Therefore, in the 
absence of HisF and in the presence of HisF without a bound ligand, glutaminase activity of 
HisH is too low to be measured. This phenomenon has been ascribed to a ligand-induced 
V-type allosteric mechanism (Beismann-Driemeyer & Sterner, 2001; Myers et al., 2003; 
Myers et al., 2005; Amaro et al., 2007; Manley et al., 2013). This tight functional coupling 
ensures that glutamine is only hydrolyzed when PRFAR is present in the cell, thus 
preventing an unnecessary waste of glutamine. HisF is able to use ammonia salts as an 
ammonia source at basic pH values. As a consequence, HisF is active in the absence of 
HisH (Klem & Davisson, 1993; Beismann-Driemeyer & Sterner, 2001).  
In an attempt to shed light on the principles of the allosteric mechanism in ImGPS 
computational methods have been combined with NMR experiments, X-ray crystallography 
and mutational studies. These studies were predominantly conducted with ImGPS from 
yeast, Escherichia coli or T. maritima. Some of the observations that have been made on 
the basis of these investigations are outlined in the following. The residue numeration is 
according to tmHisF:tmHisH. In Figure 2 (panel A) the most important residues and 
structure elements that might be involved in the allosteric mechanism and that are 
mentioned here are projected on a schematic model of tmHisF:tmHisH. 
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Figure 2: Putatively functional important residues and allosteric pathway in tmImGPS.  
Some of the depicted residues and motifs that are putatively involved in allosteric mechanism are given. A) 
Schematic representation of HisF:HisH with residues and structure elements that are mentioned in the main 
text. B) Localization of β2, α2 and α3 in the complex. The structure elements are marked in dark red. The 
view on the complex interface in HisF shows that the residue Asp98 is localized in proximity to these 
structure elements. Both As98 and the hinge residue Arg249 are given in spheres. The potential allosteric 
pathway is indicated as red dashed lines. 
 
On the basis of NMR and MD simulations (Rivalta et al., 2012; Manley et al., 2013; Rivalta 
et al., 2016) changes in protein motion at the ns and ms scale were observed upon PRFAR 
binding which allow for the construction of a potential allosteric pathway in the bi-enzyme 
complex (Figure 2; panel A). The signal transduction upon PRFAR binding is outlined in 
the following: The binding of PRFAR at the active site of HisF changes hydrophobic 
interactions in the β2 strand (residues 46-53) of the HisF barrel. These changes result in an 
alteration of the salt-bridge network in the adjacent secondary structure elements α2(HisF) 
(residues 57-71) and α3(HisF) (residues 85-95) (Figure 2, panel B), which leads to a 
stabilization of ionic interactions between residues of the α2(HisF) and α3(HisF) helices 
and adjacent residues in HisH in the interface. The stabilization of this part of the interface 
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is accompanied by a facilitated opening and closing motion (breathing motion) at the other 
side of the interface for which the conserved cation-π interaction between Arg249(HisF) 
and Trp123(HisH) acts like a hinge. This motion exposes the glutaminase active site more 
frequently to water. The loosening of interactions in this part of the interface might lead to a 
rearrangement of a conserved PGVG motif (residues 49-52) in HisH and thus to the 
formation of an oxyanion hole that stabilizes the tetrahedral thioester intermediate being 
formed during glutamine hydrolysis between Cys84 and glutamine. This hypothesis was 
promoted by the crystal structure from yeast ImGPS with bound glutaminase inhibitor 
acivicin in which the oxyanion strand adopted a conformation that is not conform with 
glutamine hydrolysis (Chaudhuri et al., 2003). Notably, the oxyanion hole is a common 
feature in many hydrolases and proteases (Ollis et al., 1992; Zalkin & Smith, 1998) and in 
the crystal structure of glutamine bound carbamoyl phosphate synthetase (Thoden et al., 
1999), pyridoxal 5´-phosphate synthase (Strohmeier et al., 2006) and cytidine triphosphate 
synthetase (Goto et al., 2004) the oxyanion strand forms a catalytically competent oxyanion 
hole. In accordance with these structures, List et al. (2012) presented a crystal structure of 
glutamine-bound tmHisF:tmHisH in which the PGVG motif is in a conformation that can 
stabilize the tetrahedral intermediate without the necessity of conformational 
rearrangements. However, the inspection of the glutaminase active site and the complex 
interface of the apo and the glutamine-bound structure of tmHisF:tmHisH revealed that 
nearby bulky residues, including the invariant residues Tyr138(HisH) and Lys181(HisH), 
block the glutaminase active site. In fact, the mutant tmHisF:tmHisH-Y138A+K181A 
exhibits glutaminase activity in the absence of PRFAR (constitutive glutaminase activity) 
which is 2800-fold enhanced compared to the wild type. Thus, glutaminase stimulation 
caused by PRFAR binding was ascribed to a rearrangement of these plugs. Yet, it is not 
clear how the rearrangement may result in a stimulation of the glutaminase activity, 
however, different options were discussed: Lys181(HisH) is involved in a conserved 
interdomain salt bridge with Asp98(HisF). Asp98 is located in the complex interface, in 
proximity to α3 (Figure 2, panel B), and additionally forms a solvent-mediated hydrogen 
bond with His178 of the catalytic triad in HisH. Mutational studies showed that the 
replacement by an alanine resulted in a drastic decrease or even loss of the glutaminase 
activity, emphasizing the essential role of Asp98 for glutaminase activity (Myers et al., 
2005, List et al., 2012). The removal of bulky side chains near the HisH active site and 
especially the replacement of Lys181 by an alanine might lead to an enhanced flexibility of 
Asp98 and thus result in an improved positioning to participate in the glutaminase active 
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site. Another option could be an enhanced diffusion of ammonia and thus the avoidance of 
product inhibition at the glutaminase active site (List et al., 2012), which was also discussed 
for other glutaminases (Raushel et al., 1978; Messenger & Zalkin, 1979; Milman et al., 
1980).  
All in all, principles of the HisF:HisH interaction and allosteric communication are 
hitherto only poorly understood. A detailed study is of interest because of two reasons: 
First, ImGPS is a key metabolic enzyme that does not occur in mammals, but in plants, 
fungi, bacteria and archaea. Thus, it is a potential target in the development of herbicides or 
fungicides and for drugs to fight pathogenic microorganisms. First steps into this direction 
were recently done with the identification of a peptides that has been found to inhibit 
ImGPS glutaminase activity. On the basis of inhibitory assays and ITC mesurements it has 
been proposed that it binds to the complex interface in HisF, however the concrete 
HisF:peptide interface and mode of inhibition are still unknown (Auburger, 2013). 
Second, HisF:HisH can serve as a paradigm to study general principles of protein-
protein interaction and allostery with various biochemical and computational methods in 
order to strengthen the mechanistic understanding of elaborate molecular machineries. 
Often, it is not possible to illuminate the functionality of a protein by analyzing a 
representative from only one organism. For example, proteins from thermophilic organisms 
can have distinctly different characteristics compared to their mesophilic counterparts and 
the study of only a thermophilic protein might lead to wrong conclusions for the mesophilic 
one (Beismann-Driemeyer & Sterner, 2001; Sterner & Liebl, 2001). The study of 
orthologous proteins can help to get a broader insight into principle molecular mechanisms. 
Moreover, with the development of ancestral sequence reconstruction (ASR) in the last 50 
years a computational tool became available which provides access to sequences from 
extinct organisms and thus increases sequence space for mechanistic studies.  
1.4 Ancestral sequence reconstruction 
1.4.1 Theory and application of ASR 
ASR is the inference of extinct nucleotide or amino acid sequences from contemporary 
ones with the help of a phylogenetic tree. Already in the early 1960s Pauling and 
Zuckerkandl (1963) brought forward the idea of reconstructing proteins. However, it took 
further eight years until the first algorithm for phylogenetic analysis was developed (Fitch, 
1971) and it was not until the 1990s that the first laboratory studies were conducted with 
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resurrected proteins produced by means of site-directed mutagenesis methods (Malcolm et 
al., 1990; Stackhouse et al., 1990; Jermann et al., 1995).  
In a first step of ASR, homologous protein sequences from extant species are 
selected for the construction of a multiple sequence alignment (MSA). The calculation of 
an MSA is a critical step in the reconstruction process as a high quality MSA is a 
prerequisite for the inference of a reliable phylogenetic tree. Though highly similar 
sequences (> 90 %) (Bar-Rogovsky et al., 2013) should be eliminated in order to ensure a 
certain degree of diversity, too a high sequence diversity impedes the reconstruction of 
primordial sequences. 
In the next step, a substitution model which defines probabilities and frequencies for 
all possible mutational events of the sequence set is chosen. This substitution model and the 
MSA are used for the construction of a phylogenetic tree.  
 
 
Figure 3: An example of a phylogenetic tree.  
The phylogenetic tree is calculated on the basis of an MSA that comprises protein sequences of contemporary 
organisms (green circles). Every node in the tree represents an ancestral protein sequence (intermediates; light 
brown). The last common ancestor (LCA; dark brown circles) is the sequence from which all the other 
sequences descend. 
 
In Figure 3 an example of a phylogenetic tree is illustrated. Every node in the tree 
represents an ancestral protein sequence (intermediate) from which the contemporary 
sequences, which form the leaves of the tree, descend. The root of the tree corresponds to 
the last common ancestor of the intermediates and the extant sequences. Computing a tree 
is a prerequisite, but not sufficient to deduce the sequences of the last common ancestor and 
the intermediates. The primordial sequences are finally inferred on the basis of the 
calculated phylogenetic tree, the chosen substitution model, and the MSA. Strictly 
speaking, ASR determines for each residue position the probabilities for all 20 amino acids. 
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Thus, the output of an ASR pipeline is not only a single ancestral sequence but a whole 
ensemble of possible ancestral sequences, whose likelihoods differ (Bar-Rogovsky et al., 
2015). The most probable ancestor (mpa) comprises the most probable residues predicted 
by ASR and is often used for further experimental analysis.  
Beside a careful selection of contemporary sequences, there are other criteria that 
have to be taken into account during the reconstruction process. For example, the tree 
topology should be robust against resampling of the original data set. What is even more 
important for a highly reliable sequence reconstruction is that the tree branches have to be 
short, representing not more than one mutation at a certain site. Moreover, evolutionary 
events like horizontal gene transfer (HGT), are not compatible with a tree-like evolution 
and thus have to be taken into account for a reliable reconstruction (Holder & Lewis, 2003; 
Merkl & Sterner, 2016). 
The genes coding for the ancestral sequences can be synthesized, expressed in E. 
coli and the proteins can be biochemically characterized (Merkl & Sterner, 2016). Some 
ASR studies examined thermostability or pH dependency of billion-of-years old proteins in 
order to get an idea of the environmental conditions of the Precambrian era (Gaucher et al., 
2008; Perez-Jimenez et al., 2011; Akanuma et al., 2013). Moreover, promiscuity of 
primordial enzymes was assessed for the β-lactamase family (Risso et al., 2013). While 
modern β-lactamase TEM-1 is a specialist for hydrolysis of penicillin, the ancient β-
lactamases are able to hydrolyze various β-lactam antibiotics due to enhanced protein 
flexibility (Zou et al., 2015).  
By comparing primordial enzymes along a phylogenetic path (vertical approach), 
instead of comparing different contemporary enzymes (horizontal approach), mutations that 
lead to different functional behavior in protein families can be more easily identified. By 
this way, two amino acid residues were found that are responsible for the different hormone 
binding behavior of estrogen receptors and non-aromatized steroid receptors (Harms et al., 
2013). A similar approach was used to unravel the mechanistic principles which are 
responsible for different affinities of the protein kinases Abl and Src to the cancer drug 
Gleevec (Wilson et al., 2015). The sequences of proteins that are represented by nodes that 
are next to each other, in a phylogenetic tree generally differ in less amino acids than extant 
proteins. Thus, in both cases, the number of positions that are putatively responsible for the 
observed differences in protein function and that had to be analyzed in mutational studies, 
was minimized by such a vertical approach.  
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1.4.2 Previous phylogenetic studies on ImGPS  
In our group, ASR was used to reconstruct the amino acid sequence of the HisF subunit 
from the last universal common ancestor (LUCA-HisF) (Richter et al., 2010). The LUCA is 
a hypothetical organism which preceded the diversification into bacteria, archaea and 
eucaryota and which inhabited earth in the Paleoarchean era, which was about 3.5 billion 
years ago (Nisbet & Sleep, 2001). The MSA that was used for the calculation of the 
phylogenetic tree comprises 87 present-day HisF and HisH sequences from the clades 
Crenarchaeota, Actinobacteria, Chlorobi, Cyanobacteria, Firmicutes, Proteobacteria, and 
Thermotogae (Figure 4). As coevolution for the HisF and the HisH subunits can be 
assumed, the sequences of HisF and HisH from the same organism were concatenated, in 
order to increase the phylogenetic signal. Sequences were chosen accounting for horizontal 
gene transfer of the his genes, which occurred between Bacteria and Archaea (Fondi et al., 
2009). The respective MSA is denoted as HisFext + HisHext.  
About 31% of the residues of the HisF proteins are less than 50% conserved, 
guaranteeing sufficient sequence diversity, and about 19% of the amino acids are strictly 
conserved (Reisinger et al., 2014). In the calculated phylogenetic tree the LUCA was 
placed between the superkingdoms Archaea and Bacteria and the protein sequence was 
reconstructed on the basis of the HisF part of the MSA. A confidence estimate for tree 
topology was expressed as posterior probabilities values (PP). The higher the PP values, the 
higher is the reliability of the tree and thus of the reconstruction.  
LUCA-HisF differs in 22% of the amino acid sequence from the most similar 
present-day HisF sequence used for the reconstruction, which is from Thermovibrio 
ammonificans. The gene coding for LUCA-HisF was synthesized, expressed in E. coli and 
the protein was biochemically characterized. LUCA-HisF folds as a (βα)8-barrel, that is 
highly thermostable (melting temperature TM1 = 73 °C, TM2 = 100 °C). In fluorescence 
titration experiments the formation of a highly affine complex with the extant HisH subunit 
from Zymomonas mobilis (zmHisH) was detected. For the LUCA-HisF:zmHisH complex, 
glutamine-dependent cyclase and glutaminase activity could be recorded. These 
observations suggested that in the LUCA era the ImGPS was an elaborate enzyme complex 
that had the modern characteristics of allosteric signal transduction and ammonia 
channeling (Reisinger et al., 2014). 
The existence of an unambiguous, reliable phylogeny of ImGPS provides a basis for 
a novel approach for the identification of residues that are involved in protein-protein 
interaction and allostery. The study of not only extant orthologs but also of primordial HisF 
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and HisH proteins will enable an extensive examination of mechanistic principles in 
ImGPS.  
 
 
Figure 4: Phylogenetic tree used for the reconstruction of LUCA-HisF and LUCA-HisH.  
The tree was calculated based on an MSA comprising 87 present-day HisF and HisH sequences from seven 
clades. Numbers indicate the posterior probabilities. Modified according to Reisinger et al. (2014). 
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2 Objectives of the thesis 
The ImGPS is an allosterically regulated bi-enzyme complex that links histidine with de 
novo purine biosynthesis. Despite intensive research, principles of protein-protein 
interaction and allostery remain elusive. Therefore, this work is directed at the 
identification of residues that are decisive for complex formation and allosteric 
communication in HisF:HisH. A detailed mechanistic examination of ImGPS is essential, 
as it can serve as a possible target for drugs but also as the insights gained from these 
studies can contribute to a better understanding of allostery and complex assembly in 
general.  
For this purpose, first, the binding interface of the recently identified inhibitory 
peptide will be localized by means of NMR spectroscopy. It was hypothesized that the 
peptide binds to HisF in the HisF:HisH complex interface. The identification of residues 
and structural elements in HisF that interact with the peptide might shed light on the mode 
of inhibition and provide further insight into the functionality of ImGPS.   
In the following, a phylogenetic approach will be used to go deeper into the subject. 
For this purpose, first, HisF subunits from various present-day organisms shall be tested for 
their ability to bind to and allosterically stimulate HisH proteins from different modern 
organisms, and vice versa. Subsequently, LUCA-HisF and intermediate HisF proteins will 
be characterized according to their abilities to bind to and allosterically interact with 
LUCA-HisH, as well as intermediate and present-day HisH proteins. Different binding or 
allosteric behavior of evolutionary nearby HisF proteins and HisH proteins, respectively, 
shall then be correlated with differences in their sequences. In order to further narrow down 
candidate residues and to substantiate and verify that certain residues are responsible for the 
observed differences in allostery and binding, the findings will be complemented by other 
computational methods, like in silico mutagenesis experiments. By this way, functional 
important candidate positions will be readily identified and validated by experimental 
mutagenesis. 
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3 Materials 
3.1 Instrumentation 
Autoclave: 
Series EC Stream Sterilizers    WEBECO, Selmsdorf 
Balances: 
MC1       SARTORIUS, Göttingen 
PL3000      METTLER TOLEDO, Gießen 
SI-114      DENVER INSTRUMENT, Göttingen 
CD spectro-polarimeter     J-815 JASCO GmbH, Groß-Umstadt 
Cell Densitiy Meter Ultrospec 10    GE HEALTHCARE, München 
Centrifuges: 
Centrifuge 5810R    EPPENDORF, Hamburg 
Centrifuge 5415D     EPPENDORF, Hamburg 
Centrifuge 5415R     EPPENDORF, Hamburg 
Sorvall RC 2B, 5C plus    DU PONT Instruments, Bad Homburg 
Avanti J-26 XP     BECKMAN COULTER, Krefeld 
Chromatographic devices: 
ÄKTA basic better     GE HEALTHCARE, München 
ÄKTA prime      GE HEALTHCARE, München 
ÄKTA purifier 10     GE HEALTHCARE, München 
LaChrome HPLC system    MERCK-HITACHI, Darmstadt 
columns: 
LiChrospher 100 RP-18, 5µm  MERCK, Darmstadt 
LiChroCART, 250x4mm 
HisTrap FF 5 ml     GE HEALTHCARE, München 
Mono Q 5/50 GL     GE HEALTHCARE, München 
Resource S     GE HEALTHCARE, München 
Superdex 75 HiLoad 26/600    GE HEALTHCARE, München 
Superdex 200 10/300 GL GE   GE HEALTHCARE, München 
Computer 
Dell Optiplex Systems    DELL Inc., Round Rock, USA 
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Fluorescence spectrometer Cary-Eclipse   VARIAN, Darmstadt 
Freezer -80° C      MDF-U72V, SANYO, Tokyo, Japan 
Freezer -20° C      LIEBHERR, Nussbaumen 
Gas burner, Gasprofi 2SCS     WLD-TEC GmbH, Göttingen 
Gel electrophoresis system: 
Agarose gel electrophoresis chamber 
Agarose electrophoresis unit   HOEFER Pharmacia Biotech, USA 
SDS electrophoresis chamber 
Mighty Small II    HOEFER Pharmacia Biotech, USA 
Multi Gel Caster Assembling  GE HEALTHCARE, München 
gel apparatus 
Glass pipettes and glassware    FISCHER SCIENTIFIC, Schwerte 
NOVOGLAS, Bern, Swiss 
SCHOTT, Mainz 
Heating block-Thermostat     HBT-2 131 HLC, Bovenden 
Incubator       BINDER GmbH, Tuttlingen 
Magnetic stirrer: 
MR0, MR2000     HEIDOLPH, Kehlheim 
MR1, MR3001 (heatable)    HEIDOLPH, Kehlheim 
Microliter pipettes Research     EPPENDORF, Hamburg 
Microwave       HMT 842C BOSCH, Nürnberg 
Mosquito LCP roboter     TTP LABTECH, Melbourn, UK 
NMR       BRUKER Avance-800, Massachusetts 
Multi-Doc-It Digital Imaging System   UVP Inc., USA 
PCR-cycler: 
Mastercycler personal    EPPENDORF, Hamburg 
Mastercycler gradients    EPPENDORF, Hamburg 
Peristaltic pump, Miniplus 2     GILSON Medical Electronics, France 
pH-Meter Level1      INOLAB, Weilheim 
Plate shaker Rocking Platform    BIOMETRA, Göttingen 
Power supply unit: 
Power Pack P25     BIOMETRA, Göttingen 
Power Supply EPS 301    GE HEALTHCARE, München 
Quartz cuvettes 
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101-QS (layer thickness 10 mm)   HELLMA GmbH & Co. KG, Müllheim 
105-QS (layer thickness 10 mm)   HELLMA GmbH & Co. KG, Müllheim 
Shaking incubator: 
Certomat H      BRAUN Biotech, Melsungen 
Certomat BS-1     BRAUN Biotech, Melsungen 
Multitron      INFORS HT, Bottmingen, Swiss 
Ultrafree-20 nanopore water system    MILLIPORE, Eschborn 
Ultrasonic system, Branson Sonifier   250 D HEINEMANN,Schwäbisch 
Gmünd 
UV-Vis spectral photometer     V650 JASCO GmbH, Groß-Umstadt 
UV-Vis Biophotometer     EPPENDORF, Hamburg 
Vakuum pump ME 2C     VACUUMBRAND, Wertheim 
Vortex Genie 2      SCIENTIFIC IND., Bohemia, USA 
3.2 Consumables 
Easy-Xtal plates      QIAGEN, Hilden 
Centrifugal Filter Device 
Amicon Ultra-15 (mwco: 10 kDa)   Millipore, Bedford, USA 
NAP-5, -10, -25 columns     GE HEALTHCARE, München 
Dialysis tubing Visking, 27/32, 14 kDa   ROTH GmbH &Co, Karlsruhe 
Disposable syringes, Omnifix® 60 ml   BRAUN Biotech, Melsungen 
Filter paper       WHATMAN, Maidstone, England 
Membrane filter ME24 Ø47 mm; 0.2 μm   SCHLEICHER&SCHUELL, Dassel 
Microtiter plates, Vis, 96 well, flat bottom   GREINER, Nürtingen 
Nitrocellulose filter (Ø13 mm)    MILLIPORE, Eschborn 
Parafilm „M“ Laboratory Film    PECHINEY, Menasha, USA 
Pasteur pipettes      HIRSCHMANN, Ebermannstadt 
PCR-tubes 0.2 ml      PEQLAB, Erlangen 
Petri dish 94/16      GREINER bio-one, Nürtingen 
Pipette tips       SARSTEDT, Nümbrecht 
Plastic cuvettes 
½ microcuvettes,   UV-transparent SARSTEDT, 
Nümbrecht 
Materials 25 
 
1ml cuvettes      SARSTEDT, Nümbrecht 
Plastic tubes:15 ml, 50 ml     SARSTEDT, Nümbrecht 
Reaction vessels 1.5 ml, 2 ml    ROTH, Karlsruhe 
EPPENDORF, Hamburg 
Reaction vessel with screw-cap, 2 ml   SARSTEDT, Nümbrecht 
Syringe filter, pore size 0.2 μm, 0.45 μm   RENNER GmbH, Daunstadt 
3.3 Chemicals 
All chemicals used were graded p.a. and purchased from the companies listed 
below. 
ALFA AESAR      Karlsruhe 
APPLICHEM GmbH     Darmstadt 
BIO101 Inc.       Carlsbad, USA 
BIO-RAD LABORATORIES    Hercules, USA 
BIOZYM      Hess. Oldendorf 
BODE CHEMIE      Hamburg 
BOEHRINGER MANNHEIM    Mannheim 
CARL ROTH GMBH & Co. KG    Karlsruhe 
DIFCO       Dreieich 
FLUKA       Neu-Ulm 
GE HEALTHCARE      München 
GERBU       Biotechnik GmbH Gailberg 
GIBCO/BRL       Eggestein 
MERCK       Darmstadt 
MP BIOCHEMICALS     Illkirch, France 
NATIONAL DIAGNOSTICS    Simerville, USA 
OXOID       Wesel 
RIEDEL-DE HAEN      Seelze 
ROCHE DIAGNOSTICS     Mannheim 
ROTH       Karlsruhe 
SERVA       Heidelberg 
SIGMA-ALDRICH      Deisenhofen 
VWR        Leuven, Belgium 
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3.4 Kits 
3.4.1 Kits for molecular biology 
GeneJET Plasmid Miniprep Kit    MBI FERMENTAS, St. Leon-Rot 
GeneJET Gel Extraction Kit     MBI FERMENTAS, St. Leon-Rot 
 
3.4.2 Kits for protein crystallization 
Morpheus II  MOLECULAR DIMENSIONS, 
Suffolk, UK 
ProPlex   MOLECULAR DIMENSIONS, 
Suffolk, UK 
3.5 Enzymes 
Alkaline phosphatase (CIP)   NEW ENGLAND BIOLABS, Frankfurt 
am Main 
DNA polymerases 
Go Taq      PROMEGA, Mannheim 
Pwo       ROCHE DIAGNOSTICS, Mannheim 
Pfu      PEGLAB, Erlangen 
Restriction endonucleases   NEW ENGLAND BIOLABS, Frankfurt 
am Main 
T4-DNA ligase      MBI FERMENTAS, St-Leon-Rot 
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3.6 Bacterial strains 
E. coli Turbo (NEW ENGLAND BIOLABS, Frankfurt a. M.) 
F' proA+B+ lacIq Δ(lacZ)M15/fhuA2 Δ(lac-proAB) glnV gal R(zgb-210::Tn10) Tets endA1 
thi-1 Δ(hsdS-mcrB)5 
E. coli Turbo cells are T1-phage resistant. As the recA function of the strain is intact, E. 
coli Turbo cells grow fast and form visible colonies after 8 h incubation at 37° C. 
 
E. coli BL21-Gold (DE3) (Agilent Technologies) 
hsdS gal [λcl ts857 cnd1 hsdR17 racA1 endA1 gyrA96 thi1 relA1]  
E. coli BL21(DE3) cells carry a gene for T7 RNA polymerase on their chromosome, which 
is used for gene expression in pET systems. E. coli BL21-Gold (DE3) are improved 
versions of BL21 cells. Derived from E. coli B, these expression strains naturally lack the 
Lon protease, which can degrade recombinant proteins. In addition, these strains are 
engineered to be deficient for a second protease, the OmpT protein. 
 
E. coli T7 Express Iq (NEW ENGLAND BIOLABS, Frankfurt am Main) 
fhuA2 lacZ::T7gene1 lon ompT gal sulA11 dcm R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-
mrr) 
114::IS10 R(mcr-73::miniTn10-TetS)2) lacIq (CamR) 
E. coli T7 Express Iq cells are derivatives of E. coli BL21(DE3), which have the gene for 
T7 polymerase in the lac operon. They are T1-phage resistent due to a deletion of fhuA2. 
The cells exhibit tetracycline resistance. 
 
E. coli M15 (pREP) (QIAGEN, Hilden) 
NaIS, StrS, RifS, Thi-, Lac-, Ara+, Gal+, Mtl-, F-, RecA+, Uvr+, Lon+ 
This expression strain includes the pREP4 plasmid which confers kanamycin resistance and 
constitutively expresses the lac repressor protein encoded by the lacI gene. 
3.7 Vectors 
3.7.1 pET vectors 
Genes inserted into the multiple cloning site (MCS) of pET vectors (plasmids for 
expression by T7 RNA Polymerase) are transcribed by the RNA-polymerase of the phage 
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T7 (Studier et al., 1990). The expression of genes takes place in special E. coli strains, 
which carry a chromosomal copy of the T7 RNA polymerase. The expression of the T7 
RNA polymerase gene proceeds under the control of the lacUV5 promotor operator and is 
induced by the addition of IPTG. The gene for the lac-repressor (lacI), which is required for 
suppression of gene expression in the absence of induction, is located on the plasmid and is 
constitutively expressed.  
The pET24a(+) vector encodes an optional C-terminal (His)6-tag sequence and 
confers kanamycin resistance. The pET21a(+) vector encodes an optional C-terminal 
(His)6-tag sequence and confers ampicillin resistance. The pET11c vector has the lowest 
basal level of expression of the pET series and does not encode a His-tag. It confers 
ampicillin resistance. The following pET based plasmids were used in this thesis (Table 1): 
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Table 1: Plasmids used in this thesis. 
plasmid gene cloning 
pET24a(+) 
tmhisF wt 
cloned with NdeI/XhoI; all genes 
include a stop codon at the C-
terminus 
tmhisF-W156Y 
pahisF wt1 
pahisF-W157Y1
Anc1pa-hisF_wt 
Anc1pa-hisF_W138Y+W156Y 
Anc1pa-hisF*_W138Y+W156Y
Anc1pa-
hisF_W138Y+W156Y+A72Q+S74F 
Anc1pa-
hisF_W138Y+W156Y+A72Q 
Anc1pa-
hisF_W138Y+W156Y+S74F 
LUCA-hisF wt2
LUCA-hisF_W138Y+W156Y2
LUCA-hisF_F74S 
Anc1tm-hisF_W138Y+W156Y
Anc2tm-hisF_W156Y
Anc2tm-hisF_W156Y+F74D  
tmhisF_W156Y+D74F 
Anc2tm-hisF_A1_W156Y 
Anc2tm-hisF_A2_W156Y 
pahisH 
zmhisH2 
zmhisH_A28R 
zmhisH_L202R 
zmhisH_A28R+L202R 
LUCA-hisH wt Cloned with NdeI/XhoI; C-terminal His6-tag 
LUCA-hisH_Y157A Cloned with NdeI/XhoI; C-terminal His6-tag 
LUCA-hisH_K202A Cloned with NdeI/XhoI; C-terminal His6-tag 
LUCA-hisH_Y157A+K202A Cloned with NdeI/XhoI; C-terminal His6-tag 
pET11c tmhisF wt3 Cloned with NdeI/BamHI, includes a stop codon 
pET21a(+) tmhisA4 Cloned with NdeI/NotI; C-terminal His6-tag 
1(Schmid, 2012), 2(Reisinger et al., 2014), 3(Beismann-Driemeyer & Sterner, 2001), 4(List, 2009) 
The Trp to Tyr exchanges in the HisF proteins are no longer specified in the main text. 
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3.7.2 pQE vectors (Qiagen, Hilden) 
pQE vectors are plasmids for protein expression that belong to the pDS plasmid family. In 
contrast to pET plasmids, they are based on a T5 promoter transcription-translation system. 
The promoter/operator element consists of a bacteriophage T5 promoter and two lac 
operator sequences, which lead to a higher probability of lac repressor binding and thus 
guarantee an efficient repression of the T5 promoter. This promoter is recognized by E. coli 
RNA polymerase. Therefore, the expression of genes can take place in all E. coli strains. As 
a terminator sequence it carries t0 from Lambda bacteriophage and T1 from E. coli rrnB 
operons. The MCS is preceded by a synthetic ribosome binding site, which allows for an 
efficient translation. 
The pQE70 vector encodes an optional C-terminal (His)6-tag sequence and confers 
ampicillin resistance. In this thesis, the expression plasmid tmhisH-pQE70 with the 
restriction sites SphI/HindIII from List et al. (2009) was used. 
 
3.7.3 pACYCDuet-1 (Novagen) 
With the pACYCDuet-1 vector two target genes can be expressed. It contains two MCSs, 
each of which is preceded by a T7 promoter/lac operator and ribosome binding site. The 
vector carries the P15A replicon, lacI gene and confers chloramphenicol resistance. For 
coexpression of Anc2tm-HisF_A1 and tmHisH, Anc2tm-hisF_A1 was cloned into MCS 1 
using the restriction sites NdeI/XhoI and tmhisH was cloned into MCS 2 using the 
restriction sites BamHI/NotI allowing for an expression with a C-terminal His6-tag. 
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3.8 Oligonucleotides 
In all oligonucleotides the newly introduced restriction sites are written in bold, the stop 
codon is indicated in italics, and the codon for a newly introduced amino acid is underlined. 
The oligonucleotides were ordered from biomers.  
 
3.8.1 Vector specific amplification and sequencing primers 
 
Table 2: Sequencing primers used in this thesis. 
oligonucleotide sequence, 5’→ 3’ usage 
5’_T7Promotor TAATACGACTCACTATAGGG sequencing of pET vectors 
3’_T7Terminator GCTAGTTATTGCTCAGCGG 
sequencing of pET vectors 
and of MCS 2 of 
pACYCDuet1 vector 
5’_pACYCDuetUp1 GGATCTCGACGCTCTCCCT sequencing of MCS 1 of pACYCDuet1 vector 
3’_pACYCDuetDown1 GATTATGCGGCCGTGTACAA  sequencing of MCS 1 of pACYCDuet1 vector 
5’_DuetUp2 TTGTACACGGCCGCATAATC  sequencing of MCS 2 of pACYCDuet1 vector 
 
3.8.2 Amplification and mutagenic primers for hisF  
 
Table 3: Amplification and mutagenic primers for hisF used in this thesis. 
oligonucleotide sequence, 5’→ 3’ usage 
5’_Anc1pa-hisF_W138Y CGTGTGGGTGGTGGTTATGAAGTTTTTGTTCG 
QuikChange mutagenesis 
(QCM)1 of Anc1pa-hisF 
3’_Anc1pa-hisF_W138Y CGAACAAAAACTTCATAACCACCACCCACACG QCM of Anc1pa-hisF 
5’_Anc1pa-hisF_W156Y CTGGATGCAGTTGAATATGCAAAAAAAGTTGAAG QCM of Anc1pa-hisF 
3`_Anc1pa-hisF_W156Y CTTCAACTTTTTTTGCATATTCAACTGCATCCAG QCM of Anc1pa-hisF 
5’_Anc1pa-hisF_NdeI GAAGCGCATATGCTGGCAAAACGTATTATTCC 
forward primer for overlap 
extension (OE)2-PCR with 
Anc1pa-hisF 
3’_Anc1pa-
hisF_Stop_XhoI 
GAAGCGCTCGAGTTACAGACGCACT
TCAATACC 
reverse primer for OE-PCR 
with Anc1pa-hisF 
5’_Anc1pa-
hisF_A72Q+S74F 
CGTACCGCAGAACAGGTTTTTATTCC
GCTGACC 
mutagenesis of Anc1pa-
hisF via OE-PCR 
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oligonucleotide sequence, 5’→ 3’ usage 
3’_Anc1pa-
hisF_A72Q+S74F 
GGTCAGCGGAATAAAAACCTGTTCT
GCGGTACG 
mutagenesis of Anc1pa-
hisF via OE-PCR 
5’_Anc1pa-hisF-
A72Q+S74F_F74S 
CGTACCGCAGAACAGGTTAGCATTC
CGCTGACCGTTGG 
QCM of Anc1pa-hisF-
A72Q+S74F 
3’_Anc1pa-hisF-
A72Q+S74F _F74S 
CCAACGGTCAGCGGAATGCTAACCT
GTTCTGCGGTACG 
QCM of Anc1pa-hisF-
A72Q+S74F 
5’_Anc1pa-hisF-
A72Q+S74F_Q72A 
CGTCGTACCGCAGAAGCAGTTTTTAT
TCCGCTG 
QCM of Anc1pa-hisF-
A72Q+S74F 
3’_Anc1pa-hisF-
A72Q+S74F_Q72A 
CAGCGGAATAAAAACTGCTTCTGCG
GTACGACG 
QCM of Anc1pa-hisF-
A72Q+S74F 
5’_LUCA-hisF_F74S CGTACCGCAGAACAGGTTAGCATTCCGCTGACCGTTGG QCM of LUCA-hisF 
3’_LUCA-hisF_F74S CCAACGGTCAGCGGAATGCTAACCTGTTCTGCGGTACG QCM of LUCA-hisF 
5’_Anc2tm-hisF_F74D GTTGCCGAACAGGTTGATATTCCGCTGACCGTTGG QCM of Anc2tm-hisF 
3’_Anc2tm-hisF_F74D CCAACGGTCAGCGGAATATCAACCTGTTCGGCAAC QCM of Anc2tm-hisF 
5’_tmhisF_D74F GTGGCCGAGCAGATCTTTATTCCGTTCACTGTTGG QCM of tmhisF 
3’_tmhisF_D74F CCAACAGTGAACGGAATAAAGATCTGCTCGGCCAC QCM of tmhisF  
5’_tmhisF_NdeI ATGCTGCATATGCTCGCTAAAAGAATAATC 
amplification of tmhisF 
from tmhisF-pET11c3 
3’_tmhisF_Stop_XhoI ATGCTGCTCGAGTCACAACCCCTCCAGTCTCAC 
amplification of tmhisF 
from tmhisF-pET11c3 
5’_tmhisF_W156Y GCATACTTCTGAGAGACTATGTGGTTGAAGTAGAAAAG QCM of tmhisF 
3’_tmhisF_W156Y CTTTTCTACTTCAACCACATAGTCTCTCAGAAGTATGC QCM of tmhisF 
1QCM is described in chapter 4.3.8, 2OE-PCR is described in chapter 4.3.9, 3(Beismann-Driemeyer & Sterner, 
2001) 
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3.8.3 Amplification and mutagenic primers for hisH  
 
Table 4: Amplification and mutagenic primers for hisH used in this thesis. 
oligonucleotide sequence, 5’→ 3’ usage 
5’_LUCA-hisH_Y157A CGGAAGGTAGCTATTTCG CGTTTGTGCACAGC QCM of LUCA-hisH 
3’_LUCA-hisH_Y157A GCTGTGCACAAACGCGAAATAGCTACCTTCCG QCM of LUCA-hisH 
5’_LUCA-hisH_K202A CCAGTTTCATCCGGAAGCGAGCGGTAAAGCAGG QCM of LUCA-hisH 
3’_LUCA-hisH_K202A CCTGCTTTACCGCTCGCTTCCGGATGAAACTGG QCM of LUCA-hisH 
5’_zmhisH_A28R GCCAATGCATTATTGCGCTCGGGATTAGCTCGC QCM of zmhisH 
3’_zmhisH_A28R GCGAGCTAATCCCGAGCGCAATAATGCATTGGC QCM of zmhisH 
5’_zmhisH_L202R AGCCAGAGCTATGGTCGCGAGTTTCTGTCCCGT QCM of zmhisH 
3’_zmhisH_L202R ACGGGACAGAAACTCGCGACCATAGCTCTGGCT QCM of zmhisH 
5’_tmhisH-BamHI GCCAGGATCCGATGCGTATCGGA 
amplification of tmhisH for 
cloning in MCS 2 of 
pACYCDuet1 
3’_tmhisH-NotI ACCGCTGCGGCCGCCTATCGCCGGGACAA 
amplification of tmhisH for 
cloning in MCS 2 of 
pACYCDuet1 
3.9 Ladders and markers 
The size of DNA fragments in agarose gels was determined with the help of the GeneRuler 
1 kb DNA Ladder Plus (MBI FERMENTAS, St. Leon-Rot). The size of proteins in SDS-
PAGE gels was determined with the help of the Unstained Protein Molecular Weight 
Marker (MBI FERMENTAS, St. Leon-Rot) (Figure 5). 
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Figure 5: DNA and protein ladder and marker.  
A) GeneRuler 1 kb DNA Ladder (MBI FERMENTAS). B) Unstained Protein Molecular Weight Marker 
(MBI FERMENTAS) for SDS-PAGE (12.5%). 
3.10 Buffers and solutions 
Unless otherwise specified, buffers were filter-sterilized and stored at room temperature 
(RT). For all preparations, Milli-Q grade water (MILLIPORE) or double distilled water 
(ddH2O) was used. 
 
3.10.1 Buffers and solutions for molecular biology 
PCR dNTP solution (2 mM)  A solution of dNTP`s (2mM of each A, C, G, and T) 
was prepared and stored at -20 °C. 
Agarose (1%)  5 g agarose dissolved in 500 mL 0.5 x TBE, boiled and 
stored at 60 °C  
Ethidium bromide solution  10 mg/mL ethidium bromide (EtBr) 
Sucrose color marker  60% (w/v) sucrose, 0.1% (w/v) bromphenol blue, 
0.1% (w/v) xylencyanole FF dissolved in 0.5 x TBE 
TBE (5x)  445 mM boric acid, 12.5 mM EDTA, 445 mM Tris 
(resulting pH-value: 8.15) 
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3.10.2 Buffers and solutions for working with E. coli 
Antibiotics 
Dissolved and filter-sterilized antibiotics were placed at -20 °C for long-term storage. 
Ampicillin (1000 x)  150 mg/mL ampicillin (sodium salt) dissolved in water 
and filter-sterilized 
Chloramphenicol (1000 x) 30 mg/mL chloramphenicol dissolved in 100% EtOH 
and filter-sterilized 
Kanamycin (1000 x)  75 mg/mL kanamycin dissolved in water and filter-
sterilized 
Glucose 20% (w/v) glucose dissolved in water, filter-sterilized, 
and stored at RT 
Glycerol (87%) autoclaved and stored at RT 
IPTG stock solution  0.5 M IPTG dissolved in water, filter-sterilized, and 
stored at -20 °C 
MgCl2 1 M MgCl2, dissolved in water, filter-sterilized, and 
stored at RT 
MgSO4 1 M MgSO4 dissolved in water, filter-sterilized, and 
stored at RT 
TFB I-buffer  100 mM KCl, 50 mM MnCl2, 30 mM KAc, 10 mM 
CaCl2, 15% glycerol; stock solution for the single 
components were stored at 4 °C. A volume of 100 mL 
TFB I-buffer was prepared prior to use. 
TFB II-buffer  100 mM Tris/HCl, pH 7.0, 10 mM KCl, 75 mM CaCl2, 
15% glycerol; A volume of 100 mL TFB II-buffer was 
prepared prior to use. 
 
3.10.3 Buffers and solutions for working with proteins 
Potassium phosphate buffer 
1 M K2HPO4 (base) and 1 M KH2PO4 (acid), pH was adjusted by mixing 
Resuspension buffer 
50 mM potassium phosphate pH 7.5 or pH 7.8 
50 mM Tris/HCl pH 7.5 or pH 9.0 
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Buffer for ion exchange chromatography 
Equilibration buffer: 50 mM potassium phosphate pH 7.5 or pH 7.8; 50 mM Tris/HCl pH 
7.5 or pH 9.0. 
Elution buffer: Equilibration buffer and 3 M NaCl 
Buffer for size exclusion chromatography 
50 mM potassium phosphate pH 7.5, 300 mM KCl; 50 mM Tris/HCl pH 7.5, 300 mM KCl 
Buffer for dialysis and storage 
50 mM or 10 mM potassium phosphate pH 7.5; 50 mM Tris/HCl pH 7.5 
 
3.10.4 Buffers and solutions for SDS-PAGE 
Ammonium persulfate (APS) solution   10% (w/v) APS solution; filter-sterilized, and 
stored at -20 °C 
Coomassie staining solution 0.2% (w/v) Coomassie Brilliant Blue G-250 
and R-250, 50% (v/v) ethanol, 10% (v/v) HAc; 
filtered and stored at RT; protected from light 
Buffer for SDS-PAGE resolving gel 0.4% (w/v) SDS, 1.5 M Tris/HCl pH 8.8 
Buffer for SDS-PAGE stacking gel  0.4% (w/v) SDS, 0.5 M Tris/HCl pH 6.8 
SDS-PAGE electrophoresis buffer  0.1% (w/v) SDS, 0.025 M Tris, 0.2 M glycine 
(resulting pH-value: 8.5) 
SDS-PAGE sample buffer (5 x) 5% (w/v) SDS, 25% (w/v) glycerol, 12.5% 
(v/v) β-mercaptoethanol, 0.025% (w/v) 
bromphenol blue, 1.25 M Tris/HCl pH 6.8 
3.11 Bacterial growth media  
For sterilization, the medium was autoclaved for 20 min at 121 °C and 2 bar. For selective 
media, the corresponding antibiotics were added after cooling down of the medium to 
60 °C in terms of a filter-sterilized, 1000-fold concentrated stock solution. 
 
Luria-Bertani (LB) medium 
0.5% (w/v) yeast extract, 1.0% (w/v) NaCl, 1.0% (w/v) tryptone 
LB agar  
LB medium plus 1.5% (w/v) Bacto-Agar 
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SOB medium  
0.5% (w/v) yeast extract, 0.05% (w/v) NaCl, 2.0% (w/v) tryptone. After autoclaving,  
10 mM MgSO4, 10 mM MgCl2, and 2.5 mM KCl (each filter-sterilized) were added prior to 
use. 
SOC medium  
SOB medium was supplemented with 20 mM glucose (filter-sterilized) following 
autoclavation. 
15NH4Cl minimal medium (Budisa et al., 1995) 
9.4 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 0.25 g MgSO4·7 H2O, 0.014 g CaCl2·2 H2O ad 
900 mL H2O; filter-sterilized 
add before use: 1 g 15NH4Cl, 4 g glucose, 10 mL mix 3 ad 1 liter H2O 
mix 1 (trace elements): 100 mg ZnSO4·7 H2O, 30 mg MnCl2, 300 mg H3BO3, 200 mg  
CoCl2·6 H2O, 10 mg CuCl2·2 H2O, 20 mg NiCl2·6 H2O, 30 mg Na2MoO4 ad 1 liter  
(filter-sterilized) 
mix 2 (fresh): 500 mg EDTA, 200 mg FeSO4·7 H2O ad 90 mL H2O 
mix 3: 1 mL Mix 1 + 0.9 mL Mix 2 ad 10 mL H2O 
3.12 Software 
ÄKTA Unicorn version 5.01 (318)   © GE HEALTHCARE 
Auremol     www.auremol.de 
Cary Eclipse version 1.2   © AGILENT TECHNOLOGIES Inc. 
CCP4 suite  Collaborative Computational Project, Number 
4, 1994, (Potterton et al., 2004) 
CLC main workbench 7.0.2    © CLC BIO 
Coot (version 0.6.2)    (Emsley & Cowtan, 2004) 
Corel Draw X6     © COREL Corp. 
Endnote Version X7    © WINTERTREE Software Inc. 
FastLM     (Ashkenazy et al., 2012) 
FoldX      (Guerois et al., 2002) 
GREMLIN     (Balakrishnan et al., 2011) 
HPLC Multi-HSM-Manager    © HITACHI 
Jalview 2.8.1      (Waterhouse et al., 2009) 
KFC2      (Zhu & Mitchell, 2011) 
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MolProbity     (Davis et al., 2007) 
MS Office 2010     © 2010 MICROSOFT CORPORATION 
Phenix      (Adams et al., 2002) 
PhyloBayes     (Boussau et al., 2008) 
PyMOL v0.99     © DELANO SCIENTIFIC LCC. 
Refmac5     (Murshudov et al., 1997) 
SigmaPlot 12.5     © SPSS Inc. 
Spectra Manager 1 and 2    © JASCO 
XDS      (Kabsch, 1993) 
YASARA     (Krieger et al., 2009) 
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4 Methods 
4.1 Preparation of instrumentation and solutions 
All thermostable solutions and media were autoclaved for 20 min at 121° C and 2 bar prior 
to use. Glassware and consumables were autoclaved and subsequently dried at 50 °C in a 
compartment drier. Additionally, glassware was incubated at 200 °C for 4 h for 
sterilization. Heat-labile solutions were prepared in stock solutions and filtered, either via a 
membrane filter with a pore size of 0.2 μm by use of a vacuum pump, or by using a syringe 
filter with a pore size of 0.2 μm or 0.45 μm. Solutions for chromatographic systems were 
degassed for at least 30 min in a desiccator prior to use. 
4.2 Microbiological methods 
4.2.1 Cultivation and storage of E. coli strains 
E. coli strains were cultivated at 37 °C while shaking at 140 rpm (1 liter cultures) or 
220 rpm (5, 50 and 250 mL cultures), respectively. For cultivation, LB-medium was used, 
unless otherwise stated. For plasmid-harboring strains, the medium was supplemented with 
the corresponding antibiotics (150 µg/mL ampicillin, 30 µg/mL chloramphenicol, 
75 µg/mL kanamycin) using a filter-sterilized, 1000 fold concentrated stock solution. To 
obtain single colonies, the cell suspension was plated on agar plates containing the adequate 
antibiotics, and incubated over night at 37 °C. For temporary storage, plates and 
suspensions were sealed and stored at 4 °C. For long-term storage, glycerol cultures were 
prepared. For this purpose an aliquot of an overnight culture was mixed in a 1:1 ratio with 
87% glycerol, and stored in a sterile screw cap reaction vessel at -80 °C. 
 
4.2.2 Preparation of chemically competent E. coli cells (Inoue et al., 1990) 
For preparation of chemically competent cells, 500 mL SOB medium was inoculated with 
the respective overnight culture to an OD600 of 0.1, and cultured at 37 °C and 220 rpm until 
an OD600 of 0.6 was reached. The culture was incubated on ice for 15 min, transferred into 
50 mL tubes, and cells were harvested by centrifugation (EPPENDORF Centrifuge 5810R, 
4000 rpm, 10 min, 4 °C). The cell pellet was resuspended in 100 mL ice-cold TFB I-buffer 
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and centrifuged a second time under the same conditions as stated above. The resulting 
pellet was resuspended in 10 mL ice-cold TFB II-buffer. Immediately after resuspension, 
100 µL aliquots of the cell suspension were transferred to Eppendorf reaction vessels on ice 
and stored at -80 °C. 
 
4.2.3 Transformation of chemically competent E. coli cells 
For transformation of chemically competent cells, a 100 µL aliquot was thawed on ice, and 
about 100 ng plasmid DNA with a maximum volume of 20 µL were added. Following 
incubation on ice for 5 min, cells were heat-shocked for 45 s at 42 °C, and subsequently 
chilled for further 5 min on ice. A volume of 900 µL LB-medium was added, and cells 
were incubated for 1 h at 37 °C in a shaker at 220 rpm to develop antibiotic resistance. 
Finally, dilutions of the cell suspension were plated on LB agar plates containing the 
appropriate antibiotics for selection. 
4.3 Molecular biology methods 
4.3.1 Isolation and purification of plasmid DNA from E. coli 
Purification of plasmid DNA was performed according to the principle of alkaline cell lysis 
(Le Gouill et al., 1994). Bacterial cell cultures were lysed by adding SDS and sodium 
hydroxide. The suspension was subsequently neutralized by addition of ammonium acetate; 
proteins and genomic DNA precipitated, whereas circular plasmid DNA remained in 
solution. 
For analytical isolation of plasmid DNA from E. coli the mini preparation kit from 
FERMENTAS (GeneJET Plasmid Miniprep Kit) was used. For this purpose 5 mL from 
overnight cell cultures were harvested by centrifugation (EPPENDORF 5415D, 13200 rpm, 
1 min, RT). The isolation of plasmid DNA was performed according to the protocol 
supplied by the manufacturer. Bound plasmid DNA was eluted from the silica column with 
50 µL sterile water. The recovered plasmid DNA was stored at -20 °C. 
 
4.3.2 Determination of DNA concentration 
The DNA concentration was spectrophotometrically determined at a wavelength of 260 nm. 
According to Lambert-Beer’s law an OD260 value of 1 (with 0.1%A260 = 20 cm2 mg-1 and a 
pathlength of 1 cm) corresponds to a DNA concentration of 50 µg/mL double-stranded (ds) 
Methods 41 
 
DNA (35 µg/mL RNA and 33 µg/mL ssDNA, respectively). Thus, the DNA concentration 
can be calculated as follows: 
 
ܿௗ௦஽ே஺ ൌ 	ܣଶ଺଴ 	 ∙ 50	 ∙ ݂1000  
Equation 2: Determination of DNA concentration. 
cdsDNA   concentration of double stranded DNA [µg/µL] 
A260   absorbance at 260 nm 
f   dilution factor 
A pure DNA solution should not show measurable absorption above 300 nm, and its 
OD260/OD280 quotient should be at least 1.8. 
 
4.3.3 Agarose gel electrophoresis 
DNA fragments are separated by agarose gel electrophorese according to their length. The 
bands in the gel become visible under UV-light by adding ethidium bromide, a DNA 
intercalating fluorescence dye (Sharp et al., 1973). For preparation of agarose gels 1% 
(w/v) agarose was dissolved in 0.5% TBE buffer by boiling in the microwave. Following 
cooling down to 50-60 °C, 0.2 µL of an ethidium bromide stock solution (10 mg/mL) was 
added per mL agarose. The solution was then cast into a gel chamber, and a comb was 
inserted. Following solidification, the gel was covered with 0.5% TBE buffer, and the comb 
was removed. The DNA samples were supplemented with DNA loading dye and pipetted 
into the gel pockets. The electrophoresis was performed using a voltage of 190 V for about 
20 min. The negatively charged DNA migrates to the anode, whereby DNA fragments are 
retarded to a different extent by the agarose matrix due to differences in size. The fragments 
were detected under UV-light (λ = 302 nm) and documented using the Imager Multi-Doc-It 
Digital Imaging system. To estimate the size of the fragments, a volume of 5 μL of the 
GeneRuler 1 kb Plus DNA Ladder (FERMENTAS) was applied to a separate pocket of the 
gel. 
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4.3.4 Isolation of DNA fragments from agarose gels 
The corresponding fragments were excised from the gel under UV-light (λ = 302 nm) with 
a scalpel and transferred to a reaction vessel. DNA was extracted using the GeneJET Gel 
Extraction Kit (FERMENTAS) according to the protocol supplied by the manufacturer. The 
isolated DNA was eluted with 30 µL sterile water and stored at -20 °C.  
 
4.3.5 Enzymatic manipulation of dsDNA 
4.3.5.1 Cleavage of dsDNA by restriction endonucleases 
Type II endonucleases, which bind to a palindromic recognition sequence (recognition site) 
were applied for specific cleavage of dsDNA (Sambrook, 1989; Wilson & Murray, 1991). 
These restriction enzymes generate single stranded overhangs (sticky ends), which contain 
3’-hydroxyl and 5’-phosphate ends. For analytical cleavage, a maximum of 1 μg DNA was 
incubated at 37 °C in the appropriate buffer with 20 U of each restriction enzyme for about 
2 h in a volume of 50 μL. For preparative cleavage, with the objective of subsequent 
ligation, 2 μg or the entire amount of PCR product and 2 μg of vector DNA were digested 
with 20 U of each restriction enzyme in a volume of 50 μL at 37 °C for 2 h. The volume of 
added restriction endonuclease in the reaction mixture should not exceed 10% of the total 
volume, as the activity of enzymes is influenced by glycerol, a component of the enzyme 
storage solution. The fragments were purified by agarose gel electrophoresis (chapter 4.3.3) 
for subsequent ligation (chapter 4.3.5.2). 
 
4.3.5.2 Ligation of DNA fragments 
For ligation, digested vector and insert were mixed at an estimated molar ratio of 1:3 and 
ligated in a total volume of 20 μL with 1 U T4-DNA ligase (FERMENTAS) in the buffer 
supplied by the manufacturer, either overnight in a thermal cycler at 16 °C or for 1 h at RT. 
Subsequently, competent E. coli cells were chemically transformed (chapter 4.2.3) with the 
ligation mixture. 
 
4.3.6 Amplification of DNA fragments by standard polymerase chain reaction  
The polymerase chain reaction (PCR) (Mullis & Faloona, 1987; Saiki et al., 1988) is used 
to amplify a specific DNA fragment in vitro. This is achieved by cyclic repetition of the 
denaturation of the dsDNA, followed by the hybridization (annealing) of primers (synthetic 
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oligonucleotides that flank the DNA sequence of interest) and enzymatic DNA synthesis 
(extension). The DNA fragment is exponentially amplified. The reaction was performed in 
a total volume of 50 μL in a thermal cycler (lid temperature 110 °C). The standard reaction 
mixture contained 5-100 ng of template DNA, 2.5 U GoTaq DNA polymerase, 5 x Green 
GoTaq reaction buffer [contains 7.5 mM MgCl2 (final concentration: 1.5 mM MgCl2) and 
loading buffer], 0.2 mM dNTP mix, and 1 μM of each primer. For a high accuracy during 
the amplification, 2.5 U Pwo polymerase, which has a 3’→5’ proofreading activity, was 
added to the reaction mixture. The standard PCR program was as follows: 
 
step temperature (°C) duration 
1. Initialization step 95 3 min 
2. Denaturation 95 45 s 
3. Annealing TA 45 s 
4. Extension 72 1 min/kb 
5. Final elongation 72 10 min 
6. Final hold 16 ∞ 
Steps 2 to 4 were repeated 30-35 times.  
 
The optimum melting temperature Tm and annealing temperature TA of the primers were 
calculated according to Equation 3 and Equation 4 (Chester & Marshak, 1993). 
 
ெܶ ൌ 69.3	 ൅ 0.41	 ∙ ሺ%ܩܥሻ െ	650݊  
Equation 3: Calculation of the melting temperature of oligonucleotides. 
TM   melting temperature of primers (°C) 
%GC   GC content of primers 
n   number of nucleotides in primers 
 
஺ܶ ൌ 	 ൬ ெܶଵ ൅	 ெܶଶ2 ൰ െ 3	°ܥ 
Equation 4: Calculation of the optimum annealing temperature of a primer. 
TA   annealing temperature (°C) 
TM1, TM2  melting temperatures of primers (°C) 
The optimum annealing temperature was also experimentally determined using a thermal 
cycler with gradient function (EPPENDORF Mastercycler gradient). To this end, different 
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PCRs with annealing temperatures between 50 °C and 70 °C were set up in parallel, and the 
yields of the amplification products were determined. 
4.3.7 Colony PCR 
To verify the success of cloning, an insert screening was performed by colony PCR. 
Transformants grown on selective LB agar were added to the PCR mixture by picking a 
single colony with a pipette tip and transferring small quantities of cells to the reaction 
mixture. The cells were subsequently disrupted in the initial denaturation step at 95 °C, and 
the released DNA was used as template in the following amplification cycles. Vector-
specific amplification primers were used. The standard reaction mixture included 1 U 
GoTaq DNA polymerase, 5 x Green GoTaq reaction buffer, 0.2 mM dNTP-mix, 1 μM of 
each primer, and water to a final volume of 20 μL. The amplification was performed 
according to the standard PCR protocol described in chapter 4.3.6. 
 
4.3.8 QuikChange site-directed mutagenesis 
The QuikChange site-directed mutagenesis (QCM) method allows for the efficient 
introduction of point mutations, insertions and deletions in any type of dsDNA plasmid. It 
is performed using Pfu DNA polymerase, which replicates both plasmid strains with high 
fidelity due to its 3’→5’ proofreading activity. The technique originally developed by 
STRATAGENE (La Jolla, USA) was modified according to a protocol published by Wang 
and Malcolm (1999) using a two-stage mutagenesis protocol. For introduction of point 
mutations, complementary mutagenic primers with up to 35 bases in length and 12-15 bases 
of template complementary sequence on both sides of the mismatch were used. Pfu DNA 
polymerase extends and incorporates mutagenic primers during temperature cycling and 
generates a mutated plasmid containing staggered nicks. To avoid unproductive primer 
dimer formation, two separate primer extension reactions were performed initially. In the 
second step both primer extension reactions are combined and linearly amplified. 
Methylated DNA template is digested by treatment of the product with DpnI. E. coli cells 
are transformed with the nicked vector DNA carrying the desired mutations, and the nicks 
are sealed by the DNA repair apparatus of the cells. See Figure 6 for illustration. 
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Figure 6: Overview of the QuikChange site-directed mutagenesis method.  
In the first step the mutated plasmids containing staggered nicks are generated in two parallel primer 
extension reactions (E1 and E2). The reactions E1 and E2 are combined and amplified. In the second step, the 
DNA template is digested by treatment with DpnI, and E. coli cells are transformed with the nicked vector 
DNA containing the desired mutations. The figure was adapted from the QuikChange Site-Directed 
Mutagenesis Kit manual (STRATAGENE). 
 
The two separate primer extension reactions (E1 and E2) were performed each in a total 
volume of 50 μL containing 50 ng of template plasmid comprising the gene of interest, 
2.5 U Pfu DNA polymerase, 10 x Pfu DNA polymerase reaction buffer [contains 20 mM 
MgCl2 (final concentration: 2 mM MgCl2)], 0.2 mM dNTP mix, and 1.6 μM of either the 5’ 
or 3’ primer. The standard primer extension program using Pfu DNA polymerase was as 
follows: 
 
step temperature (°C) duration 
1. Initialization step 95 3 min 
2. Denaturation 95 45 s 
3. Annealing TA 1 min 
4. Extension 72 2 min/kb 
5. Final elongation 72 10 min 
6. Final hold 16 ∞ 
Steps 2 to 4 were repeated four times. 
 
Subsequently, 25 μL of each primer extension reaction (E1 and E2) were mixed, 
supplemented with additional 2.5 U Pfu DNA polymerase and subjected to 18 cycles of 
QCM as described above. The methylated template DNA was digested by directly adding 
20 U DpnI to 25 μl of the QCM reaction mix and incubated at 37 °C for 1.5 h. Then, 
chemically competent E. coli Turbo cells were transformed using 10 μL of DpnI-digested 
QCM mix.  
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4.3.9 Overlap Extension PCR (Ho et al., 1989) 
Site-directed mutagenesis by overlap extension PCR (OE-PCR) uses two complementary 
mutagenic primers with a length of 25-35 bp that are complementary to the target DNA and 
comprise the nucleotide changes in the central region of their sequences. The first two 
separate PCRs generated two overlapping fragments carrying the desired mutation, using a 
set of mutagenic primer and flanking primer each. These mutagenic fragments were 
subsequently purified by preparative gel electrophoresis (chapter 4.3.3 & 4.3.5). The gel-
purified fragments were used as templates in combination with the flanking primers to 
amplify the entire gene. The amplification was carried out according to the standard 
protocol described in chapter 3.3.5. For an illustrating scheme see Figure 7. 
 
 
Figure 7: Scheme for standard OE-PCR.  
In the first step the 5’ and 3’ fragments are amplified in two separate PCRs with a gene flanking primer and a 
mutagenic primer using the target DNA as template. In the second step the fragments served as template and 
the mutagenized full length construct is amplified using the flanking primers. 
 
4.3.10 DNA sequencing 
All constructs generated and used in this work were sequenced to validate the sequences. 
The determination of nucleotide sequences was performed by the company Seqlab 
(Göttingen). Samples for sequencing orders at Seqlab contained about 600 ng DNA and 
2 μM of sequencing primer in a total volume of 15 μL. The generated .ABI files were 
analyzed by the program CLC main workbench. 
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4.3.11 Gene synthesis  
Gene sequences for the reconstructed proteins (LUCA-HisH, Anc1pa-HisF, Anc1pa-HisF*, 
Anc1tm-HisF, Anc2tm-HisF, Anc2tm-HisF_A1, and Anc2tm-HisF_A2) were optimized for 
expression in E. coli and synthesized by the company Geneart (THERMO FISHER 
SCIENTIFIC, Regensburg). Genes were sent as GeneArt Strings DNA fragments with 
NdeI/XhoI restriction sites.  
 
4.4 Protein biochemistry methods 
4.4.1 Gene expression 
4.4.1.1 Gene expression at analytical scale 
To test, whether cloned genes are overexpressed and in order to analyze whether the 
recombinant proteins were produced in soluble form, expression was performed at 
analytical scale. To this end, 5 mL LB medium were supplemented with the appropriate 
antibiotics, inoculated with an overnight culture of a single colony to an OD600 of 0.1, and 
incubated at 37 °C and 220 rpm. At an OD600 of 0.4-0.6, the cultures were induced by 
adding IPTG to a final concentration of 0.5 mM. Following incubation at 30 °C and 20 °C 
overnight, 1.5 mL of the cell suspension were centrifuged (EPPENDORF Centrifuge 
5415R, 4000 rpm, 10 min, 4 °C). The pellet was resuspended in 350 μL of 50 mM 
potassium phosphate pH 7.5. The cells were disrupted by sonication (amplitude 20%, 30 s, 
2 s intervals, 4 °C). Following centrifugation (EPPENDORF Centrifuge 5415R, 13200 rpm, 
5 min, 4 °C) the supernatant (containing soluble protein) was taken off, and the pellet 
(containing insoluble protein) was resuspended in 350 µL of the resuspension buffer. 
100 µL of the supernatant were subjected to a heat step (70 °C/15 min) and subsequently 
centrifuged (EPPENDORF Centrifuge 5415R, 13200 rpm, 5 min, 4 °C). Aliquots of the 
supernatant (S), the heat step (HS), and the resuspended pellet (P) were supplemented with 
SDS sample buffer (5 x), and incubated for 5 min at 95 °C. Subsequently, a volume of 5-
10 μL of S, HS and P was analyzed by SDS-PAGE (chapter 4.5.2). 
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4.4.1.2 Gene expression at preparative scale 
For purification of proteins at preparative scale, 1 to 6 liters LB or minimal medium as 
given in chapter 3.11 (15N-tmHisF) was supplemented with the corresponding antibiotics. 
The medium was inoculated with a freshly prepared overnight E. coli culture to an OD600 
value of 0.1. The suspension was incubated at 37 °C and 140 rpm. At an OD600 of 0.4-0.6 
the suspension was induced with 0.5 mM IPTG and cells were grown at 30 °C (HisF 
proteins, paHisH, tmHisH, tmHisA, LUCA-HisH and LUCA-HisH mutants) or 20 °C 
(zmHisH and zmHisH mutants). The cells were harvested by centrifugation (BECKMANN 
COULTER Avanti J-26SXP, JLA-8.1000, 20 min, 4000 rpm, 4 °C), and the pellet was 
resuspended in resuspension buffer (chapter 3.10.3). Cells were disrupted by sonication on 
ice (HEINEMANN branson sonifier W-250D, 3 min in 5 s intervals, 45% pulse, 0 °C). The 
cell depris was removed by centrifugation (BECKMAN COULTER Avanti J-26SXP, JA-
25.50, 30 min, 13000 rpm, 4 °C) and the supernatant was further processed. 
 
4.4.2 Protein purification 
A heat step, metal affinity chromatography, ion exchange chromatography and preparative 
size exclusion chromatography were used for protein purification. Subsequently, the buffer 
was exchanged by dialysis. The proteins were concentrated by ultrafiltration (MILLIPORE, 
Amicon 10 kDa cut-off) and stored at -80 °C. 
 
4.4.2.1 Heat step 
TmHisH, paHisH, LUCA-HisH, and 15N-tmHisF proteins were purified by a heat step. For 
this purpose, the solution of soluble proteins was heated in a waterbath for 15 to 20 min at 
70 °C. Aggregated host cell proteins were subsequently removed by centrifugation 
(BECKMAN COULTER Avanti J-26SXP, JA-25.50, 30 min, 13000 rpm, 4 °C). 
 
4.4.2.2 Metal affinity chromatography  
Metal affinity chromatography is based on specific, reversible interactions between proteins 
and immobilized metal ions. The columns consist of sepharose and a covalently linked 
iminodiactetic acid (IDA)-type chelator. IDA coordinates metal ions such as Ni2+, Cu2+, 
Fe3+, and Co2+. Nitrogen and sulfur atoms can bind to the free binding sites at the metal 
ions.  
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In the framework of this thesis, proteins with a C-terminal hexahistidine tag (His6-
tag) (LUCA-HisH wt and mutants) were purified on a HisTrap FF crude Ni2+-IDA column 
(GE HEALTHCARE, CV: 5 mL, pressure limit: 0.3 MPa). Bound proteins were eluted by 
increasing concentrations of imidazole, which competes with the histidines for binding to 
the immobilized Ni2+ ions. Protein samples were sterile filtered (0.45 μm) and applied on 
the HisTrap FF crude column in an Äkta chromatographic system.  
The purification with the HisTrap FF was performed using the chromatographic 
system ÄKTA Purifier 10 (GE HEALTHCARE) as follows (Table 5). 
 
Table 5: Protocol for protein purification with HisTrap column. 
flow rate 4 mL/min 
equilibration 2 column volumes (CV) binding puffer1 
sample application 40-200 mL protein solution in resuspension buffer2 
wash 10 CV 
elution 15 CV gradient from 0-75% elution buffer3; 2 mL fractions were collected
final wash-out 5 CV elution buffer 
reequilibration 3 CV binding buffer 
purging and storage 3 CV H2O, 3 CV 20 % ethanol 
150 mM potassium phosphate pH 7.5, 300 mM KCl, 10 mM imidazole or 50 mM Tris/HCl pH 7.5, 300 mM 
KCl, 10 mM imidazole. 
2Resuspension buffer and binding buffer were identical 
3The elution buffer is identical with the binding buffer except that it contains 500 mM imidazole.  
 
The elution of protein was monitored by following the absorbance at 260 and 280 nm. The 
eluted fractions were analyzed by SDS-PAGE (chapter 4.5.2). 
 
4.4.2.3 Ion exchange chromatography 
Ion exchange chromatography is based on the competition of charged molecules (proteins 
and salt ions) for interaction with immobilized ion exchange groups of opposite charge. In 
the first stage, charged molecules adsorb reversibly to the immobilized support material. 
Subsequently, bound molecules are eluted by a gradient of steadily increasing ionic 
strength, or alternatively a pH-gradient. The charge of the protein is mainly dependent on 
the amino acids with charged side chains. In the acidic or neutral pH-range the amino 
groups, mainly those of Lys, Arg, and His, are protonated and the protein exposes cationic 
behavior, whereas in a neutral or basic pH-range, the carboxyl groups of Asp and Glu 
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residues are negatively charged and consequently the protein is anionic. The total charge of 
proteins is mainly dependent on the amino acid composition and the pH-value of the 
surrounding buffer. Ion exchange chromatography can be subdivided into cation exchange 
chromatography, in which positively charged ions bind to a negatively charged resin, and 
anion exchange chromatography, where negatively charged ions bind to a positively 
charged resin.  
All HisF proteins, tmHisH, zmHisH and zmHisH mutants were purified using an 
anion exchange column (Mono Q HR 16/10, GE HEALTHCARE, 20 mL). PaHisH was 
purified using a cation exchange column (Resource S, GE HEALTHCARE, 1 mL). Protein 
samples were steril filtered (0.45 μm) and applied on the column using the chromatographic 
system ÄKTA Purifier 10 (GE HEALTHCARE). 
The purification with the Mono Q column was performed as follows (Table 6). 
 
Table 6: Protocol for protein purification with Mono Q column. 
flow rate 5 mL/min 
equilibration 1 CV binding buffer1 
sample application 40-200 mL protein solution in resuspension buffer2 
wash 10 CV binding buffer 
elution 15 CV gradient from 0-75% with elution buffer3; 4 mL fractions were collected 
final wash-out 2 CV elution buffer 
reequilibration 3 CV binding buffer 
purging and storage 5 CV H2O, 3 CV 20% ethanol 
150 mM potassium phosphate pH 7.5 (HisF proteins) or 7.8 (tmHisH); 50 mM Tris/HCl pH 9.0  
(zmHisH and zmHisH mutants) 
2Resuspension buffer and binding buffer were identical 
3The elution buffer is identical with the binding buffer except that 3 M NaCl is added. 
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The purification of paHisH with the Resource S column was performed as follows (Table 
7). 
 
Table 7: Protocol for protein purification with Resource S column. 
flow rate 1 mL/min 
equilibration 5 CV 50 mM Tris/HCl pH 7.5 
sample application 20 mL protein solution in 50 mM Tris/HCl pH 7.5 
wash 5 CV 50 mM Tris/HCl pH 7.5 
elution 15 CV gradient from 0-100% with 50 mM Tris/HCl pH 7.5, 3 M NaCl; 
1 mL fractions were collected 
final wash-out 5 CV 50 mM Tris/HCl pH 7.5, 3 M NaCl 
reequilibration 3 CV 50 mM Tris/HCl pH 7.5 
purging and storage 5 CV H2O, 3 CV 20% ethanol, 0.2 M NaAc 
 
The elution was monitored by following the absorbance at 260 and 280 nm. The eluted 
fractions were analyzed by SDS-PAGE (chapter 4.5.2).  
 
4.4.2.4 Ammonium sulfate precipitation  
Ammonioum sulfate precipitation (ASP) is an efficient method used for initial sample 
concentration and cleanup. In this work, ASP was used to purify proteins from DNA 
impurities after anion exchange chromatography. During ASP, proteins will salt out as 
increased salt concentrations enhance hydrophobic interactions between proteins, whereas 
nucleic acids remain soluble.  
In a first step, protein was desalted by dialysis (chapter 4.4.3) before it was subjected to 
ASP. Subsequently, (NH4)2SO4 was added to a final concentration of 80% saturated 
solution, portion-wise as crystalline salt using a spatula, while stirring vigorously on ice. 
The amount of (NH4)2SO4 was calculated using the weblink provided by EnCor 
Biotechnology Inc (Gainesville, USA; http://www.encorbio.com/protocols/AM-SO4.htm). 
The suspension was stirred for a further hour at 4 °C and subsequently centrifuged 
(BECKMAN COULTER Avanti J-26SXP, JA-25.50, 30 min, 13.000 rpm, 4 °C). The 
pellet, containing the protein of interest, was dissolved in 8-10 mL of the buffer used in 
subsequent preparative size exclusion chromatography (chapter 4.4.2.5). 
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4.4.2.5 Preparative size exclusion chromatography 
Size exclusion chromatography is based on the principle of a reverse molecular sieve. 
When the mobile phase passes through the porous support material at a constant flow rate, 
small molecules are able to diffuse into the pores, while larger molecules are excluded. As a 
consequence, small molecules are retarded with respect to larger molecules, which cause 
proteins to be separated according to their size. In this work, preparative gel filtration was 
performed with the ÄKTA prime (GE HEALTHCARE) at 4° C, using a Superdex 75 (GE 
HEALTHCARE, HiLoad 26/600, 320 mL). The column consists of highly cross-linked 
porous agarose beads (mean particle size: 34 μm) to which dextran has been covalently 
bound. Protein samples were sterile-filtered (0.45 µm) and applied on the column by a 
10 mL sample loop. In the case of HisF proteins the column was run with 50 mM 
potassium phosphate pH 7.5; for the purification of tmHisH 300 mM KCl was added to the 
buffer. In the case of zmHisH and zmHisH mutants, the column was run with 50 mM 
Tris/HCl pH 7.5, 300 mM KCl. Proteins were eluted with 1.2 CV of the respective buffer at 
a flow rate of 1.5 ml/min (back pressure: max. 0.38 MPa). The run was recorded using a 
manual plotter, which measured the absorbance at 280 nm. The fraction collector was 
started at the beginning of the elution, and fractions of 4 ml volume were collected. The 
fractions were further analyzed by SDS-PAGE (chapter 4.5.2).  
 
4.4.3 Buffer exchange by dialysis 
To exchange the buffer of a protein solution or to remove salt, a dialysis was performed two 
times for at leat 4 hours against a 100-fold volume excess of buffer at 4 °C in the cold 
room. A dialysis tubing (Visking) with a molecular cut-off of 14 kDa was used, which 
retains the protein while low molecular substances can pass through the membrane. 
Commonly, HisF and HisH proteins were dialyzed against 50 mM potassium phosphate pH 
7.5 and 50 mM Tris/HCl pH 7.5, respectively. TmHisH and LUCA-HisH wt were dialyzed 
against 10 mM potassium phosphate pH 7.5. For NMR measurements 15N-tmHisF was 
dialyzed against 15 mM Tris/HCl pH 7.5. 
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4.4.4 Concentrating protein solutions 
Protein solutions were concentrated using Amicon Ultra-15 centrifugal filter devices 
(MILLIPORE; molecular cut-off: 10 kDa; for complexes 30 kDa) by centrifugation 
(EPPENDORF Centrifuge 5810R, 4000 rpm, 4° C) according to the instructions of the 
manufacturer. 
 
4.4.5 Storage of purified proteins 
Purified and concentrated proteins were frozen in liquid nitrogen either dropwise or as 
500 μL aliquots (for NMR spectroscopy) in reaction vessels and stored at -80° C. 
 
4.4.6 Synthesis of ProFAR 
PRFAR is labile and spontaneously hydrolyzes (Klem & Davisson, 1993). Therefore, 
PRFAR was synthesized from N´-[(5´-phosphoribosyl)formimino]-5-aminoimidazole-4-
carboxamide-ribonucleotide (ProFAR) in situ with tmHisA (Beismann-Driemeyer & 
Sterner, 2001). ProFAR is moderately stable (Henn-Sax et al., 2002) and can be stored at -
80 °C for a limited period. ProFAR was produced according to Davisson et al. (1994) from 
ATP and PRPP, precursors of histidine biosynthesis, in an enzymatic reaction with ATP- 
phosphoribosyltransferase (HisG) and phosphoribosyl-ATP 
pyrophosphohydrolase:phosphoribosyl-AMP cyclohydrolase (HisIE) from E. coli. The 
reaction mixture with a final volume of 10 mL contained 6 mg ATP, 12 mg PRPP, and 
15.2 mg MgCl2 in 50 mM Tris/Ac pH 7.8. The enzymatic reaction was started by adding 
about 2 mg HisG-IE (dissolved in 50 mM potassium phosphate pH 7.5, 2.5 mM EDTA and 
1 mM DTT) while stirring vigorously. At regular intervals, spectra were recorded in a 
wavelength interval from 200 to 400 nm. An increase of absorption at 290 nm is 
characteristic for the formation of ProFAR. When there was no further change in absorption 
at 290 nm, ProFAR was isolated from the reaction mixture via anion exchange 
chromatography on a Poros HQ-20 column (CV of 7.9 mL). For this purpose, the column 
was equilibrated with 50 mM Tris/Ac pH 8.0 and ProFAR was eluted with a linear gradient 
of acetate (0-1 M, 12 CV, 4 mL fractions). ProFAR concentration was determined via 
absorption at 300 nm  (ε300 = 6069  M-1cm-1) (Klem & Davisson, 1993) and purity was 
estimated with the help of A290/A260, with values between 1.1 and 1.2 being optimal (Smith 
& Ames, 1964). Fractions with pure ProFAR were pooled and stored as 1 mL aliquots at -
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80°C. In the case that ProFAR was lyophilized, the anion exchange column was 
equilibrated with 50 mM ammonium acetate pH 7.8. ProFAR was eluted with a linear 
gradient of acetat as described above. After determining concentration and purity, ProFAR 
was pooled and aliquots were lyophilized. All steps were carried out under exclusion of 
light.  
 
4.4.7 Peptide synthesis 
The peptide for NMR titration experiments (Ac-ARVRYYQSLQAHLKVG-NH2) was 
ordered from JPT Peptide Technologies (Berlin) with a purity of > 95%, an acetylated N-
terminus and an amidated C-terminus and chloride as counter ion. For titration experiments, 
a solution of 30 mM in 15 mM Tris/HCl pH 7.5 in perdeuterated DMSO (97%) was 
prepared. 
4.5 Analytical methods 
4.5.1 Protein concentration determination via absorption spectroscopy 
The aromatic amino acids Trp, Tyr and Phe as well as disulfide bonds (cystine) absorb UV-
light in a wavelength interval between 250 and 300 nm. The molar extinction coefficient at 
280 nm (ɛ280) can be determined from the amino acid composition (Pace et al., 1995) 
(Equation 5).  
 
ߝଶ଼଴ ൌ 	෍ܶݎ݌ ∙ 5500 ൅෍ܶݕݎ ∙ 1490 ൅෍ܥݕݏݐ݅݊݁	 ∙ 125 
Equation 5: Determination of the molar extinction coefficient ε280. 
ε280   molar extinction coefficient at 280 nm [M-1cm-1]. 
The specific extinction coefficient (0.1%A280) can be calculated according to Equation 6 
taking the molecular weight into account. 
 
ܣଶ଼଴ ൌ 	 ߝଶ଼଴ܯܹ
଴.ଵ%  
Equation 6: Determination of the specific extinction coefficient 0.1%A280. 
0.1%A280  specific extinction coefficient at 280 nm [cm2/mg] 
MW   molecular weight [g/mol] 
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Using Lambert-Beer’s law, the protein concentration can be determined by measuring the 
absorbance at 280 nm (Equation 7). 
 
ܣଶ଼଴ ൌ 	 ܣଶ଼଴଴.ଵ% ∙ ܿ ∙ ݀ 
ܿ ൌ 	 ܣଶ଼଴ܣଶ଼଴଴.ଵ% ∙ ݀	 
Equation 7: Determination of the protein concentration by using the specific extinction coefficient 
0.1%A280. 
A280   absorbance at 280 nm 
c   concentration [mg/mL] 
d   pathlength [cm] 
0.1%A280  specific extinction coefficient at 280 nm [cm2/mg] 
Absorbance spectra were recorded between 220 and 350 nm. The absorbance maximum 
should be at 278 nm and the A280/A250 ratio should be at least 1.8 for a pure protein 
solution. No absorbance above 300 nm should be detectable to exclude any distortion of the 
results caused by light scattering resulting from aggregation. 
 
4.5.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins are denatured by the detergent sodium dodecyl sulfate (SDS) and negatively 
charged proportional to their molecular weights. SDS binds to the protein in a ratio of 
approximately one molecule SDS per 1.4 amino acid residues. The net charge of proteins 
can be neglected compared to the negative charge of the protein complexed with SDS, 
which yields an approximately uniform mass to charge ratio. As a consequence, 
electrophoretic mobility depends only on the sieve effect of the gel: the migration speed is 
inversely proportional to the logarithm of mass (Laemmli, 1970). Table 8 shows the 
composition of the 12.5% SDS gels used in this work. 
 
Table 8: Composition of 12.5% SDS-PAGE gel.  
Amount specification applies to 13 gels. 
 resolving gel (12.5%) stacking gel (6%) 
resolving/sacking gel buffer 19.5 mL 7.38 mL 
acrylamide-SL (30%) 26.2 mL 5.9 mL 
H2O 31.58 mL 15.95 mL 
TEMED 0.089 mL 0.029 mL 
APS (10%) 0.195 mL 0.089 mL 
56 Methods 
 
 
Samples were supplemented 1:4 with 5 x SDS-PAGE sample buffer and incubated for 
5 min at 95 °C. Gel pockets were loaded with 5-20 μL of sample, and gels were run at 
50 mA and 300 V for about 30 min. Subsequently, gels were stained with SDS-PAGE 
staining solution, whereby the detection limit of the Coomassie Brilliant Blue dye G-250 is 
between 200-500 ng protein/mm2. Gels were swayed for 10 min in the staining solution and 
excess dye was removed by repeatedly boiling in water (microwave 900 W). 
 
4.5.3 Analytical size exclusion chromatography 
Apparent molecular weights (MWapp) of proteins were determined by analytical size 
exclusion chromatography. Proteins are separated according to their size. The retention 
volume decreases approximately linear with the logarithm of the molecular weight. 
Globular calibration proteins were used for a standard curve in order to determine the 
apparent molecular weights (chapter 8.7). In this work, a Superdex 75 10/300 GL (GE 
HEALTHCARE, 23.56 mL) was used with an Äkta Basic 10 better (GE HEALTHCARE) 
chromatographic device. Protein samples were centrifuged (EPPENDORF 5415R, 14000 
rpm, 30 min, 4° C) and applied on the pre-equilibrated column, which was run with 50 mM 
Tris/HCl pH 7.5, 300 mM KCl. The elution was followed by absorbance measurement at 
280 nm.  
 
4.5.4 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy in the far-UV range is used to analyze the secondary 
structure of proteins. Right- and left-circular polarized light are absorbed to a different 
extent when passing through a solution of chiral molecules. As a result, the circular 
dichroism signal over the corresponding wavelengths can adopt positive and negative 
values. Different secondary structure elements like α-helix, β-sheet and random coil have 
characteristic CD spectra in the range of 170-250 nm. In this work, far-UV circular 
dichroism spectra of all proteins were recorded in a JASCO J-815 spectrometer. The 
spectra were measured with 20 μM or 30 μM HisF protein in 10 mM or 50 mM potassium 
phosphate, pH 7.5, in a 0.02 cm cuvette at 25 °C. The curves are the result of five 
accumulations and were smoothed. Data were normalized to obtain the molar ellipticity per 
amino acid according to Equation 8 (Schmid, 1997): 
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ߠெோௐ ൌ 	 ߠ௢௕௦ܿ	 ∙ ݀	 ∙ 	 ஺ܰ 	 ∙ 10 
Equation 8: Calculation of mean molar ellipticity per amino acid. 
ΘMRW  mean molar ellipticity per amino acid (deg · cm2 · dmol-1) 
Θobs  measured ellipticity (mdeg) 
c   protein concentration (M) 
d   pathlength (cm) 
NA   number of amino acids 
The change in ellipticity at 220 nm with increasing temperature was observed to determine 
the thermostability of proteins. Thermal denaturation curves were recorded for 9-12 µM 
protein in 50 mM potassium phosphate pH 7.5. Data were fitted with the two-state model. 
 
4.5.5 Fluorescence titration 
Upon complex formation with HisF, a conserved Trp residue of HisH is shielded from the 
solvent (Beismann-Driemeyer & Sterner, 2001), which leads to a blueshift of the Trp 
fluorescence maximum from about 345 nm to about 330 nm. The concomitant increase of 
the fluorescence emission at 318 nm was used in titration experiments to determine the 
dissociation constants for the formation of the various HisF:HisH complexes. For this 
purpose, 5 μM HisH were titrated at 25 °C with various Trp-free HisF variants in 50 mM 
potassium phosphate pH 7.5. The Trp fluorescence was excited at 295 nm and the 
fluorescence emission intensity at 318 nm in dependence of the applied HisF concentration 
was followed. As the addition of HisF led to a fluorescence emission background signal at 
318 nm, all titrations were corrected for this signal. The corrected fluorescence at 318 nm 
was plotted against the HisF concentration and the resulting curves were analyzed with a 
quadratic fit (Equation 9).  
 
ܨ ൌ 	ܨ଴ ൅ 12 ሺܨ௠௔௫ െ ܨ଴ሻ ∙ ቌ1 ൅
ܮ଴ ൅ ܭௗ
ܧ଴ െ
ඨቆ1 ൅ ሺܮ଴ ൅ ܭௗሻܧ଴ ቇ
ଶ
െ 4 ∙ ܮ଴ܧ଴ቍ 
Equation 9: Quadratic function for Kd determination. 
F   measured fluorescence intensity 
F0   initial fluorescence signal 
Fmax   fluorescence signal at saturation 
L0   concentration of HisF 
E0   concentration of HisH 
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For the illustration of the curves, the normalized fluorescence signal was plotted against the 
molar ratio of HisF/HisH, and only the data points until a molar ratio HisF/HisH of 2 are 
shown. All titrations were done in duplicate at a Cary-Eclipse fluorimeter (VARIAN, 
Darmstadt). For high-affinity complexes, only an upper limit of Kd < 50 nM can be given 
(Figure 8). 
 
 
Figure 8: Comparison of data of tight binding LUCA-HisF:zmHisH fitted with increasing Kd-values.  
A) Kd set at 0.5 and 5 nM B) Kd set at 50 nM C) Kd set at 300 nM. Quadratic fits with Kd > 50 nM deviate 
from the data points. Kd < 50 nM fit well to the data points. Thus, for high-affinity complexes only a Kd < 50 
nM can be given. 
 
4.5.6 Steady-state enzyme kinetics 
For functional characterization of diverse HisF:HisH complexes steady-state enzyme 
kinetics were measured at 25 °C. Recorded were ammonia- and glutamine-dependent HisF 
reaction and glutaminase HisH reaction. In order to guarantee that the characterized subunit 
is completely complexed, an excess of the other subunit was added.  
 
4.5.6.1 Ammonia-dependent cyclase activity 
Ammonia- and glutamine-dependent HisF reactions were followed as a decrease in 
absorption at 300 nm. Initial velocities (vi) were calculated via the initial slope of each 
conversion curve  with the help of Δε300 (PRFAR-AICAR) = 5637 M-1s-1 (Klem & 
Davisson, 1993). As the substrate PRFAR is very labile, the more stable biological 
precursor ProFAR was used to generate PRFAR in situ by adding an excess of tmHisA. For 
each data point, the total PRFAR concentration was determined via the absorption 
difference between the start and the end of the reaction. Below a PRFAR concentration of 
0.5 µM an accurate determination of vi was difficult due to low absorption signal. Thus, in 
the case that the KmPRFAR was lower than that, only vi-values at PRFAR saturation (0.5-
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5 µM) were determined and the maximum velocity (vmax) was defined as the average of 
these vi-values. Kcat was finally calculated via vmax/[E0] with E0 being the total 
concentration of enzyme. If vi-values at PRFAR concentrations under KmPRFAR could be 
determined, complete Michaelis-Menten curves were recorded and the data points were 
fitted with a hyperbolic equation, yielding Km and vmax. 
For the characterization of ammonium-dependent HisF reaction, ammonium acetate 
(NH4+Ac; 100 mM) was used as ammonium source. According to the Henderson-
Hasselbalch equation 100 mM NH4+Ac in 50 mM Tris/Ac at pH 8.5 result in about 17 mM 
ammonia. Complete conversion curves were recorded under ammonia saturation at various 
PRFAR concentrations and the kinetic parameters kcat and Km were determined as described 
above. 
 
Typical reaction conditions: 
100 mM NH4+Ac (saturation) 
variable PRFAR concentrations 
0.6 µM tmHisA 
in 50 mM Tris/Ac pH 8.5 
 
Catalytic parameters were determined in the absence of HisH. The reactions were started 
with 0.01–0.1 µM HisF. 
 
4.5.6.2 Glutamine-dependent cyclase activity 
The glutamine-dependent activity is the physiological reaction of the HisF:HisH complex. 
Glutamine is hydrolyzed to glutamate and ammonia, which is subsequently channeled to 
the active site of HisF, where it reacts with PRFAR to ImGP and AICAR. Complete 
conversion curves were recorded under glutamine saturation. Data points were recorded 
and KM and kcat were determined as described for ammonia-dependent activity. 
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Typical reaction conditions: 
8-20 mM glutamine; in the case of Anc2pa-HisF:paHisH 80 mM 
glutamine (saturation) 
variable PRFAR concentrations 
0.6 µM tmHisA 
in 50 mM Tris/Ac pH 8.0 
 
HisH was already in the mixture when HisF (0.01-0.1 µM) was added to start the reaction. 
 
4.5.6.3 Glutaminase activity 
The HisH subunit catalyzes the conversion of glutamine to glutamate and ammonia. As the 
glutaminase activity is only measurable in the presence of HisF and an activating ligand 
that is bound to the active site of HisF, ProFAR was added to the reaction mixture in 
saturating concentrations. The hydrolysis of glutamine to glutamate does not result in a 
change of absorption. Therefore, the reaction was coupled to the reduction of NAD+ to 
NADH via the glutamate dehydrogenase (GDH). The formation of NADH can be followed 
as an increase of absorption at 340 nm. Vi values were determined for various glutamine 
concentrations via the initial slope of each conversion curve with the help of Δε340 (NADH-
NAD+ ) = 6300 M-1s-1. 
 
Typical reaction conditions:  
40 µM ProFAR 
variable glutamine concentrations 
10 mM NAD+ 
1 mg/mL GDH 
in 50 mM Tricine/KOH pH 8.0 
 
Reactions were started with 0.01-1 µM HisF:HisH. As glutamine spontaneously hydrolyzes 
to glutamate the constant slope of the baseline was substracted from the initial slope of the 
enzymatic reaction.  
Glutaminase activity was tested under saturating glutamine concentrations in order 
to determine the ability of HisF proteins to allosterically stimulate various HisH proteins.  
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4.5.7 HPLC-analysis for the determination of basal glutaminase activity 
A qualitative high-performance liquid chromatography (HPLC) assay was used in order to 
determine if LUCA-HisH can hydrolyze glutamine to glutamate without being stimulated 
by the binding of PRFAR to LUCA-HisF. As neither glutamine nor glutamate can be 
detected spectrophotometrically, the amino acids have to be derivatized with light 
absorbing or fluorescent reagents. In this work, 9-fluorenylmethylchloroformate (FMOC-
Cl), which reacts with primary and secondary amines, was used as derivatizing agent 
(Melucci et al., 1999).  
For testing glutaminase basal activity, LUCA-HisF wt:LUCA-HisH and LUCA-
HisF wt:zmHisH were incubated in 50 mM Tricine/KOH pH 8.5 for 14 h at 25 °C with 
glutamine either in presence or in absence of ProFAR. As a negative control the complexes 
were incubated for 5 min at 100 °C and denatured protein was added to the reaction 
mixture. Each reaction mixture contained 10 µM complex, 10 mM glutamine and either 
100 µM or no PRFAR in a total volume of 100 µL. For derivatization of glutamine and 
glutamate, 25 µL of the enzymatic reaction was mixed with 600 µL of 0.2 M sodium borate 
pH 9.2 and 300 µL of an Fmoc-Cl solution in acetonitrile (1.7 mg/mL) and adjusted to 
1 mL with 50 mM Tricine/KOH pH 8.5. The samples were incubated for 30 min at RT and 
centrifuged for 2 h (EPPENDORF Centrifuge 5810R, 14000 rpm, 4 °C). 
The reaction samples were analyzed via reversed-phase (RP) chromatography. RP 
chromatography is used for the separation of analytes according to their polarity. The 
stationary phase of RP columns consists of silica particles, which are modified by long-
chain hydrocarbons. Analytes are retained on the column by hydrophobic interaction with 
the stationary phase. They are eluted by a decrease in the polarity of the mobile phase. 
Commonly, a gradient with increasing concentration of organic solvent is used for the 
separation of analytes.  
For the analysis of the reaction samples a C18 RP HPLC column (MERCK, 
LiChrospher 100 RP-18, 5µm, LiChroCART, 250x4mm) was used with a LaChrom 
(MERCK-HITACHI) chromatographic device and the following program (Table 9). 
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Solvent A: 50 mM sodium acetate pH 4.2 
Solvent B: acetonitrile 
Flow-rate: 0.5 mL/min 
Column temperature: RT 
Applied volume: 50 µL 
 
Table 9: Protocol for qualitative HPLC assay. 
Time/min 0 3 10 22.5 28 30 35 36 45 
% B 30 30 40 50 80 100 100 30 30 
 
Derivatized glutamine and glutamate standards were also applied to the column in order to 
determine the retention time for the amino acids. The retention time for derivatized 
glutamine was 12.3 min and for glutamate 14.3 min. 
 
4.5.8 Protein crystallization and X-ray structure determination 
Data collection and X-ray structure determination was performed in collaboration with Dr. 
Chitra Rajendran (group of Prof. Dr. Christine Ziegler, University of Regensburg). 
For complex crystallization the isolated HisF and HisH subunits were mixed in 
equimolar amounts and subjected to preparative size exclusion chromatography (chapter 
4.4.2.5). Subsequently, the pure complex was dialyzed against 10 mM potassium phosphate 
pH 7.5 and 1mM DTT. The protein was concentrated using an Amicon Ultra-15 centrifugal 
filter device (MILLIPORE; molecular cut-off: 30 kDa) (chapter 4.4.4). Protein 
crystallization was performed by hanging drop vapor diffusion methods using protein 
concentrations of 25-30 mg/mL. To explore various conditions, initial crystal screening was 
done using commercially available crystallization kits containing 96 unique conditions. 
Initial crystal screening was performed using an automatic robotic system, following 
manual refinement.  
LUCA-HisF wt:LUCA-HisH was crystallized using Morpheus II Screen 
(MOLECULAR DIMENSIONS, Suffolk). Crystals were obtained under the following 
conditions: rubidium chloride 0.01 M, strontium acetate 0.01 M, cesium acetate 0.01 M, 
barium acetate 0.01 M (all in all 4 mM of the mix of these additives), 30% w/v PEG 3000, 
40% v/v 1,2,4-butanetriol, 2% w/v NDSB 256 (all in all 50% of the mix of these 
precipitants). 
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Crystals of LUCA-HisF wt:tmHisH were obtained after manual refinement in 0.1 M 
sodium citrate pH 5.0 and 15% PEG 4000. For co-crystallization, the reservoir solution was 
supplemented with 20 mM glutamine. 
Single crystals were transferred to a cryo protectant solution and flash frozen in 
liquid nitrogen. Diffraction data were collected on-site at the Swiss Light Source (SLS; at 
Paul Scherrer Institute, Villigen, Switzerland). 
The data processing was done using XDS (Kabsch, 1993) and the data quality 
assessment was done using phenix.xtriage (Adams et al., 2002). Molecular replacement was 
performed with MOLREP within the CCP4i suite (Potterton et al., 2004) using 4EVZ 
(Reisinger et al., 2014) and 1K9V (Douangamath et al., 2002) as search model. Initial 
refinement was performed using REFMAC (Murshudov et al., 1997). The model was 
further improved in several refinement rounds using automated restrained refinement with 
the program PHENIX (Adams et al., 2002) and interactive modelling with Coot (Emsley & 
Cowtan, 2004). The final model was analyzed using the program MolProbity (Davis et al., 
2007). 
Details about data collection and refinement statistics for apo LUCA-HisF wt:tmHisH and 
glutamine-bound LUCA-HisF wt:tmHisH are given in the appendix (chapter 8.8). 
 
4.5.9 NMR spectroscopy 
[1H-15N] Heteronuclear Single Quantum Coherence (HSQC) experiments were conducted 
in order to localize the binding of a peptide at tmHisF in the tmHisF:tmHisH complex 
interface. Data collection and evaluation was performed in collaboration with Dr. Michael 
Spörner (group of Prof. Dr. Dr. Hans Robert Kalbitzer, Institute of Biophysics and Physical 
Biochemistry, University of Regensburg). 
The sample initially contained uniformly 15N isotopic labeled 1.2 mM HisF in 
15 mM Tris/HCl, pH 7.5, 2 mM DTE, 0.2 mM DSS, and 10% D2O. To this sample a 
30 mM solution of the peptide [Ac-ARVRYYQSLQAHLKVG-NH2 in 15 mM Tris/HCl 
pH 7.5 in perdeuterated DMSO (97%)] was added stepwise. 
NMR spectra were recorded with a Bruker Avance-800 NMR spectrometer 
equipped with a 5 mm TCI cryoprobe operating at 1H and 15N resonance frequencies of 
800.12 and 81.08 MHz, respectively. At every titration step (0, 0.3, 0.6, 0.9, 1.2, and 
1.5 mM of peptide in perdeuterated DMSO or the same volume of perdeuterated DMSO as 
control) a phase-sensitive [1H, 15N]-HSQC and a [1H, 15N]-TROSY-HSQC experiment 
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were performed at 298 K. Each 2D spectrum was recorded as a complex data matrix 
comprised of 2048 x 256 points using a spectral width of 11.200 Hz in the 1H-dimension 
and 3200 Hz in the 15N-dimension. 16 scans/FID were recorded using a recycle delay of 
2.2 s. Before and after each 2D experiment a 1D NOESY 1H NMR spectrum was recorded. 
1H chemical shifts were directly and 15N chemical shifts were indirectly referenced to DSS 
using a -value 10.1329118 (Wishart et al., 1995).The absolute temperature of 298 K inside 
the probe was calibrated by measuring the chemical shift difference  between the methyl 
and hydroxyl resonance of 100% methanol (Raiford et al., 1979). After processing the 
spectra, the assignment of Liebold et al. (2010) and Lipchock and Loria (2008) was 
transferred and the chemical shift values were determined using Auremol package 
(Auremol). 
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5 Results and Discussion 
5.1 Assessing the binding of a peptide to the HisF:HisH interface by 
means of [1H-15N] HSQC spectroscopy 
As a first step towards a better understanding of mechanistic principles in ImGPS, the 
binding of a peptide to tmImGPS was analyzed. The peptide inhibits the glutaminase 
activity of ImGPS and it was thought that it does so by binding to the HisF subunit in the 
tmHisF:tmHisH complex interface (Auburger, 2013). However, the concrete mode of 
inhibition is not clear yet. The identification of the HisF:peptide interface will not only give 
insight into the mode of inhibition of the peptide but might also provide information on 
mechanistic principles of the functionality of the ImGPS complex. 
 
5.1.1 Preliminary work and aim of this project 
As only plants, fungi, bacteria, and archaea are able to synthesize histidine, the inhibition of 
this biosynthetic pathway is a potential therapeutic strategy to fight pathogenic 
microorganisms or a strategy for the development of herbicides. HisF:HisH catalyzes the 
fifth and sixth step in histidine biosynthesis (Papaleo et al., 2009) and thus can serve as a 
possible drug target. The allosterically driven bi-enzyme complex has three sites at which 
inhibitory molecules can bind. The complex activity can be disrupted by blocking the 
glutaminase active site or the PRFAR binding site; moreover, complex formation and 
allosteric signal transduction can be perturbed by binding to the complex interface. The 
inhibition of complex activity with a molecule that binds to the interface can have 
advantages in comparison to the direct blockage of the HisF or HisH active sites. For 
example, an inhibitor that binds to the interface is more specific than a glutamine analogon, 
which might bind to glutaminase subunits from various GATases. For the design of such 
inhibitors the knowledge of interface hot spots is helpful, as thus key interactions in the 
interfaces can be specifically blocked (Fry & Vassilev, 2005). However, to date, the 
principles of protein-protein interaction in ImGPS are only poorly understood. In such a 
case, screening is a method of choice for the identification of effective interaction 
inhibitors.  
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Using an ultra high throughput screen (uHTS) of a library comprising 261292 
peptides, Auburger (2013) found a 16 amino acids comprising peptide that is a putative 
inhibitor of the protein-protein interaction of the ImGPS. The uHTS was based on the 
detection of the glutaminase activity of tmHisF:tmHisH-W123K. For this purpose, a 
fluorescence assay was used (McElroy et al., 2000). In the first step of this assay, the 
glutamate, which is formed by HisH after stimulation with ProFAR, is turned into ammonia 
and α-ketoglutarat by glutamate oxidase. ProFAR is the biological precursor of the cyclase 
substrate PRFAR. As PRFAR spontaneously hydrolyzes (Klem & Davisson, 1993), the 
more stable ProFAR is used as an activating ligand in the glutaminase assays. In a second 
step, H2O2, which is a product of the previous redoxreaction, is used by horseradish 
peroxidase to oxidize AmplexRed to Resofurin, which emits fluorescence light at 590 nm. 
For the assay the mutant tmHisH-W123K was used as it binds 90 times worse to tmHisF 
than the wild type (List, 2009), which increases the probability to detect peptides that 
inhibit the HisF:HisH interaction.  
In a first round of the screening, the glutaminase activity was determined via the 
fluorescence intensity, which was measured after 40 minutes of incubation of 
tmHisF:tmHisH-W123K with various peptides at a constant concentration. 1320 peptides 
showed significant reduction of fluorescence emission and thus of glutaminase activity 
compared to the complex without peptide. The peptides of this first hit set were then 
clustered according to similar amino acid patterns. The most potent representatives of each 
cluster were chosen for further analysis, resulting in 126 candidates. In a second round, for 
34 peptides the inhibitory effect could be confirmed and further tests ruled out that these 
peptides were direct inhibitors of the glutamate oxidase, the horseradish peroxidase, or of 
the active site of HisH. In order to exclude artifacts during peptide synthesis, 12 of the 34 
peptides were resynthesized (JPT; chapter 4.4.7) and characterized according to their 
inhibitory potential of the HisF:HisH interaction. Competitive inhibitory assays and ITC 
experiments were conducted in order to determine Ki and Kd-values. One of the eleven 
peptides (Ac-ARVRYYQSLQAHLKVG-NH2) which was identified as a putative 
competitive HisF:HisH interaction inhibitor with a Ki = 1.7 µM binds to the HisF subunit 
with a Kd = 3.2 µM. However, the exact location of the HisF:peptide interface was not 
clear.  
Thus, in the course of this work, NMR spectroscopy experiments were conducted in 
order to determine the binding of the peptide ligand to tmHisF. NMR is a highly sensitive 
method for the detection of protein-ligand interactions (Schumann et al., 2007) that does 
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not only detect the binding event itself but also allows for the localization of the binding 
interface. A common NMR technique for the detection of protein-ligand interactions is a 
2D HSQC titration experiment. In the titration experiment a 15N or 13C labeled protein is 
titrated with a ligand. At each titration step, a 2D HSQC experiment records shifts of all 
protons that interact with the ligand and the heteronuclei they are bound to. The experiment 
is performed via an INEPT (Insensitive Nuclei Enhanced by Polarization Transfer) 
sequence, which includes the transfer of magnetization from 1H, which is a highly sensitive 
NMR active nucleus to – in the case of this work – 15N, which is a nucleus of less 
sensitivity. In a reverse INEPT the magnetization is retransferred to the proton and a signal, 
which presents a characteristic 1H and 15N chemical shift, can be recorded (Pelton & 
Wemmer, 1995). In the course of this work, 15N labeled tmHisF was titrated with increasing 
amounts of the peptide and [1H-15N] HSQC spectra were recorded after each step (chapter 
4.5.9). [1H-15N] HSQC titration experiments and evaluation of the spectra were carried out 
by Dr. Michael Spörner (group of Prof. Dr. Dr. Kalbitzer, Institute of Biophysics and 
Physical Biochemistry, University of Regensburg).  
 
5.1.2 Expression and purification of 15N-tmHisF 
For the titration experiments, 15N labeled tmHisF was expressed in 1 liter of minimal 
medium which contained 1 g 15NH4Cl (chapter 3.11) in E. coli BL21-Gold (DE3) cells. In a 
first purification step, soluble E. coli proteins were precipitated by heating the cell extract 
(chapter 4.4.2.1). Subsequently the target protein was purified in three steps via anion 
exchange chromatography (chapter 4.4.2.3), ASP with 80% ammonium sulfate (chapter 
4.4.2.4) and size exclusion chromatography (chapter 4.4.2.5). Fractions with pure protein 
were pooled and dialyzed against 15 mM Tris/HCl pH 7.5 (chapter 4.4.3). According to 
SDS-PAGE (12.5% acrylamide), 15N-tmHisF was more than 95% pure (chapter 4.5.2). The 
yield was 70 mg pure protein per liter of expression medium.  
 
5.1.3 HSQC titration experiments of 15N-tmHisF with peptide 
15N labeled tmHisF was titrated with increasing amounts of peptide and chemical shift 
perturbation (CSP) was analyzed, using the software package Auremol (www.auremol.de). 
The sample contained 1.2 mM 15N isotopic labeled tmHisF in 15 mM Tris/HCl, pH 7.5, 
2 mM DTE, 0.2 mM DSS and 10% D2O. The peptide [solution of 30 mM in 15 mM 
Tris/HCl pH 7.5 in perdeuterated DMSO (97%)] was added stepwise in the following 
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concentrations: 0.3, 0.6, 0.9, 1.2 and 1.5 mM (chapter 4.5.9). In order to exclude that the 
observable chemical shifts were due to conformational changes caused by increasing 
DMSO concentrations, 15N labeled tmHisF was titrated with perdeuterated DMSO in the 
same concentrations as in the titration experiments with the peptide. All CSPs of the 
titration experiments with peptide were corrected for the DMSO shifts.  
The assignment of the NMR signals was carried out on the basis of the assignments 
of Liebold et al. (2010) and Lipchock and Loria (2008). On the chemical shift timescale the 
binding and dissociation event is fast and each signal of every titration step can be seen as 
an average signal over the signals of free and bound species (Williamson, 2013). Some 
residues could not be assigned unambiguously to a signal, and thus were not considered in 
the analysis. 
Figure 9 (panel A) illustrates the superposition of the [1H-15N] HSQC spectra of 
15N-tmHisF titrated with the maximum volume of DMSO (red) and 15N-tmHisF titrated 
with the complete amount of peptide (blue). Thus, signal shifts that can be observed are due 
to the binding of the peptide to 15N-tmHisF. Whereas many residues showed no CSP in the 
titration experiments, some residues, like Asp74 and Asp98, showed significant chemical 
shifts upon the stepwise addition of the peptide ligand (Figure 9, panel B and C). 
In Figure 10 (panel A and B) the total chemical shift changes Δδ values for 15N 
(ΔδN) and 1H (ΔδH) for each amino acid residue of tmHisF after the peptide has been added 
completely are given. Actually, the Δδ values of the two nuclei do not correlate with each 
other. This result could be explained by the fact that 15N shifts are highly sensitive to 
hydrogen bonding to the carbonyl of the preceding amino acid residue which does not 
influence the 1H nucleus. Moreover, the electric field caused by a charged atom i of a 
ligand has a different effect on N and H due to their different geometric positioning relative 
to i. Thus, an interacting ligand can result in different shift responses for 1H and 15N. It is 
obvious, that the analysis of either 15N or 1H signals would result in the loss of information 
and thus may deliver a biased view of the binding site (Williamson, 2013). For a better 
analysis of the observed CSPs, combined chemical shifts (Δδcomb) for each amino acid were 
calculated according to Schumann et al. (2007). Δδcomb is a single numerical chemical shift 
value that combines the information of all involved nuclei of a given amino acid. The 
calculation of Δδcomb includes amino acid specific weighting factors for each nucleus of this 
amino acid, which are empirically derived. The total Δδcomb values for each amino acid of 
tmHisF after the complete addition of the ligand are shown in Figure 10 (panel C). The 
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analysis of Δδcomb does account for all the significant CSPs of the 1H and 15N nuclei and 
thus is a suitable method to evaluate the HisF:peptide interaction. 
 
 
Figure 9: [1H- 15N] HSQC spectra for the identification of a putative interaction site for the binding of 
the peptide ligand to tmHisF.  
For the detection of the binding event, 1.2 mM 15N isotopic labeled tmHisF in 15 mM Tris/HCl pH 7.5, 2 mM 
DTE, 0.2 mM DSS and 10% D2O was titrated stepwise with 0.3, 0.6, 0.9 1.2, and 1.5 mM peptide at 25 °C. 
A) Illustrated are the final [1H- 15N] HSQC spectra of tmHisF after complete addition of peptide (blue) and 
DMSO as control (red). B, C) The residues Asp74 and Asp98 showed significant chemical shift perturbation 
as a result of stepwise addition of the peptide ligand. The signal for each titration step is displayed in a 
different color. The yellow and black arrows indicate the shifting direction of the signal. The titration 
experiments were conducted and the results were evaluated by Dr. Michael Spörner (group of Prof. Kalbitzer, 
Institute of Biophysics and Physical Biochemistry, University of Regensburg). 
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Figure 10: Total chemical shift changes (Δδ) of tmHisF induced by the peptide ligand.  
Depicted are the Δδ-values of tmHisF after complete addition of peptide ligand for 1H (ΔδH) (A), 15N (ΔδN) 
(B) and the combined chemical shift (Δδcomb) (C) according to Schumann et al. (2007). The horizontal line 
represents the standard deviation. The residues with the highest Δδ values and that are part of the HisF:HisH 
interface are labeled. Asp97, which shows a strong chemical shift response, is not part of the complex 
interface. The Δδ-values were corrected for the shifts that occurred upon the titration with DMSO. 
 
The horizontal lines in Figure 10 (panel A, B and C) mark the standard deviations σ of all 
Δδ-values. In the case of Δδcomb 34 residues show shifting signals that are above this value. 
Plotting these residues on the crystal structure of tmHisF (pdb: 1gpw) (Douangamath et al., 
2002) shows, that 12 of these residues are part of the HisF:HisH interface and nine are 
located next to it. The map reveals that the residues with high Δδcomb are mainly arranged in 
a belt that stretches out over one side of the HisF:HisH interface (Figure 11, panel B). 
When applying a more stringent threshold of two times the standard deviation 12 residues 
remain which have Δδcomb values beyond this threshold. Among these residues, five are part 
of the HisF:HisH interface and four are located next to it. Figure 11 (panel C) illustrates, 
that the interface residues with the strongest chemical shift response to the peptide ligand 
are part of the belt that stretches out over one half of the HisF:HisH interface. These results 
confirm previous assumptions that the peptide binds to the interface of the HisF:HisH 
complex (Auburger, 2013).  
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Figure 11: Putative binding site of the peptide ligand on tmHisF as determined in [1H- 15N] HSQC 
titration experiments.  
A) Depicted is the crystal structure of the tmHisF:tmHisH complex (pdb: 1gpw). Residues of HisF that form 
part of the complex interface are marked in orange. B, C) Presented is the view onto the interface of HisF. 
Residues that form part of the interface are non-transparent, residues of the remainder are given in transparent. 
Residues that showed Δδcomb values beyond one times the standard deviation σ (B) and two times σ (C) are 
marked in red (transparent and non-transparent). Residues, which could not be assigned to a chemical shift are 
given in white (transparent and non-transparent). All other residues of the HisF interface are labeled in 
orange. The surface map shows that the peptide interacts with HisF residues that are arranged in a belt, 
spanning one side of the HisF:HisH complex interface. Asp74 and Asp98 are part of this belt. For orientation, 
α helices 2 and 3 are marked. 
 
5.1.4 Conclusion 
In activity tests it was observed that the peptide impairs the glutaminase activity of the 
HisF:HisH-W123K complex. As it could be ruled out that the peptide is a direct inhibitor of 
the glutaminase active site it was suggested that it inhibits the glutaminase activity of HisH 
by disrupting the formation of an intact HisF:HisH complex interface, which is a 
prerequisite for a measurable glutaminase activity of HisH. In ITC experiments, binding of 
the peptide to tmHisF has been proven, however, the binding site remained uncertain. The 
[1H-15N] HSQC titration experiments presented here provide information about the putative 
interaction site of tmHisF and the peptide ligand. The interface residues are arranged in a 
belt that spans part of the complex interface and which is in accordance with a putative 
interaction face of a peptide chain. This is a simplified view on the HisF:peptide 
interaction, as the peptide may form various secondary structures and may bind to HisF in 
many ways, but nevertheless it is an interface of reasonable dimension.  
The interaction site of the peptide with tmHisF mainly comprises residues that are 
located in the region around the loop that links α2/β3 (71-77), the α3 helix (85-95) and the 
following loop (96-99). These regions comprise residues that are part of the HisF:HisH 
complex interface, judged on the basis of the interface analysis of the crystal structure of 
tmHisF:tmHisH. They have also proven to make a large contribution to the HisF:HisH 
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binding in NMR experiments on complex formation (Lipchock & Loria, 2009). This region 
of the complex interface also seems to play an important role in the conduction of the 
allosteric signal from HisF to HisH (cf. Figure 2), as juged by MD simulations and NMR 
experiments (Amaro et al., 2007; Manley et al., 2013). Furthermore, mutational studies 
proved that Asp98 is essential for glutaminase activity (Myers et al., 2005; Amaro et al., 
2007; List et al., 2012). Thus, by binding to this region, the peptide may result in a 
destabilization of the HisF:HisH complex interface and even more, impair an effective 
transmission of the allosteric signal from HisF to HisH, leading to a decrease in the 
glutaminase activity. This hypothesis is further substantiated by the findings recently 
published by Rivalta et al. (2016). They identified a small heterocyclic organic molecule 
that acts as a non-competitive allosteric inhibitor of ImGPS. MD simulations suggested that 
the inhibitor binds to the interface in proximity to structure motifs that might be essential 
for allosteric communication in HisF:HisH. Among them are the α3 helix in HisF and the 
oxyanion strand in HisH. NMR studies proved that by binding to this part of the interface 
the inhibitor blocks the propagation of the allosteric signal beyond the interaction face.  
Thus, this suggests that the peptide also perturbs the allosteric communication 
between HisF and HisH, however, the effect of the inhibitor on conformational changes in 
the HisH active side remains elusive. In the following, a novel phylogenetic approach based 
on ASR was used in order to further narrow down residues that contribute to HisF:HisH 
interaction and allostery. 
5.2 Analysis of protein-protein interaction and allostery in ImGPS with 
the help of contemporary and primordial proteins 
5.2.1 General concept and initial interaction and allosteric studies with 
contemporary HisF and HisH proteins 
To get a better insight into the functionality of a protein in general and of ImGPS in 
particular it is reasonable to characterize and compare representatives from different 
contemporary organisms. The phylogeny calculated for HisF:HisH comprises 87 modern 
sequences from seven clades. At a first stage of the project, various modern HisF proteins 
from these clades should be expressed and tested for their ability to bind to and 
allosterically activate HisH proteins from other clades. Subsequently, ancient HisF and 
HisH proteins which are represented by nodes along the paths from the LUCA to the 
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respective modern organisms should be reconstructed. Analogously to the modern HisF 
proteins, the reconstructed ones should be expressed and characterized for their ability to 
form complexes and allosterically interact with reconstructed and modern HisH proteins. 
By this way, differences in binding and allosteric behavior between various proteins can be 
identified and ascribed to sequence differences in the respective proteins, which can be 
verified in mutational studies. Thus, this approach can be successful for the identification of 
residues that are crucial for protein-protein interaction and allostery. 
In the course of the thesis most of the modern HisF and HisH proteins turned out to 
be insoluble or prone to aggregation when produced heterologously in E. coli (data not 
shown). As HisF and HisH from T. maritima and Pyrobaculum arsenaticum (paHisF, 
paHisH) and HisH from zmHisH form stable proteins, they were first tested for their ability 
to form chimeric complexes in fluorescence titration experiments (chapter 4.5.5). These 
experiments are based on a strictly conserved Trp residue of HisH which becomes shielded 
from solvent upon binding of HisF. In order to determine the Kd-value for the HisF:HisH 
interaction the Trp fluorescence was excited at 295 nm and the fluorescence signal at 
318 nm was detected and plotted against the concentration of HisF. Three titration curves 
are exemplarily shown in Figure 12. 
 
Figure 12: Fluorescence titration experiments to determine dissociation constants (Kd) for the 
interaction of present-day HisF with HisH proteins.  
5 µM HisH were titrated with HisF in 50 mM potassium phosphate, pH 7.5, at 25 °C. Fluorescence of the 
conserved Trp residue was excited at 295 nm, and the emission intensity was determined at 318 nm. Data 
points were fitted with a quadratic equation (Equation 9), which yielded a 1:1 stoichiometry and different Kd-
values. 
 
The Kd-values determined from all fluorescence titration experiments with contemporary 
HisF and HisH proteins are given in Table 10. 
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Table 10: Dissociation constants (Kd) for the interaction of various present-day HisF proteins with HisH 
proteins. 
The Kd-values were determined in fluorescence titration experiments with 5 µM HisH in 50 mM potassium 
phosphate, pH 7.5, at 25 °C. The shown Kd-values are the mean as determined from two independent titration 
experiments. (The individually determined values are given in parenthesis.) For high-affinity complexes, only 
an upper limit Kd < 50 nM can be given. No complex formation could be detected between paHisF and 
zmHisH, indicating that Kd > 5000 nM. 
 
HisF HisH Kd (nM) 
paHisF 
paHisH < 50 
tmHisH < 50 
zmHisH >5000 
tmHisF 
paHisH 128 (99; 156) 
tmHisH < 50 
zmHisH 1560 (943; 2170) 
 
According to these fluorescence titration measurements, paHisF and tmHisF exhibit strong 
binding to tmHisH (Kd < 50 nM) and paHisH (Kd = 128 nM), respectively. In contrast to 
that, no binding could be detected between paHisF and 5 µM zmHisH, which indicates that 
the Kd-value for this interaction must be higher than 5000 nM. Likewise, a high Kd-value of 
1560 nM was obtained for the binding of tmHisF to zmHisH.  
Obviously, although residues of PPIs are generally more conserved than other 
residues (Janin et al., 2008), the interfaces of at least some modern HisH and HisF enzymes 
are incompatible due to divergent evolution in the post-LUCA era. In agreement with this 
finding, the number of identical residues in the interfaces of zmHisF, paHisF, and tmHisF, 
which comprise between 34 and 36 residues, is only in the range of 47% - 59%. 
The ability of HisF to allosterically interact with HisH was tested via the 
glutaminase activity (chapter 4.5.6.3, Figure 13).  
 
 
Figure 13: Detection of glutaminase HisH reaction in a NAD+ coupled assay.  
Glutamate produced in the HisF:HisH complex reaction is converted into α-ketoglutarate and ammonia by 
glutamate dehydrogenase (GDH) . Simultaneously, NAD+ is reduced to NADH/H+ which can be followed via 
an increase in absorption at 340 nm. 
 
For this purpose, the HisF:HisH complex was incubated with glutamine and saturating 
concentrations of an activating ligand. As the biological substrate PRFAR spontaneously 
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hydrolyzes (Klem & Davisson, 1993), the more stable ProFAR is used as an activating 
ligand in the glutaminase assays. The conversion of glutamine into glutamate was followed 
at 340 nm via the reduction of NAD+ to NADH with the help of GDH. The measurements 
showed that the allosteric mechanism in the ImGPS has not been conserved, as well. For 
example, no glutaminase activity could be detected for 2 µM paHisF and 1 µM tmHisH 
(8 mM Gln, 40 µM ProFAR). 
The low binding affinities between HisF and HisH proteins from different species 
and the lacking allosteric interactions must be due to differences in the sequences of the 
proteins. However, mutational studies with the contemporary proteins are not feasible due 
to the following reasons: In the case of protein-protein interaction, tmHisF and paHisF 
show a different affinity to zmHisH compared to zmHisF, which is expected to form a tight 
native complex with zmHisH. However, as zmHisF is not soluble (Schmid, 2012) no 
sequence swap experiments can be carried out between the HisF proteins. As far as 
allostery is concerned, paHisF cannot stimulate glutaminase activity of tmHisH, whereas 
tmHisF forms an allosterically active complex with tmHisH. However, paHisF and tmHisF 
differ by 107 amino acids, which excludes mutational studies to identify those residues that 
are responsible for the functional divergences. 
Because of the unsatisfactory knowledge derived from the work with present-day 
proteins, in the following, focus was put on the approach with reconstructed proteins. Two 
advantages can be expected from such an approach: First, it has often been observed that 
reconstructed proteins are markedly more stable than their modern counterparts (Romero-
Romero et al., 2016). Thus, it can be expected that reconstructed HisF and HisH proteins 
are also stable and available for experimental analysis. Second, ancient proteins that are 
represented by nearby nodes along a phylogenetic path and that show different 
characteristics of binding and allosteric communication commonly differ in less positions 
than contemporary proteins. Thus laborious mutational studies can be circumvented. 
As a first step, the glutaminase from the LUCA era (LUCA-HisH) was 
characterized. The reconstruction of LUCA-HisH is interesting because it will not only be 
available for comparative HisF:HisH studies but will also enable the characterization of 
LUCA-HisF:LUCA-HisH. This study will strengthen the understanding of the functionality 
of primordial molecular assemblies. 
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5.2.2 Reconstruction and characterization of a putative glutaminase subunit 
from the LUCA era  
5.2.2.1 Wild type LUCA-HisH 
5.2.2.1.1 Reconstruction of LUCA-HisH 
The sequence of LUCA-HisF has been reconstructed and the properties of this enzyme have 
been characterized in previous studies (Richter et al., 2010; Reisinger et al., 2014). For 
sequence reconstruction, the sequences of corresponding HisF and HisH sequences were 
concatenated to increase the phylogenetic signal (cf. chapter 1.4.2). A comparison of the 
HisH sequences from the 87 extant organisms, used for the calculation of the phylogenetic 
tree, made clear that these sequences show a much lower degree of sequence identity than 
the HisF sequences. While overall 19% of the positions of the HisF proteins are invariant 
(Reisinger et al., 2014) only about 9% of the positions in the HisH proteins are strictly 
conserved. Moreover, the sequences strongly vary in their lengths. Thus, the MSA contains 
many gaps, which impedes the reconstruction of reliable sequences. In order to model more 
precisely the history of indels, the phylogeny-aware gap placement algorithm PRANK was 
used for the reconstruction of LUCA-HisH. PRANK improves MSA quality as it accounts 
for the phylogeny of the sequences and distinguishes between deletion and insertion events 
in an MSA (Löytynoja & Goldman, 2005; Löytynoja & Goldman, 2008). PRANK does 
also predict ancestral sequences, however, it utilizes a relatively primitive substitution 
model. Thus, in order to combine state-of-the-art sequence reconstruction [for example 
PhyloBayes software suite (Boussau et al., 2008)] with phylogeny-aware gap placement, 
the following protocol was utilized. 
I) The phylogenetic tree used for the reconstruction of LUCA-HisF and the MSA HisFext + 
HisHext were taken as input for PRANK to predict a LUCA-HisHPRANK sequence. 
II) The same tree and the same MSA were taken as input for PhyloBayes to predict a 
LUCA-HisHPhyloBayes sequence. 
III) The alignment of LUCA-HisHPRANK and LUCA-HisHPhyloBayes indicates gaps related to 
the phylogeny-aware gap placement model of PRANK. The corresponding positions of 
LUCA-HisHPhyloBayes were deleted resulting in a LUCA-HisH*PhyloBayes sequence having the 
same length as LUCA-HisHPRANK. In the following the sequence LUCA-HisH*PhyloBayes will 
be named LUCA-HisH. 
The nucleotide and protein sequences of LUCA-HisH are given in the Appendix 
(chapter 8.2). 9% of the 226 positions in LUCA-HisH are strictly conserved. Moreover, the 
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protein has 54% of identical residues if compared with the most similar extant HisH 
enzyme from the organism Syntrophothermus lipocalidus by means of BLAST (Boratyn et 
al., 2013; Reisinger et al., 2014). 
 
5.2.2.1.2 Cloning, heterologous expression and purification of LUCA-HisH 
The gene coding for LUCA-HisH was synthesized (chapter 4.3.11) cloned into a vector 
(chapter 3.7), and expressed in E. coli BL21-Gold (DE3) cells (chapter 4.4.1.2). E.coli host 
proteins were removed in a heat step (chapter 4.4.2.1) and LUCA-HisH was further purified 
via metal affinity chromatography (chapter 4.4.2.2). Pure protein was dialyzed against 10 
mM potassium phosphate pH 7.5 (chapter 4.4.3).The protein was more than 95% pure as 
judged by SDS-PAGE (chapter 4.5.2, Figure 14). About 26 mg LUCA-HisH was obtained 
per one liter of expression culture.  
 
Figure 14: SDS-PAGE (12.5% polyacrylamide) for the analysis of the purity of LUCA-HisH.  
M: protein marker and ladder (LMW), 1: LUCA-HisH. 
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5.2.2.1.3 Structural integrity and thermal stability of LUCA-HisH 
The structural integrity of LUCA-HisH was analyzed by means of size exclusion 
chromatography (chapter 4.5.3) and far-UV CD spectroscopy (chapter 4.5.4, Figure 15).  
 
Figure 15: Structural integrity of LUCA-HisH.  
A) Analytical size exclusion chromatography was performed with 155 µM LUCA-HisH on an analytical 
Superdex 75 column that was equilibrated with 50 mM Tris/HCl, pH 7.5, 300 mM KCl. The protein was 
eluted with a flow rate of 0.5 mL/min and the elution was observed at 280 nm. B) Far-UV CD spectra were 
recorded with 34 µM LUCA-HisH (green) in 50 mM potassium phosphate, pH 7.5, and – for comparison – 
25 µM zmHisH (red) in 10 mM potassium phosphate, pH 7.5, at 25°C. The shown curves are the result of five 
accumulations and were smoothed with the method of Savitzky-Golay (Savitzky & Golay, 1964). The elution 
profile and the CD spectrum are indicative of a well-defined structure of a homogeneous sample of LUCA-
HisH. 
 
LUCA-HisH elutes from the analytical Superdex 75 column as a symmetrical peak with a 
retention volume of 13.26 mL. This corresponds to an apparent molecular weight (MWapp) 
of 17.3 kDa, which was determined with a calibration curve (chapter 8.7) (Figure 44). The 
MWapp deviates from the calculated MW (MWcalc) of 26.2 kDa for monomeric LUCA-
HisH. However, deviation of MWapp from MWcalc was also observed for tmHisH in former 
size exclusion chromatography analyses (Klem & Davisson, 1993; Beismann-Driemeyer & 
Sterner, 2001). The elution profile of the analytical size exclusion chromatography 
indicates a homogeneous population of well-folded protein. This is supported by the far-UV 
CD spectrum of LUCA-HisH. A comparison with the CD spectrum of the present-day 
glutaminase zmHisH suggests a defined secondary structure of LUCA-HisH, which is 
similar to modern glutaminases. 
The thermal stability of LUCA-HisH was determined by following the loss of 
ellipticity at 220 nm (chapter 4.5.4). The corresponding curve shows a single thermal 
transition with a TM of about 79 °C (Figure 16). The steep curve progression of the 
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transition phase suggests a cooperative unfolding of LUCA-HisH, which is a further 
indicator of a compactly and correctly folded native protein.  
 
Figure 16: Thermal denaturation of LUCA-HisH.  
The loss of ellipticity at 220 nm was recorded for 9 µM LUCA-HisH in 50 mM potassium phosphate, pH 7.5. 
By fitting the data with the two-state model a melting temperature (TM) of 79 °C was obtained. 
 
5.2.2.1.4 Complex formation of LUCA-HisF and LUCA-HisH 
Complex formation between LUCA-HisF and LUCA-HisH was analyzed in a fluorescence 
titration experiment (chapter 4.5.5). The titration experiments were performed with the Trp-
free variant LUCA-HisF-W138Y+W156Y. As this variant is used in most of the following 
experiments, it is denoted as LUCA-HisF. Where the wild type is used, it is marked with 
the abbreviation wt (LUCA-HisF wt). The resulting curve is illustrated in Figure 17. 
According to the titration, LUCA-HisH and LUCA-HisF form a highly affine complex with 
a Kd < 50 nM and a 1:1 stoichiometry. This binding strength is similar to the interaction 
affinities observed for present-day ImGPSs like tmHisF:tmHisH and paHisF:paHisH, 
which both also display a Kd-value lower than 50 nM (Table 10). 
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Figure 17: Fluorescence titration experiment to determine the dissociation constant (Kd) for the 
interaction of  LUCA-HisF with LUCA-HisH. 
5 µM LUCA-HisH were titrated with LUCA-HisF in 50 mM potassium phosphate, pH 7.5, at 25 °C. 
Fluorescence of the conserved Trp residue was excited at 295 nm, and the emission intensity was determined 
at 318 nm. Data points were fitted with a quadratic equation (Equation 9), which yielded a 1:1 stoichiometry 
and a Kd < 50 nM. 
 
5.2.2.1.5 Activity tests with LUCA-HisF:LUCA-HisH complex 
In a next step the LUCA-HisF:LUCA-HisH complex was tested for its glutaminase activity 
(chapter 4.5.6.3). For this purpose, 20 µM LUCA-HisH were incubated with 12 mM 
glutamine and 200 µM ProFAR, and 20 µM LUCA-HisF wt were added to start the 
reaction. No turnover of glutamine could be observed under these conditions.  
The physiological reaction of the HisF:HisH complex is the glutamine-dependent 
conversion of PRFAR into AICAR and ImGP (chapter 4.5.6.2). When the LUCA complex 
was tested for it, no glutamine dependent cyclase activity could be recorded for 10 µM 
LUCA-HisF wt:LUCA-HisH in presence of 10 mM glutamine, 100 µM ProFAR and an 
excess of tmHisA. TmHisA was added in order to generate in situ the HisF substrate 
PRFAR from ProFAR. 
On the basis of these observations the following can be concluded: As LUCA-HisF 
with bound ligand allosterically stimulates the glutaminase activity of zmHisH (Reisinger et 
al., 2014), the LUCA-HisF barrel can undergo conformational and dynamic changes that 
are induced by the binding of PRFAR or ProFAR and transmitted beyond the complex 
interface to the glutaminase active site. Obviously, however, in the LUCA-HisF:LUCA-
HisH complex the pipeline of conformational changes may be blocked at the complex 
interface, due to steric clashes or an interface arrangement that is, despite tight interaction, 
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not in accordance with the allosteric pathway. Alternatively, the active site of LUCA-HisH 
might be per se unable to catalyze glutaminase hydrolysis.  
 
5.2.2.2 Putatively constitutively active LUCA-HisH mutants 
5.2.2.2.1 Mutagenesis of LUCA-HisH, heterologous expression and purification of 
LUCA-HisH mutants 
A strategy for uncoupling the glutaminase activity from the allosteric activation was 
recently published by List et al. (2012) (cf. chapter 1.3): Studies revealed that the 
replacement of the bulky side chains Tyr138(tmHisH) and Lys181(tmHisH), which are 
located in proximity to the interface and the glutaminase active site in tmHisF:tmHisH, by 
alanines, led to constitutive HisH activity. These findings suggested that the unblocking of 
the glutaminase active site mimics the allosteric stimulation which is caused by PRFAR 
binding. Thus, equivalent mutations in LUCA-HisH could also lead to constitutive 
glutaminase activity.  
To test this, Tyr157 and Lys202 in LUCA-HisH, which are equivalent to Tyr138 
and Lys181 in tmHisH, were replaced by alanines, yielding the variants LUCA-HisH-
Y157A, LUCA-HisH-K202A, and LUCA-HisH-Y157A+K202A. The mutants were 
generated via QCM (chapter 4.3.8) with LUCA-hisH-pET24a as template and the primers 
given in chapter 3.8.3 and expressed in E. coli BL21-Gold (DE3) cells (chapter 4.4.1.2). 
The soluble target proteins were subjected to metal affinity chromatography (chapter 
4.4.2.2). Pure protein was dialyzed against 50 mM Tris/HCl pH 7.5 (chapter 4.4.3). As 
judged by SDS-PAGE (chapter 4.5.2) the proteins were more than 95% pure (Figure 18). 
The yield per one liter of expression culture was 15 mg for LUCA-HisH-Y157A, 7.8 mg 
for LUCA-HisH-K202A and 12.6 mg for LUCA-HisH-Y157A+K202A.  
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Figure 18: SDS-PAGE (12.5% polyacrylamide) for the analysis of the purity of LUCA-HisH mutants.  
1: LUCA-HisH-Y157A, 2: LUCA-HisH-K202A, 3: LUCA-HisH-Y157A+K202A, M: protein marker and 
ladder (LMW). 
 
5.2.2.2.2 Structural integrity and thermal stability of LUCA-HisH mutants 
As for LUCA-HisH, the structural integrity of the mutants was determined by size 
exclusion chromatography on an analytical Superdex 75 column (chapter 4.5.3), and by far-
UV CD spectroscopy (chapter 4.5.4, Figure 19). 
 
Figure 19: Structural integrity of LUCA-HisH-Y157A, LUCA-HisH-K202A and LUCA-HisH-
Y157A+K202A in comparison with LUCA-HisH wt.  
A) Analytical size exclusion chromatography was performed with about 50 to 100 µM protein on an 
analytical Superdex 75 column that was equilibrated with 50 mM Tris/HCl, pH 7.5, 300 mM KCl. The 
proteins were eluted with a flow rate of 0.5 mL/min and the elution was observed at 280 nm. B) Far-UV CD 
spectra were recorded with about 25 µM protein in 50 mM potassium phosphate, pH 7.5, at 25 °C. The shown 
curves are the result of five accumulations and were smoothed with the method of Savitzky-Golay (Savitzky 
& Golay, 1964). The elution profiles and the CD spectra are indicative of a well-defined structure of 
homogeneous samples of the LUCA-HisH mutants. 
 
The MWapp for the mutants and the wild type protein, determined by size exclusion 
chromatography, are listed in Table 11.  
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Table 11: Apparent molecular weights (MWapp ) of LUCA-HisH mutants and wild type (wt) determined 
via size exclusion chromatography on an analytical Superdex 75 column.  
The column was run with 50 mM Tris/HCl pH 7.5 and 300 mM KCl. MWapp-values were calculated with the 
calibration curve given in chapter 8.7 (Figure 44). MWcal denotes the calculated molecular weight. 
 
LUCA-HisH variant elution volume (mL) MWapp (kDa) MWcal (kDa) 
wt 13.26 17.3 26.2 
Y157A 13.22 17.6 26.1 
K202A 13.51 15.3 25.2 
Y157A+K202A 13.33 16.7 26.1 
 
The MWapp of the LUCA-HisH mutants resemble the MWapp obtained for the wild type 
protein (chapter 5.2.2.1.3). Again, MWapp is smaller than MWcalc , however, a retarded 
elution has also been observed for tmHisH (Klem & Davisson, 1993; Beismann-Driemeyer 
& Sterner, 2001). Overall, the symmetrical shape of the peaks is indicative of 
homogeneously folded proteins. The far-UV CD spectra of the LUCA-HisH variants are 
similar to the wild type spectrum, which proves that the secondary structure is not perturbed 
in consequence of the introduction of alanines. 
The thermal stability of the LUCA-HisH mutants was analyzed by following the CD 
signal at 220 nm (chapter 4.5.4, Figure 20). 
 
Figure 20: Thermal denaturation of LUCA-HisH mutants in comparison with wild type. 
The loss of ellipticity at 220 nm was recorded for 9 to 12 µM protein in 50 mM potassium phosphate, pH 7.5. 
By fitting the data with the two-state model different melting temperatures (TM) were obtained. The TM-values 
are given in the legend. 
 
With TM = 78 °C LUCA-HisH-K202A has a similar thermostability as LUCA-HisH. 
However, the replacement of Tyr157 by an alanine results in a loss of thermostability of 
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about 8 °C. Obviously, Tyr157 forms more stabilizing interactions with surrounding 
residues compared to Lys202, though both residues are located at the protein surface. 
Nevertheless, all three mutants are thermostable. They unfold cooperatively, indicated by 
the steep curve progress in the transition phase. This is a further characteristic of correctly 
folded native proteins.  
 
5.2.2.2.3 Complex formation of LUCA-HisF and LUCA-HisH mutants 
Before testing the LUCA-HisH variants for constitutive activity, their affinity to LUCA-
HisF was determined in fluorescence titration experiments (chapter 4.5.5, Figure 21).  
 
Figure 21:  Fluorescence titration experiments to determine dissociation constants (Kd) for the 
interaction of LUCA-HisF with LUCA-HisH mutants. 
5 µM of each LUCA-HisH mutant were titrated with LUCA-HisF in 50 mM potassium phosphate, pH 7.5, at 
25 °C. Fluorescence of the conserved Trp residue was excited at 295 nm, and the emission intensity was 
determined at 318 nm. Data points were fitted with a quadratic equation (Equation 9), which yielded a 1:1 
stoichiometry. The resulting Kd-values are given in the legend. The shown Kd-values are the mean as 
determined from two independent titration experiments. (The individually determined values are given in 
parenthesis.) For the high-affinity complex, only an upper limit of Kd < 50 nM can be given. 
 
Like LUCA-HisH, LUCA-HisH-Y157A binds to LUCA-HisF with Kd-values in the low 
nanomolar range. However, the introduction of an alanine at position 202 leads to an 
increase of the Kd by at least a factor of four in comparison to the wild type protein, and the 
combination of the exchanges Tyr157Ala and Lys202Ala results in a further impairment of 
the interaction by a factor of five. Lys202 is equivalent to Lys181 from tmHisH, which 
forms the conserved salt bridge with Asp98 in tmHisF (cf. Figure 2, panel A). Therefore, it 
can be supposed that Lys202 is also involved in an interdomain salt bridge with Asp98 in 
LUCA-HisF. The replacement of Lys202 by an alanine disrupts this interaction and thus 
may result in a destabilization of the complex. It is however, not clear, why the double 
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mutant binds even worse to LUCA-HisF. In fact, the single exchanges at the equivalent 
positions in tmHisH did not impair the interaction with tmHisF [tmHisF:tmHisH Kd < 50 
nM, cf. Table 10; tmHisF:tmHisH-Y138A and tmHisF:tmHisH-K181A Kd < 50 nM (List, 
2009)]; no Kd-value has been reported for the interaction of tmHisF with tmHisH-
Y138A+K181A. Obviously, the contribution of particular equivalent interface residues to 
the complex stability varies in LUCA-HisF:LUCA-HisH and tmHisF:tmHisH. This may be 
due to electrostatic, conformational or geometric differences between the interfaces of both 
complexes. Attempts to solve the crystal structure of LUCA-HisF wt:LUCA-HisH were 
made in order to be able to compare the interfaces in both complexes. Dr. Chitra Rajendran 
(group of Prof. Dr. Christine Ziegler, Institute of Biophysics and Physical Biochemistry) 
collected the X-ray data and solved the structure. However, the structure could only be 
solved with a resolution of 3.8 Å (data collection and refinement statistics not shown). The 
superposition of LUCA-HisF:LUCA-HisH with tmHisF:tmHisH (pdb: 1gpw, chain AB) 
does not reveal a different subunit arrangement in the two complexes. The moderate 
resolution does, however, not allow for a detailed inspection of side chain conformations. 
Thus, it is not clear why equivalent residues in LUCA-HisF:LUCA-HisH and 
tmHisF:tmHisH make different contribution to complex stability. 
 
5.2.2.2.4 Activity tests with complexes of LUCA-HisF and LUCA-HisH mutants 
Despite partly moderate Kd-values, all LUCA-HisH mutants were tested, in complex with 
LUCA-HisF, for their constitutive glutaminase activity (chapter 4.5.6.3).  
For 1 µM of each LUCA-HisH mutant, glutaminase activity was tested in the 
presence of 15 mM glutamine. In the case of LUCA-HisH-Y157A the reaction mixture was 
supplemented with 40 µM ProFAR, in the case of the other mutants, 100 µM ProFAR was 
added. In order to start the reaction, 2 µM, 5 µM and 10 µM LUCA-HisF were added to the 
reaction mixture with LUCA-HisH-Y157A, LUCA-HisH-K202A and LUCA-HisH-
Y157A+K202A, respectively. In fact, ProFAR is not needed for the observation of 
constitutive glutaminase activity. Nevertheless, in a first experiment, the ligand was added 
to the reaction mixture and measurements without ProFAR should follow. However, as no 
glutaminase activity could be observed for any mutant under the tested conditions, no 
further activity tests were conducted. 
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5.2.2.3 Basal glutaminase activity of LUCA-HisH 
The fact that neither for LUCA-His wt nor for the putatively constitutive LUCA-HisH 
mutants glutaminase activity could be observed, suggests that the missing catalytic activity 
is not due to failures in the allosteric communication, but that the hydrolysis of glutamine 
itself is impaired in the reconstructed HisH. To validate this hypothesis, LUCA-HisH was 
tested for its basal activity in a qualitative HPLC assay (chapter 4.5.7) (Melucci et al., 
1999). For this purpose, 10 µM LUCA-HisF wt:LUCA-HisH were incubated with 10 mM 
glutamine and either with or without 100 µM ProFAR at 25 °C for 14 h. As a positive 
control, identical samples were prepared with 10 µM LUCA-HisF wt:zmHisH. As a 
negative control, identical samples as decribed above were prepared, however, enzyme that 
was denatured by heat (100 °C for five minutes) was added to the reaction mixtures. After 
incubation, the glutamine and glutamate in the reaction samples were derivatized with 
Fmoc-Cl as described in chapter 4.5.7. After 2 h of centrifugation (EPPENDORF 
Centrifuge 5810R, 14000 rpm, 4 °C) the samples were subjected to C18 RP HPLC column 
(MERCK, LiChrospher 100 RP-18, 5µm, LiChroCART, 250x4mm). The derivatized amino 
acids were eluted with an increasing gradient of acetonitrile, which was detected by 
following absorption at 280 nm. 
The elution profiles for the LUCA-HisF wt:LUCA-HisH and LUCA-HisF 
wt:zmHisH wt preparations are illustrated in Figure 22. 
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Figure 22: HPLC assay for the determination of the basal glutaminase activity of LUCA-HisH wt.  
10 µM of LUCA-HisH wt (run 1 + 2) and zm-HisH wt (run 3 + 4) were incubated each with 10 µM LUCA-
HisF wt and 10 mM glutamine in presence of either 100 µM ProFAR (+) or without ProFAR (-) in 50 mM 
Tricin/KOH pH 8.5 for 14 h at 25 °C. After derivatization with Fmoc-Cl the samples were loaded on a C-18 
reversed phase column and derivatized glutamine and glutamate were eluted with 0.5 mL/min with an 
increasing gradient of acetonitrile. The elution was detected by following absorption at 280 nm. In order to 
discriminate between glutamine and glutamate, amino acid standards were subjected to the column, as well 
(run 5 + 6). While in the case of LUCA-HisF wt:zmHisH wt a turnover of glutamine to glutamate is observed 
both with and without ProFAR (run 3 + 4), no glutaminase activity is detected for LUCA-HisF wt:LUCA-
HisH wt (run 1 + 2). 
 
Glutamine and glutamate are well separated under the given conditions. For the negative 
controls with denatured protein no conversion of glutamine to glutamate was observed 
(data not shown). In the case of LUCA-HisF wt:zmHisH wt a glutamate peak is detected 
both, when ProFAR is present in the reaction mixture and when not. The fact that a peak is 
observed for the sample without ProFAR proves that the basal glutaminase activity of 
LUCA-HisF wt:zmHisH wt is sufficient for the conversion of 10 mM glutamine in 14 h. In 
the case of LUCA-HisF wt:LUCA-HisH a glutamine peak is detected under all tested 
conditions. This observation proves that, despite of its structural integrity, LUCA-HisH is 
not able to hydrolyze glutamine to glutamate. 
 
5.2.2.4 Conclusion 
Recently, the Trp synthase from the last bacterial common ancestor has been reconstructed. 
The subunits are catalytically active and the primordial complex displays sophisticated 
features of contemporary complexes like substrate channeling and allosteric communication 
(Busch et al., 2016).  
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In the case of ImGPS, the reconstruction of a complex was only partly successful. 
For the reconstruction of LUCA-HisF and LUCA-HisH the same MSA and phylogenetic 
tree were used. The characteristics displayed by LUCA-HisF prove, that the protein 
sequence was successfully reconstructed. All in all, LUCA-HisF is a thermostable enzyme 
that forms a stable and fully active complex with zmHisH. LUCA-HisF is equipped with all 
characteristics of modern HisF proteins: It stimulates the glutaminase activity of a modern 
HisH in an allosteric mechanism and channels ammonia to its substrate binding site 
(Reisinger et al., 2014).  
In contrast, the characteristics of LUCA-HisH suggest that in this case, the 
reconstruction was less successful. Other than for LUCA-HisF, the set of HisH sequences 
selected for the reconstruction of LUCA-HisH display considerably higher heterogeneity in 
amino acid composition (only about 9% of conserved positions) and sequence length, 
hampering the construction of a high-quality MSA. The application of the phylogeny-aware 
gap placement algorithm PRANK (Löytynoja & Goldman, 2005; Löytynoja & Goldman, 
2008) for the improvement of the MSA quality resulted in the reconstruction of a 
structurally stable HisH, with an intact interaction face, however, no catalytic activity. A 
comparison with tmHisH proves that LUCA-HisH has all sequence motifs that are essential 
for the catalytic glutaminase mechanism, that is the catalytic triad (Cys89-His199-Glu201), 
the oxyanion hole (Pro49-Gly50-Val51-Gly52) that stabilizes the transition state of the 
substrate during catalysis (Ollis et al., 1992; Zalkin & Smith, 1998), and residues that are 
involved in the binding of glutamine according to the crystal structure of tmHisF:tmHisH 
with bound glutamine (Gln93, Glu101) (pdb: 3ZR4) (List et al., 2012). Reconstruction 
errors obviously occurred for parts in HisH that are only moderately conserved due to 
deletion and insertion events that occurred in the course of evolution (Reisinger et al., 
2014). These parts may, for example, involve loops, which might undergo specific 
conformational and dynamic transitions that are important for the catalytic mechanism in 
HisH. The example of LUCA-HisH makes clear that algorithms in ASR still have to be 
optimized for the correct handling of complex evolutionary scenarios like insertion and 
deletion events. 
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5.2.3 Reconstruction of primordial HisF proteins 
The fact that the reconstruction of HisH underlies uncertainties makes clear that it is not 
reasonable to include ancient HisH proteins in studies on protein-protein interaction and 
allostery. Therefore, in the following, only HisF intermediates were reconstructed and 
tested for their ability to bind to and stimulate glutaminase activity of present-day HisH 
proteins. Thus, ancestral HisF proteins that exhibit different binding or allosteric behavior 
toward a present-day HisH can be identified and the differences can be correlated with the 
differences in their sequence. Functional important residues can then be found among the 
residues in which the HisF proteins differ. 
The phylogenetic tree in Figure 23 gives an overview of the ancestral proteins that 
were reconstructed and characterized in the following studies in order to identify positions 
that are decisive for protein-protein interaction and allosteric communication in ImGPS: 
Anc1pa-HisF, Anc1tm-HisF, and Anc2tm-HisF. The nucleotide and the amino acid 
sequences of these reconstructed intermediate proteins are given in the Appendix (chapter 
8.2). The proteins were inferred on the basis of the MSA HisFext + HisHext and the 
phylogenetic tree used for the reconstruction of LUCA-HisH and LUCA-HisF (Figure 4). 
However, while LUCA-HisF and LUCA-HisH were calculated with a Bayesian approach, 
due to the unsatisfactory outcome for LUCA-HisH, now the FastML server was utilized for 
reconstruction. The calculation was based on an alternative substitution model applied to a 
maximum likelihood (ML) tree with optimized branch lengths (chapter 8.1, Figure 36)1.  
                                                     
 
1 In the course of the ML reconstruction also a new LUCA-HisF sequence was reconstructed. The sequence of 
this LUCA-HisF is identical to the sequence of its subsequent descendant Anc1tm-HisF, however, differs in 
20 positions from the LUCA-HisF which was reconstructed in Richter et al. (2010) on the basis of a Bayesian 
approach. The characterization of the HisF proteins will show that both LUCA-HisF enzymes exhibit similar 
binding and allosteric behavior with the same present-day HisH. This emphasizes the reliability and 
robustness of ASR of HisF proteins and both HisF can be seen as potential representatives of the real LUCA-
HisF protein. Nevertheless, the LUCA-HisF reconstructed on the Bayesian approach was used in the 
following studies as the enzyme had been characterized comprehensively at the beginning of the work and a 
crystal structure had been available. 
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Figure 23: Phylogenetic tree of HisF and HisH.  
The phylogenetic paths between LUCA and Thermotoga maritima (tm), and LUCA and Pyrobaculum 
arsenaticum (pa) are colored blue and brown, respectively. The ancestral HisF proteins along these two paths 
(blue path, Anc1pa-HisF; red path, Anc1tm-HisF and Anc2tm-HisF) that were reconstructed and 
characterized to study the protein-protein interaction and the allostery of ImGPS are marked with filled 
circles. Zymomonas mobilis (zm) is marked in olive. The numbers give the amino acid differences between 
the HisF proteins that are represented by the respective nodes. 
 
5.2.4 Studies on protein-protein interaction with the help of primordial HisF 
proteins 
Parts of this chapter have been published equally worded in Holinski et al. (2017). The 
manuscript was written by Prof. Dr. Reinhard Sterner, Prof. Dr. Rainer Merkl, Kristina 
Heyn and myself. All computational methods were carried out by Kristina Heyn (group of 
Prof. Dr. Rainer Merkl, Institute of Biophysics and Physical Biochemistry, University of 
Regensburg). That is ASC, homology modeling with YASARA (chapter 5.2.4.3) (Krieger 
et al., 2009), FoldX analysis (chapter 5.2.4.3) (Guerois et al., 2002), coevolution analysis 
with GREMLIN (chapter 5.2.4.4) (Balakrishnan et al., 2011), and correlation analysis 
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(chapter 5.2.5.1). Experimental studies were done by myself. The results were evaluated 
and the further procedure was determined together. 
 
5.2.4.1 Concept 
First the binding of LUCA-HisF to present-day HisH subunits was analyzed. It has already 
been shown that LUCA-HisF forms a tight complex with LUCA-HisH and zmHisH with a 
Kd < 50 nM. Interestingly, LUCA-HisF also forms highly stable complexes with paHisH 
and tmHisH (Figure 24). Although this finding suggests that the interaction face has been 
conserved throughout evolution, the studies on contemporary HisF and HisH proteins 
(chapter 5.2.1) showed that paHisF and tmHisF do not form stable complexes with zmHisH 
due to divergent evolution in the post-LUCA era. Accordingly, mutations that occurred 
along the path from LUCA-HisF to tmHisF/paHisF are responsible for a decrease in the 
affinity of HisF to zmHisH (Figure 23). 
 
Figure 24:  Fluorescence titration experiments to determine dissociation constants (Kd) for the 
interaction of LUCA-HisF with modern HisH proteins.  
5 µM HisH were titrated with LUCA-HisF in 50 mM potassium phosphate, pH 7.5, at 25 °C. Fluorescence of 
the conserved Trp residue was excited at 295 nm, and the emission intensity was determined at 318 nm. Data 
points were fitted with a quadratic equation (Equation 9), which yielded a 1:1 stoichiometry and Kd-values <  
50 nM. 
 
All Kd-values determined to date are summarized in Table 12. 
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Table 12: Dissociation constants (Kd) for the interaction of various HisF with HisH proteins.  
The Kd-values were determined in fluorescence titration experiments with 5 µM HisH in 50 mM potassium 
phosphate, pH 7.5, at 25 °C. The shown Kd-values are the mean as determined from two independent titration 
experiments. (The individually determined values are given in parenthesis.). For high-affinity complexes, only 
an upper limit Kd < 50 nM can be given. No complex formation could be detected between paHisF and 
zmHisH, indicating that Kd > 5000 nM. 
 
HisF HisH Kd (nM) 
LUCA-HisF 
LUCA-HisH < 50 
paHisH < 50 
tmHisH < 50 
zmHisH < 50 
paHisF 
paHisH < 50 
tmHisH < 50 
zmHisH >5000 
tmHisF 
paHisH 128 (99; 156) 
tmHisH < 50 
zmHisH 1560 (943; 2170) 
 
Based on the interest to identify interaction hot spots in HisF:HisH, residues that are 
responsible for the different affinities of LUCA-HisF and paHisF/tmHisF to zmHisH 
should be identified. LUCA-HisF, paHisF and tmHisF consist of about 250 amino acids of 
which 103 and 79 residues are still different between LUCA-HisF and paHisF and LUCA-
HisF and tmHisF, respectively. However, HisF proteins that are represented by neighboring 
nodes along the phylogenetic path from LUCA-HisF to paHisF/tmHisF differ in less amino 
acids. Thus, analyzing and comparing evolutionary neighboring HisF proteins along the 
phylogenetic path linking LUCA-HisF and paHisF/tmHisF that show significantly distinct 
affinities to zmHisH will be a potent way to narrow down specificity determining 
interaction hot spots.  
For this purpose, ancestral HisF proteins that link LUCA-HisF with paHisF and 
tmHisF, respectively, were produced in E. coli, purified and characterized for their ability 
to bind to zmHisH in fluorescence titration experiments. By means of in silico mutagenesis 
studies based on homology modeling, candidate residues for protein-protein interaction 
could be drastically narrowed down. The results were verified in subsequent site-directed 
mutagenesis studies. The cloning, heterologous expression, and purification of HisF and 
HisH proteins used in the interaction studies are outlined in the following. The detailed 
interaction study is given in chapter 5.2.4.3. Subsequent coevolution studies with the hot 
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spot position identified in chapter 5.2.4.3 allowed for the indentification of positions in 
zmHisH that influence the affinity for HisF and help to get an insight into physicochemical 
principles of complex formation in ImGPS, which is outlined in chapter 5.2.4.4. The 
cloning, expression and purification of the zmHisH mutants is described in the following, 
as well. 
 
5.2.4.2 Cloning, heterologous expression and purification of HisF and HisH proteins 
used for interaction studies 
The genes coding for HisF and HisH proteins were all cloned into a vector as given in 
chapter 3.7. Mutagenesis of the plasmids was done via QCM (chapter 4.3.8) or OE-PCR 
(chapter 4.3.9) with the primers given in chapter 3.8.2 and chapter 3.8.3.  
All genes were expressed at preparative scale in E. coli BL21-Gold (DE3) cells 
transformed with the respective plasmid, only tmhisH was expressed in E. coli M15 (pREP) 
cells (chapter 4.4.1.2). The HisF and HisH proteins were subjected to a three step 
purification via anion exchange chromatography (chapter 4.4.2.3), precipitation with 80% 
ammonia sulfate (chapter 4.4.2.4), and preparative size exclusion chromatography (chapter 
4.4.2.5). PaHisH was purified via a heat step (chapter 4.4.2.1) and cation exchange 
chromatography (chapter 4.4.2.3). Pure HisF proteins were dialyzed against 50 mM 
potassium phosphate, tmHisH and the other HisH proteins were dialyzed against 10 mM 
potassium phosphate pH 7.5 and 50 mM Tris/HCl pH 7.5, respectively (chapter 4.4.3). 
According to SDS-PAGE (12.5% acrylamide) (chapter 4.5.2), all proteins were more than 
95% pure (Figure 25). The yield was about 15 mg to 220 mg per liter of culture for the 
HisF proteins. In the case of tmHisH, zmHisH and zmHisH mutants about 10 mg per liter 
expression culture were obtained, as far as paHisH is concerned the yield was about 0.4 mg 
per liter expression culture. 
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Figure 25: SDS-PAGE (12.5% polyacrylamide) for the analysis of the purity of HisF and HisH proteins 
used in interaction studies.  
A) M: protein marker and ladder (LMW), 1: paHisF wt, 2: paHisF, 3: Anc1pa-HisF, 4: Anc1pa-HisF*, 5: 
Anc1pa-HisF-A72Q+S74F, 6: Anc1pa-HisF-A72Q, 7: Anc1pa-HisF-S74F, 8: LUCA-HisF wt, 9: LUCA-
HisF, 10: LUCA-HisF-F74S. B) M: protein marker and ladder (LMW), 1: tmHisF wt, 2: tmHisF, 3: Anc1tm-
HisF, 4: Anc2tm-HisF, 5: Anc2tm-HisF-F74D, 6: tmHisF-D74F. The wild type proteins were applied for 
comparison. C) M: protein marker and ladder (LMW), 1: tmHisH, 2: paHisH. D) M: protein marker and 
ladder (LMW), 1: zmHisH. E) M: protein marker and ladder (LMW), 2: zmHisH-A28R, 3: zmHisH-L202R, 
3: zmHisH-A28R+L202R. 
 
5.2.4.3 Identifying a protein-protein interaction hot spot in HisF on the basis of ASR 
and in silico as well as experimental mutagenesis 
As a first step in interaction studies, the reconstructed evolutionary intermediate Anc1pa-
HisF, which differs from LUCA-HisF and paHisF by 29 and 74 residues (Figure 23), 
respectively, was produced and characterized. Titration experiments yielded a Kd-value of 
2730 nM for the formation of the Anc1pa-HisF:zmHisH complex, corresponding to a 
binding affinity which is at least 55-fold lower than that of the LUCA-HisF:zmHisH 
complex (Figure 28, Table 13). It is reasonable to assume that residues responsible for these 
different binding affinities are mainly localized at the interface region, which was inferred 
from the known crystal structure of ImGPS from T. maritima (Douangamath et al., 2002). 
When analyzing the 29 residue differences between LUCA-HisF and Anc1pa-HisF, nine of 
them are located in the putative interface with zmHisH (Figure 26). 
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Figure 26: 3D model of the LUCA-HisF:zmHisH complex.  
The nine interface residues in which LUCA-HisF and Anc1pa-HisF differ are marked in orange. The two 
positions predicted by FoldX (Guerois et al., 2002) as crucial for complex stability are marked with arrows. 
The model was created by means of YASARA (Krieger et al., 2009). FoldX analysis and the homology 
modeling were carried out by Kristina Heyn. 
 
The nine residues of Anc1pa-HisF were replaced by the corresponding residues from 
LUCA-HisF, yielding Anc1pa-HisF* (Figure 29). A Kd-value of less than 50 nM was 
determined for the formation of the Anc1pa-HisF*:zmHisH complex (Figure 28, Table 13), 
which proves that nine residues at most are decisive for the different zmHisH-affinities of 
LUCA-HisF and Anc1pa-HisF. In order to estimate whether some of these residues are 
more important than others a combination of in silico approaches was applied. 
As a first step, homology models for LUCA-HisF:zmHisH and Anc1pa-
HisF:zmHisH were built by means of YASARA (Krieger et al., 2009). In literature, various 
algorithms are described that allow for the identification of interaction hot spots with the 
help of 3D structures. In the context of this work, two computational methods for predicting 
and assessing hot spot positions were then tested and the results were subsequently verified 
in experimental mutagenesis studies. The first computational method is the KFC2 server 
(Zhu & Mitchell, 2011), which identifies hot spots on the basis of geometric and 
biochemical features. Based on an analysis of the crystal structure of tmHisF:tmHisH and 
the model of LUCA-HisF:zmHisH, the KFC2 server predicted that only position 74 (Phe in 
LUCA-HisF, Ser in Anc1pa-HisF) is a hot spot. As a second method, in order to analyze 
the effect of different amino acid exchanges between LUCA-HisF and Anc1pa-HisF on 
complex stability, FoldX (Guerois et al., 2002) was used for in silico mutagenesis. FoldX 
predicts ΔΔG-values, i. e. the effect of a mutation on complex stability. In the case that 
ΔΔG < 0, the mutation stabilizes the complex, in the case that ΔΔG > 0, the mutation leads 
to a destabilization. In the framework of this analysis, the nine candidate residues were 
reciprocally exchanged in all combinations between LUCA-HisF and Anc1pa-HisF (Figure 
27, panel A). The 12 combinations of mutual residue exchanges leading to the largest 
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predicted effects on complex stability (|ΔΔG| > 2 kcal/mol) are depicted in Figure 27, panel 
B.  
 
 
Figure 27: Identification of interface residues determining the affinity of LUCA-HisF and Anc1pa-HisF 
for zmHisH by means of in silico design.  
A) Nine interface residues distinguish LUCA-HisF and Anc1pa-HisF; these residues were reciprocally 
exchanged individually and in all possible combinations. For each of these exchanges their effect on complex 
stability was assessed by means of FoldX. B) Combinations of reciprocal residue exchanges that have – 
according to FoldX – the largest effects on complex stability. A ΔΔG-value < 0 indicates a stabilization of the 
complex, ΔΔG > 0 indicates a destabilization. For comparison, the predicted effects of the individual 
reciprocal exchanges at positions 72 and 74 are also shown. The FoldX analysis was conducted by Kristina 
Heyn. 
 
A comparison of the ΔΔG-values indicated that the largest destabilizing effects have to be 
expected for a combination of three or four substitutions, and most of those combinations 
contained residues 74 and 72. Most strikingly, FoldX predicted for the single substitution of 
Ser74 from Anc1pa-HisF with Phe74 from LUCA-HisF a stabilization of the complex with 
zmHisH (ΔΔG = -1.9 kcal/mol); for the inverse substitution of Phe74 from LUCA-HisF 
with Ser74 from Anc1pa-HisF, a destabilization of the complex was predicted (ΔΔG = + 
3.4 kcal/mol). For the exclusive mutual exchange of residue 72 a much weaker effect was 
forecasted.  
In order to test the validity of the in silico analysis, Ala72 and Ser74 of Anc1pa-
HisF were simultaneously replaced by Gln72 and Phe74 from LUCA-HisF, yielding 
Anc1pa-HisF-A72Q+S74F (Figure 29). The Kd-value of less than 50 nM as measured for 
the formation of the Anc1pa-HisF-A72Q+S74F:zmHisH complex (Figure 28, Table 13) 
resembles the value for LUCA-HisF:zmHisH, narrowing down the crucial differences 
between LUCA-HisF and Anc1pa-HisF to two residues. In the next step, Ala72 and Ser74 
of Anc1pa-HisF were replaced individually by Gln72 and Phe74 from LUCA-HisF, 
yielding Anc1pa-HisF-A72Q and Anc1pa-HisF-S74F (Figure 29). The Kd-values for the 
formation of the Anc1pa-HisF-A72Q:zmHisH and Anc1pa-HisF-S74F:zmHisH complexes 
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were 3080 nM and less than 50 nM (Figure 28, Table 13), respectively. This result 
indicated that the LUCA-HisF residue Phe74 is much more important than residue Gln72 
for binding to zmHisH, which is in accordance with the prediction of FoldX. This 
conclusion was finally confirmed by the replacement of Phe74 from LUCA-HisF with 
Ser74 from Anc1pa-HisF (Figure 29): the Kd-value of 1440 nM as determined for the 
formation of the LUCA-HisF-F74S:zmHisH complex was at least 29-fold higher than for 
LUCA-HisF:zmHisH but only two-fold lower than for Anc1pa-HisF:zmHisH (Figure 28, 
Table 13).  
The analysis showed that Phe74 of LUCA-HisF is decisive for its affinity for 
zmHisH. This residue is not conserved: Within the 74 bacterial HisF sequences used to 
compute LUCA-HisF, the frequency of Phe was 72% and the 13 archaeal HisF sequences 
contained Ser (84%) or Thr (16%) residues only. The occupancy of position 74 might have 
in general a strong influence on the affinity of a given HisF enzyme for zmHisH. TmHisF, 
which exhibits with a Kd-value of 1560 nM a low affinity for zmHisH (Figure 28, Table 13) 
has an Asp residue at position 74. The replacement of Asp74 with Phe in tmHisF resulted 
in a Kd-value of less than 50 nM for the tmHisF-D74F:zmHisH complex, corresponding to 
an at least 31-fold affinity increase. The reconstructed evolutionary intermediates Anc1tm-
HisF and Anc2tm-HisF, which link LUCA-HisF with tmHisF (Figure 23), both carry a Phe 
at position 74. Both proteins were produced and characterized with respect to their binding 
to zmHisH. The Kd-values for the formation of Anc1tm-HisF:zmHisH and Anc2tm-
HisF:zmHisH are less than 50 nM, testifying to high affinities. In contrast, the Kd-value for 
the formation of Anc2tm-HisF-F74D:zmHisH is 380 nM, corresponding to an at least 8-
fold affinity decrease (Figure 28, Table 13). These data indicate that, indeed, Phe74 of HisF 
is a hot spot with respect to binding zmHisH.  
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Figure 28: Fluorescence titration experiments to determine dissociation constants (Kd) for the 
interaction of various HisF proteins with zmHisH. 
5 µM of zmHisH were titrated with HisF in 50 mM potassium phosphate, pH 7.5, at 25 °C. Fluorescence of 
the conserved Trp residue was excited at 295 nm, and the emission intensity was determined at 318 nm. Data 
points were fitted with a quadratic equation (Equation 9), which yielded a 1:1 stoichiometry and various Kd-
values. 
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Table 13: Dissociation constants (Kd) for the interaction of various HisF proteins with zmHisH.  
The Kd-values were determined in fluorescence titration experiments with 5 µM HisH in 50 mM potassium 
phosphate, pH 7.5. The shown Kd-values are the mean as determined from two independent titration 
experiments. (The individually determined values are given in parenthesis.) For high-affinity complexes, only 
an upper limit Kd < 50 nM can be given. No complex formation could be detected between paHisF and 
zmHisH, indicating that Kd > 5000 nM. 
 
HisH HisF Kd (nM) 
zmHisH 
LUCA-HisF < 50 
paHisF > 5000 
Anc1pa-HisF 2730 (2400; 3050) 
Anc1pa-HisF* < 50 
Anc1pa-HisF-A72Q+S74F < 50 
Anc1pa-HisF-A72Q 3080 (2630; 3520) 
Anc1pa-HisF-S74F < 50 
LUCA-HisF-F74S 1440 (1040; 1830) 
tmHisF 1560 (943; 2170) 
tmHisF-D74F < 50 
Anc1tm-HisF < 50 
Anc2tm-HisF < 50 
Anc2tm-HisF-F74D 380 (312; 447) 
 
An overview of the described stepwise identification of a hot spot in LUCA-HisF for 
binding to zmHisH is given in Figure 29.  
 
Figure 29: Stepwise identification of a HisF hot spot for binding to zmHisH.  
The rationale for the generation of the HisF variants shown in panels A - E is detailed in the text. HisF 
variants with high affinity (nM range) and low affinity (μM range) for zmHisH are framed in orange and gray, 
respectively. 
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5.2.4.4 Analysis of physicochemical principles of complex stability with the help of in 
silico mutagenesis and coevolution analysis  
It has been demonstrated in the previous chapter that ASR can be successfully used for the 
identification of moderately conserved hot spots. Interestingly, a Phe at position 74 
stabilizes the complex between a HisF protein and zmHisH, however a Ser or Asp at this 
position results in destabilization. What are the structural and physicochemical principles 
that cause the different stabilities? 
To gain more insight, in a first step, the effect onto complex stability was estimated 
for all possible amino acid replacements at position 74 in Anc1pa-HisF:zmHisH by means 
of in silico mutagenesis with FoldX. The results of this analysis indicated that the most 
stabilizing residues are Phe and Trp. The homology model of Anc1pa-HisF:zmHisH 
indicates no increase of the number of hydrogen bonds upon the introduction of Ser74Phe 
or Ser74Trp substitutions. However, it suggests that shape complementarity is improved by 
filling a small cavity at the interface of the complex.  
Nevertheless, complexes like tmHisF:tmHisH and paHisF:paHisH, which carry an 
Asp or Ser at position 74 in HisF, are also highly stable. Therefore and because when 
analyzing protein interfaces it is generally not sufficient to study only one partner, 
interaction studies were extended to the HisH subunit. 
As ImGPS belongs to the group of permanent, obligatory complexes (Ofran & Rost, 
2003) coevolution of the interface subunits can be assumed (Richter et al., 2010). Thus, a 
coevolutionary analysis might identify positions in HisH that in concert with position 74 in 
HisF affect the stability of the ImGPS complex. Coevolution analysis was conducted with 
GREMLIN (Generative Regularized ModeLs of proteINs). This method learns a global 
statistical model of the amino acid composition in an MSA capturing coevolution, which 
allows for the determination of residues that are in contact with each other (Balakrishnan et 
al., 2011). In the case of ImGPS, the results signaled the co-variation of position 74 in HisF 
with positions 28 and 202 in HisH (numbering according to zmHisH). Table 14 lists the 
amino acids that occupy positions 74 in HisF as well as positions 28 and 202 in HisH. 
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Table 14: Amino acid distribution at coevolving interface positions in different HisF and HisH subunits.  
The numbering of the positions in HisH and in HisF is according to zmHisH and LUCA-HisF, respectively. 
 
organism position 28(HisH) position 202(HisH) position 74(HisF) 
T. maritima Arg Arg Asp 
P. arsenaticum Arg Leu Ser 
Z. mobilis Ala Leu Phe 
LUCA - - Phe 
Anc1pa - - Ser 
 
The crystal structure of tmHisF:tmHisH (pdb: 1gpw) shows that Asp74 in HisF 
indeed faces Arg28 and Arg202 in HisH, which are located next to each other. The small 
negative Asp74 and the large Arg28 and Arg202 are of optimal electrostatic and shape 
complementarity leading to high complex affinity. In the case of the LUCA-HisF:zmHisH 
homology model, the combination of the large hydrophobic Phe74 in HisF and the small 
hydrophobic Ala28 and the medium-size Leu202 in zmHisH leads to optimal shape 
complementarity with optimized Van der Waals interactions, resulting in a high affinity of 
both subunits. In contrast, in the low-affinity complexes paHisF:zmHisH, Anc1-
paHisF:zmHisH, and LUCA-HisF-F74S:zmHisH the small and polar Ser74 from HisF can 
presumably interact less favorably with Ala22 and Leu202 from HisH. Instead, this 
constellation leads to an energetically highly unfavorable cavity. Based on these 
observations, it was speculated that Ala28Arg and Leu202Arg exchanges in zmHisH could 
enhance its affinity for Anc1pa-HisF or LUCA-HisF-F74S. To test this, the Arg residues 
were introduced in zmHisH at the corresponding positions and the Kd-values for the 
binding of zmHisH-A28R, zmHisH-L202R and zmHisH-A28R+L202R to Anc1pa-HisF 
and the binding of zmHisH-A28R+L202R to LUCA-HisF-F74S were determined (Figure 
30). 
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Figure 30:  Fluorescence titration experiments to determine dissociation constants (Kd) for the 
interaction of Anc1pa-HisF or LUCA-HisF-F74S with zmHisH mutants. 
5 µM of each zmHisH mutant were titrated with Anc1pa-HisF (red, green, blue and violet curves) or LUCA-
HisF-F74S in 50 mM potassium phosphate, pH 7.5, at 25 °C. Fluorescence of the conserved Trp residue was 
excited at 295 nm, and the emission intensity was determined at 318 nm. Data points were fitted with a 
quadratic equation (Equation 9). The resulting Kd-values are given in the legend. The shown Kd-values are the 
mean as determined from two independent titration experiments. (The individually determined values are 
given in parenthesis.). 
 
While the Leu202Arg exchange only has a marginal effect on the affinity of zmHisH for 
Anc1pa-HisF, the Ala28Arg exchange results in a nine- to 15-fold improvement of the Kd-
value. The difference in the Kd-values of Anc1pa-HisF:zmHisH-A28R and Anc1pa-
HisF:zmHisH-A28R+L202R is smaller than the precision of the method and thus is not 
significant. 
All in all, the measurements show that an Arg at position 28 in zmHisH enhances its 
affinity to HisF proteins that carry a Ser at position 74 in HisF. Thus, these findings 
confirm that complex stability can be restored by optimizing geometric and electrostatic 
complementarity.  
In order to rule out that weak complex formation was due to misfolding the 
structural integrity of all HisF proteins used in the interaction studies and of the zmHisH 
mutants was analyzed by size exclusion chromatography (chapter 4.5.3) and far-UV CD 
spectroscopy (chapter 4.5.4), which is given in the Appendix (chapter 8.3 & 8.4). 
 
5.2.4.5 Conclusion 
With the help of ASR, in combination with in silico protein design and experimental 
mutagenesis, Phe74 in LUCA-HisF could be identified as a hot spot for the interaction with 
zmHisH. Phe74 is not conserved within the HisF proteins and is located at the rim of the 
interface. Thus, this hot spot does not fulfill typical characteristics of hot spots, which are 
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high conservation and a central position in the interface (Zhang et al., 2013). How can this 
be explained? In the case of ImGPS, the interface residues are not only responsible for 
complex stability but may also be involved in the propagation of the allosteric signal and 
substrate channeling, which imposes a strong selection pressure on these residues. In 
accordance with that, most residues in the core of the interface are highly conserved in 
LUCA-HisF and present-day enzymes. However, in the post-LUCA era, divergent 
evolution occurred in ImGPS, and due to the evolutionary constraints, rim residues of both 
interfaces were affected.  
Thus, the presented results make clear that the conservation of interface residues is 
no strong signal for interaction hot spots.  
The study also shows that a strategy involving ASR can only be applied to proteins 
which can be reliably reconstructed. As this is not possible for the glutaminase subunit, the 
complex interface in HisH cannot be analyzed with the help of ancient proteins. In cases 
like the one presented here, where only one complex subunit can be successfully 
reconstructed other methods such as coevolution can be used to obtain information about 
crucial interface positions. 
 
5.2.5 Studies on allosteric regulation with the help of ancient HisF proteins 
5.2.5.1 Concept, mutational studies and computational approach 
Differences in the affinities of LUCA-HisF and paHisF for zmHisH formed the basis for 
the identification of an interaction hot spot, with Anc1pa-HisF being of great importance 
for these studies. An analog approach should also be useful for the identification of residues 
that are involved in the allosteric mechanism in ImGPS. A prerequisite for the successful 
identification of such positions is that LUCA-HisF and a present-day HisF exhibit different 
allosteric behavior with respect to a modern HisH protein. Therefore, LUCA-HisF was 
tested for its ability to allosterically interact with modern glutaminases. It has already been 
shown before that LUCA-HisF allosterically interacts with zmHisH (Reisinger et al., 2014). 
Additionally, glutaminase activities of LUCA-HisF:paHisH and LUCA-HisF:tmHisH in the 
presence of saturating concentrations of ProFAR and glutamine were determined (chapter 
4.5.6.3). While glutaminase activity was detected in the case of 2 µM LUCA-HisF and 1 
µM paHisH (15 mM glutamine, 40 µM ProFAR), no turnover was observed even for 
20 µM LUCA-HisF:tmHisH (8 mM glutamine, 200 µM ProFAR). This outcome suggests 
that a distinct allosteric mechanism has evolved along the phylogenetic path from LUCA-
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HisF to tmHisF (Figure 23). This is in accordance with the observation that present-day 
paHisF does not induce glutaminase activity of tmHisH. TmHisF, of course, allosterically 
interacts with tmHisH. Table 15 provides an overview of the allosteric stimulation of HisH 
in chimeric complexes with LUCA-HisF or present-day HisF proteins. 
 
Table 15: Overview of allosteric activation in chimeric HisF:HisH complexes.  
AS: Allosteric stimulation; X: No allosteric stimulation. Allosteric stimulation is assumed when glutaminase 
activity can be observed according to the kinetic assay described in chapter 4.5.6.3. 
 
 LUCA-HisF paHisF tmHisF
zmHisH AS - - 
paHisH AS AS - 
tmHisH X X AS 
 
LUCA-HisF and tmHisF are separated by 79 residues. The intermediates along the 
phylogenetic path from LUCA-HisF to tmHisF differ in even less amino acids: Anc1tm-
HisF is separated from LUCA-HisF and Anc2tm-HisF by 20 and 22 mutations, respectively 
(Figure 23). Anc2tm-HisF differs from extant tmHisF in 69 residues (Figure 23).  
Therefore, Anc1tm-HisF and Anc2tm-HisF were analyzed for their ability to 
allosterically stimulate tmHisH. In a first step, the ability of Anc1tm-HisF and Anc2tm-
HisF to interact with tmHisH was examined. In fluorescence titration experiments (chapter 
4.5.5) a tight subunit interaction with Kd < 50 nM was detected for both HisF proteins. 
Glutaminase activity (chapter 4.5.6.3) was then tested for 1 µM tmHisH and 2 µM Anc1tm-
HisF or Anc2tm-HisF in the presence of 40 µM ProFAR and 8 mM glutamine. As no 
glutaminase activity was observed under these conditions for both complexes, tmHisA was 
added to the reaction. TmHisA converts ProFAR into PRFAR, which is less stable than 
ProFAR (Klem & Davisson, 1993). However, in previous studies it was demonstrated that 
the stimulation of glutaminase activity with the native substrate PRFAR is more efficient 
than with its precursor ProFAR (Beismann-Driemeyer & Sterner, 2001). Yet, no 
glutaminase activity could be detected under these conditions. Furthermore, no turnover 
occurred in the case of 20 µM complex and 200 µM ProFAR. On the basis of these 
observations it can be concluded that Anc1tm-HisF and Anc2tm-HisF are not able to 
allosterically induce glutaminase activity of tmHisH.  
Obviously, at least some of the 69 mutations that interconvert Anc2tm-HisF into 
extant tmHisF are involved in the allosteric stimulation of tmHisH. It follows that the 
replacement of these residues in Anc2tm-HisF by residues from extant tmHisF must enable 
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Anc2tm-HisF to allosterically stimulate glutaminase activity of tmHisH. However, 69 
positions are not feasible to be sampled in mutational studies. Thus candidate positions 
were preselected according to the following consideration: Kinetic studies that are 
presented in the Appendix in chapter 8.5.4 show that Anc1tm-HisF and Anc2tm-HisF are 
able to induce glutaminase activity of zmHisH. This demonstrates that after binding of 
ProFAR at the active site, the reconstructed HisF proteins can apparently undergo 
conformational motions that are transferred beyond the complex interface and that prompt 
zmHisH to set free glutamate and ammonia. It can be assumed that these motions also 
occur in the reconstructed HisF proteins complexed with tmHisH. However, the signaling 
mechanism might be interrupted at the interface, for example by steric clashes. Positions 
that are part of the interface or located in the loops connecting α-helices with β-sheets could 
be responsible for the different allosteric behavior. Therefore, at candidate positions 
residues in Anc2tm-HisF were exchanged for corresponding residues from tmHisF. This 
yielded the following mutant named Anc2tm-HisF_A1: 
Anc2tm-HisF-
N40S+E42I+A44I+R67E+V73I+F74D+L77F+L93I+S195T+I196L+I247V+ 
E248N+EGL 
EGL are the three C-terminal residues of tmHisF which are missing in Anc2tm-HisF. The 
gene coding for Anc2tm-HisF_A1 was synthesized (chapter 4.3.11) and cloned into a 
vector (chapter 3.7.1). Gene expression at analytical scale (chapter 4.4.1.1) in E.coli BL21-
Gold (DE3) and T7 Express cells at 20 °C and 30 °C overnight did not provide soluble 
protein. It seemed reasonable to assume that the Anc2tm-HisF_1 variant is more stable 
when bound to an interaction partner. In order to co-express Anc2tm-HisF_A1 and tmHisH 
the genes were cloned into a pACYC-Duet1 vector (chapter 3.7). However, expression at 
20 °C and 30 °C over night in E. coli BL21-Gold (DE3) did not yield soluble complex.  
Therefore, in a second approach for the identification of residues that are involved 
in the allosteric mechanism, dynamic cross correlations (DCC) analysis was used. A DCC 
analysis quantifies the correlated motions of atoms in a MD simulation and thus can help to 
analyze the dynamic communication between subunits of molecular systems (Kasahara et 
al., 2014). For this purpose a homology model of Anc2tm-HisF:tmHisH was generated with 
YASARA. A DCC analysis for tmHisF:tmHisH (pdb: 1gpw) and Anc2tm-HisF:tmHisH 
with bound PRFAR was subsequently conducted by Kristina Heyn (Figure 31).  
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Figure 31: Dynamic cross correlation analysis (DCC) of HisF:tmHisH complexes with bound PRFAR.  
A) tmHisF:tmHisH (pdb: 1gpw). B) Model of Anc2-tmHisF:tmHisH generated with YASARA. Correlative 
motions between residues are depicted with red lines. N- and C-terminus and position 74 in HisF shows more 
correlative motions with HisH in tmHisF:tmHisH compared with Anc2tm-HisF:tmHisH complex. The model 
of Anc2-tmHisF:tmHisH was generated and the DCC analysis was conducted by Kristina Heyn. 
 
The results were as follows: Position 74 and the N- and C-terminus of tmHisF display 
numerous correlated motions with residues in the tmHisH subunit. In contrast to that, the 
complex Anc2tm-HisF:tmHisH exhibits significantly less correlated motions in the 
respective parts of the interface. Therefore, the exchange Phe74Asp and the extension of 
the C-terminus for the residues EGL were maintained in the new mutant. Moreover, as 
positions 40 and 77 are in proximity to position 74, the exchanges Asn40Ser and Leu77Phe 
were maintained as well. Thus, the number of mutations was reduced from 12 (plus 3 
residues as C-terminal extension) in Anc2tm-HisF_A1 to only 3 mutations (plus C-terminal 
extension) in the new mutant Anc2tm-HisF-N40S+F74D+L77F (Anc2tmHisF_A2). The 
gene coding for Anc2tm-HisF_A2 was synthesized (chapter 4.3.11), expressed at 
preparative scale and purified as described for the reconstructed HisF proteins (chapter 
5.2.4.2). About 63 mg protein were obtained per 1 liter of expression culture. According to 
SDS PAGE the protein was more than 95% pure (chapter 4.5.2, Figure 32). 
Results and Discussion 107 
 
 
Figure 32: SDS-PAGE (12.5% polyacrylamide) for the analysis of the purity of Anc2tm-HisF_A2.  
M: protein marker and ladder (LMW), 1: Anc2tm-HisF_A2. 
 
In fluorescence titrations (chapter 4.5.5) a Kd ≤ 50 nM was determined for the binding of 
Anc2tm-HisF_A2 to tmHisH. Glutaminase activity of Anc2tm-HisF_A2:tmHisH was 
assayed under the same conditions as described for LUCA-HisF:tmHisH, however 12 mM 
glutamine were used instead of 8 mM. Under these conditions no glutaminase activity was 
observed.  
Kinetic characterizations, which were conducted in order to rule out that the 
reconstructed HisF proteins discussed in this chapter are per se catalytically inactive or 
unable to induce glutaminase activity of a HisH protein are given in the Appendix (chapter 
8.5). For comparison kinetic parameters of present-day HisF and HisH proteins and of 
Anc1-paHisF, which was used in the interaction studies, are also given in this chapter. 
Moreover, for Anc2tm-HisF_A2, structural integrity was assayed via analytical size 
exclusion chromatography (chapter 4.5.3) and far-UV CD spectroscopy (chapter 4.5.4) in 
order to exclude that the amino acid exchanges resulted in structural perturbations (chapter 
8.6). 
All in all, mutational studies with primordial HisF proteins were not successful to 
identify residues that are decisive for allosteric activation. Therefore, X-ray crystallography 
was attempted in order to detect structural differences which might be responsible for the 
different allosteric behavior of an allosterically active and an inactive HisF:HisH complex. 
In this context, the inactive complex LUCA-HisF wt:tmHisH turned out to crystallize well. 
Because of this, the apo-complex and the glutamine-bound structure of LUCA-HisF 
wt:tmHisH were compared with the crystal structures of tmHisF:tmHisH with and without 
bound glutamine. 
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5.2.5.2 Crystal structure of LUCA-HisF wt:tmHisH with and without bound 
glutamine 
For the crystallization of apo complex LUCA-HisF wt:tmHisH and the complex with bound 
glutamine (chapter 4.5.8), LUCA-HisF and tmHisH were mixed in equimolar amounts, and 
the complex was subjected to size exclusion chromatography (chapter 4.4.2.5). Fractions 
containing pure complex were pooled and dialyzed against 10 mM potassium phosphate pH 
7.5 and 1 mM DTT. Crystals were obtained in 0.1 M sodium citrate pH 5.0 and 15% PEG 
4000 (Figure 33). For co-crystallization, the reservoir solution was supplemented with 
20 mM glutamine. 
 
Figure 33: Crystallization of LUCA-HisF wt:tmHisH. Crystals were obtained in in 0.1 M sodium citrate 
pH 5.0 and 15% PEG 4000. 
 
X-ray data were collected at Swiss Light Source (SLS, Switzerland) and the crystal 
structures were determined at 2.2 Å and 2.5 Å resolution, respectively, by Dr. Chitra 
Rajendran (chapter 4.5.8). The asymmetric unit (ASU) contains two LUCA-HisF and two 
tmHisH domains, one of each forming a complex. The respective complex partners of the 
other two polypeptide chains are part of another ASU. Each the LUCA-HisF and the 
tmHisH domains of one ASU do not significantly differ from each other. In both the apo 
complex and the complex with bound glutamine two C-terminal Arg of tmHisH are missing 
due to high flexibility of the C-terminus. The structure of the apo complex LUCA-HisF 
wt:tmHisH was superimposed with the apo complex tmHisF:tmHisH (pdb: 1gpw chains 
CD) and the structure of LUCA-HisF wt:tmHisH with glutamine was superimposed with 
the glutamine-bound structure of tmHisF:tmHisH (pdb:3ZR4, AB) (List et al., 2012) in 
order to pinpoint structural differences between the complexes that might be the source of 
the differences in glutaminase activity. The LUCA-HisF wt:tmHisH complexes 
superimpose well with the respective tmHisF:tmHisH complexes with root mean square 
deviations (r.m.s.d) of about 0.9 Å, determined with Pymol. As the superposition of the apo 
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complexes does not provide additional information, in the following, only the glutamine-
bound structures are discussed. Figure 34 depicts the superposition of residues and motifs 
which were found to putatively play a role in the allosteric mechanism.  
 
 
Figure 34: Superposition of tmHisF:tmHisH with bound glutamine (pdb: 3ZR4, cahin AB; List et al. 
2012, cell) and LUCA-HisF:tmHisH with bound glutamine.  
A) Salt bridge cluster that forms the gate at the entrance into the tunnel of HisF. Polar contacts between the 
residues are illustrated as dashed lines in red (3ZR4) and in green (LUCA-HisF:tmHisH). B) Residues that 
belong to the active site of HisH and that play a role in the allosteric mechanism. D98 belongs to HisF. The 
red asterisk marks the oxyanion hole, which is properly formed. The hydrogen bond between the polar main 
chain of Gly52 and the carbonyl group of glutamine is shown as a dashed line. The green glutamine belongs 
to 3ZR4, the pink one belongs to LUCA-HisF:tmHisH. Residues belonging to 3ZR4 are colored in orange, 
residues that belong to LUCA-HisF:tmHisH are given in olive.  
 
In the following, an overview of the analysis of the gate into the barrel (Arg5, 
Glu46, Lys99 and Glu167; all in HisF), the glutaminase active site, and the glutamine 
binding site is given. Overall, these parts of the complex superimpose well with the 
respective parts in the glutamine-bound tmHisF:tmHisH complex. 
The gate residues Arg5(HisF), Glu46(HisF) and Glu167(HisF) superimpose well 
with each other and form a salt bridge cluster. In tmHisF:tmHisH with bound glutamine, 
Lys99(HisF) interacts with Tyr138(HisH) thus flipping downwards and opening the gate 
(List, 2009). This flip is not definitely seen in the structure of LUCA-HisF wt:tmHisH 
(Figure 34, panel A). The interdomain contact Asp98(HisF) – Lys181(HisH), 
Tyr138(HisH) and the conserved PGVG motif (residues 49-52 in HisH) superimpose well 
and do not display markedly different conformations. The residues of the catalytic triad 
(Cys84, His178 and Glu180 in tmHisH) adopt different rotamers in both structures (Figure 
34, panel B). However, different rotamers are also observed for these residues in the three 
complexes in the ASU of apo tmHisF:tmHisH and for His178 also in the glutamine-bound 
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structure. Furthermore, different rotamers are also found in the superposition of 
tmHisF:tmHisH with the complex structure of constitutively active tmHisF:tmHisH-
Y138A+K181A (pdb 2WJZ) (List, 2009). Therefore, the different rotamers are not the 
reason for glutaminase inactivity of LUCA-HisF wt:tmHisH. In the structure of 
tmHisF:tmHisH with bound glutamine Asp98(HisF) and His178(HisH) interact via a water-
mediated hydrogen bond (List et al., 2012). In the structure of LUCA-HisF wt:tmHisH with 
bound glutamine this particular water molecule is not visible. The investigation of the 
binding site of glutamine in tmHisH reveals that in both complexes the ligands are engaged 
in comparable interactions. Thus in the LUCA-HisF wt:tmHisH complex the ligand forms 
hydrogen bonds with Gln88(HisH) and Glu96(HisH) and interacts with the main-chain of 
Thr142(HisH) and Tyr143(HisH) (not shown in Figure 34). In tmHisF:tmHisH Gln123 
from tmHisF interacts with the glutamine ligand via a weak hydrogen bond. In the structure 
of LUCA-HisF wt:tmHisH the distance between Gln123(LUCA-HisF) and the ligand is 
6.9 Å, which is too far for an interaction. In tmHisF:tmHisH, Gly52(HisH), which is part of 
the oxyanion strand, forms a hydrogen bond of about 2.5 Å distance with the reactive 
carbonyl group of the glutamine ligand. Notably, this hydrogen bond stabilizes the thioester 
intermediate during the catalysis. In the LUCA-HisF wt:tmHisH complex a hydrogen bond 
of 3.7 to 4.0 Å is found, which is a weak interaction (Jeffrey, 1997).  
In summary, subtle conformational deviations become evident, however, it is not 
possible to relate these differences to different allosteric behavior. In all cases where the 
side chains in LUCA-HisF wt:tmHisH slightly deviate from the respective side chains in 
tmHisF:tmHisH, flexibility of the residues cannot be excluded, as judged by electron 
density. Therefore, the side chains in glutamine-bound LUCA-HisF wt:tmHisH might adopt 
identical conformations as can be observed in the catalytically active glutamine-bound 
tmHisF:tmHisH complex.  
 
5.2.5.3 Conclusion 
As far as the mutational studies are concerned, the introduction of putatively decisive 
residues from tmHisF at equivalent positions in Anc2tm-HisF, which does not allosterically 
stimulate tmHisH, did not result in glutaminase activity of Anc2t-HisF:tmHisH. One 
obstacle is that Anc2tm-HisF and tmHisF are separated by 69 mutations, which are too 
many to be tested in mutational studies. The computational methods used to narrow down 
the number of mutations were not successful. Moreover, introducing a large number of 
Results and Discussion 111 
 
amino acid exchanges renders Anc2tm-HisF insoluble, which limits the number of variants 
that can be examined in mutational studies. 
With the help of X-ray crystallography analysis, no significant structural differences 
could be identified between the allosterically active tmHisF:tmHisH and the allosterically 
non-active LUCA-HisF:tmHisH complex. A shortcoming of investigating allosteric 
principles with the help of protein crystals is that the structures are a snapshot of a single 
conformational state. Fast dynamic changes that may occur during the allosteric process 
cannot be identified with this method. Certainly, a structure of both complexes with bound 
PRFAR in the active site of HisF would be more helpful to identify differences in 
conformational changes of active and non-active complexes, however, attempts to soak or 
co-crystallize LUCA-HisF:tmHisH with PRFAR were not successful.  
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6 Final discussion and outlook 
6.1 Implications for protein-protein interaction and allostery in ImGPS 
ImGPS is a highly elaborate key metabolic enzyme complex, which serves as a paradigm to 
study protein-protein interaction and allostery. On the basis of data from X-ray 
crystallography and mutational studies, single residues that may be involved in the 
allosteric mechanism have been identified and in NMR studies conformational and dynamic 
transitions haven been observed (Amaro et al., 2007; List et al., 2012; Rivalta et al., 2012). 
Nevertheless, the complete molecular mechanism of allosteric HisF:HisH communication 
and the individual amino acids responsible for protein-protein interaction have remained 
elusive to date (List, 2009; List et al., 2012). The results of this work provide further insight 
into the mechanistic principles of complex stability and allostery in ImGPS. 
In NMR titration experiments the binding sites of HisF for a peptide which inhibits 
ImGPS glutaminase activity have been identified. The HisF:peptide interaction face 
comprises and is in proximity to residues and structural elements that have been shown to 
be involved in glutaminase activity and the allosteric signal transduction in previous 
studies, such as Asp98 and the N-terminal face of the α2 and α3 helices (List et al., 2012; 
Rivalta et al., 2012; Manley et al., 2013). The N-terminal face of the α2 and α3 helices is 
formed by the loops connecting α2/β3 and α3/β4. These loops comprise positions 71-77 and 
96-98. Notably, the interaction site covers position 74 in HisF, which is part of the loop that 
protrudes into the HisH:HisF interaction face (Figure 35). 
 
Figure 35: Proximity of position 74 to putatively allosterically important motifs in HisF.  
Depicted is the crystal structure of tmImGPS. The N-terminal face of the α2 and α3 helices is formed by the 
loops connecting α2/β3 and α3/β4, which bear residues Asp74 and Asp98. 
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Interestingly, position 74 has never been subject of previous studies on ImGPS, however, 
the outcome of this work suggests a central role for the stability of the complex: the 
replacement of Phe74 by Ser in HisF results in an impairment of the affinity for zmHisH, 
and in tmHisF the exchange of Asp74 by Phe enhances the binding to zmHisH by a factor 
of at least 31. In studies on allosteric communication in HisF:HisH by means of DCC 
analysis, again it is position 74 in tmHisF that exhibits correlation with interface residues in 
tmHisH upon PRFAR binding. This finding and the mapping of the interaction sites of the 
inhibiting peptide suggests that position 74 might also be involved in the propagation of the 
allosteric signal from HisF to HisH. 
Interaction hot spots are commonly characterized as being highly conserved and 
located in the center of the interface (Zhang et al., 2013). However, the results of the 
protein-protein interaction analysis of ImGPS presented in this work illustrates that the hot 
spot position 74, which is located at the rim of the interface, has diverged in the course of 
evolution. As a consequence, it was found that paHisF and tmHisF only weakly bind to 
zmHisH, however, though not measured, a tight interaction between zmHisF and zmHisH 
can be assumed. Likewise, allosteric pathways are not highly conserved (Murciano-Calles 
et al., 2016). This is also in accordance with the findings of this work: no glutaminase 
activity could be detected for the paHisF:tmHisH complex, indicating that tmHisF:tmHisH 
has evolved an allosteric mechanism that differs from paHisF:paHisH.  
These findings make clear that functional important residues cannot be identified on 
the basis of “simple” rules like residue conservation. In the case that mechanistic principles 
have diverged in a protein family in the course of evolution, ASR is a powerful method to 
identify such specificity determining positions.  
6.2 ASR as an effective method for disentangling protein-protein 
interaction and allostery 
In the framework of this thesis, ASR was used to identify residues that are decisive for 
protein-protein interaction and allosteric communication in the model enzyme ImGPS. 
Such residues could in principle also be detected by comparing modern orthologues. 
However, in the case of the analysis of complex stability, amino acid swap experiments in 
positions that distinguish paHisF and tmHisF from zmHisF would be necessary. Overall, 
zmHisF differs from paHisF and tmHisF on average in 120 amino acids, which is a huge 
number of candidate residues. It is most likely that the amino acids that are responsible for 
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different binding behavior are located in the putative interaction face, but even then about 
20 positions would have to be sampled. Analogously, for the identification of residues that 
are involved in allosteric pathways of ImGPS, tmHisF and paHisF have to be compared, 
which differ in 107 residues. Moreover, a lot of modern HisH and HisF proteins, among 
them zmHisF, are insoluble or unstable and thus not available for experimental 
characterization. This makes clear that experimental comparative mutagenesis studies 
between modern HisF proteins are not feasible.  
In the context of this thesis it was demonstrated for ImGPS that the horizontal 
approach has two decisive advantages if compared to the vertical approach: First, all 
reconstructed HisF proteins were stable proteins, available for experimental 
characterization and turned out to be catalytically active at a biologically realistic scale (cf. 
chapter 8.5). Second, the positions that have to be sampled in mutational studies are 
drastically reduced. In the case of protein-protein interaction, LUCA-HisF and Anc1pa-
HisF, which display markedly distinct binding behavior for zmHisH, differ in 29 amino 
acids, but not more than 9 positions are located in the interface. As far as allosteric studies 
are concerned, Anc2tm-HisF, which does not allosterically stimulate tmHisH, differs from 
tmHisF in 69 positions.  
However, also these limited numbers are too large to allow for a comprehensive 
experimental mutagenesis analysis. Thus, other computational methods must be applied to 
further narrow down candidate residues. In the case of the hot spot analysis, FoldX was 
successfully used to predict effects of mutations on the complex stability and thus to find a 
hot spot that contributes to complex formation.  
It is fair to note, that ASR has limitations. The ASR methodology contains several 
sources of uncertainty. For example, the substitution models are based on implicit 
assumptions which do not always represent the evolution of a given protein family. 
Although, studies on reconstructed proteins prove that a certain degree of uncertainty is 
tolerated (Ugalde et al., 2004; Gaucher et al., 2008; Bar-Rogovsky et al., 2015; Eick et al., 
2016; Randall et al., 2016), even the usage of a state-of-the-art ASR method can lead to 
erroneous ancestral proteins. For example, an inaccurate enzyme from the leucine 
biosynthetic pathway was reconstructed, which displayed biologically unrealistic catalytic 
parameters (Hobbs et al., 2012). Moreover, ASR cannot be applied to all protein families. 
The computation of a phylogeny requires a sufficient number of present-day sequences 
(Merkl & Sterner, 2016) and a low quality or a strong heterogeneity of the sequences can 
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also impede ASR. Most plausibly, the latter problem is the reason for the reconstruction of 
a catalytically inactive LUCA-HisH. 
As a consequence, it is advisable to test and compare proteins that have been 
reconstructed on the basis of different substitution models and different sampling methods 
(Eick et al., 2016). Moreover, a recent study on ancestral enzymes proposed the systematic 
phenotypical evaluation of reconstructed proteins that carry less likely amino acids at 
ambiguous positions in comparison to the mpa (Bar-Rogovsky et al., 2015). This does not 
only increase the probability to find stable and functional ancestral enzymes but it also 
helps to estimate the validity of the results. However, such approaches do not cover all 
possible sources of uncertainty. Moreover, it is questionable if such approaches would have 
led to the identification of an active LUCA-HisH as the erroneous reconstruction is 
probably a consequence of the limitations in the handling of insertion and deletion events in 
the MSA and thus a problem of ASR to correctly treat loops. This makes clear, that 
algorithms for ASR still have to be optimized to tackle such difficult problems.  
As far as protein-protein interaction and allosteric studies presented here are 
concerned, a certain degree of deviation of the reconstructed phenotype from the real 
biological primordial phenotype can be accepted, as long as the proteins differ in binding 
and allosteric behavior.  
Despite these limitations, ASR can be applied to a variety of proteins and protein 
complexes and it will further be improved by the continously growing number of high-
quality sequence data.  
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8 Appendix 
8.1 Phylogenetic tree for reconstructing intermediate primordial HisF 
sequences 
 
Figure 36: Phylogenetic tree used for reconstruction of ancestral HisF sequences after optimization 
with FastML.  
The indicated lengths of the individual branches correspond to the rate of mutations per site. Posterior 
probabilities at the splits below 0.95 are shown in green. The horizontal bar indicates the branch length that 
corresponds to 0.1 mutations per site (Holinski et al., 2017). 
126 Appendix 
 
 
8.2 Nucleotide and amino acid sequences of LUCA-HisH, Anc1pa-HisF, 
Anc1tm-HisF and Anc2tm-HisF 
The nucleotide sequences were optimized for expression in E. coli. The introduced 
restriction sites for NdeI (5’) and XhoI (3’) are in bold, and the introduced stop codon is in 
italics. In the case of LUCA-HisH the His6-tag and the amino acids LE, which are derived 
from the expression vector are underlined. 
 
LUCA-HisH 
Nucleotide sequence  
5’CATATGAGCAAAACCATGCGTGTGGCCATTATTGATTATGGTATGGGTAATC
TGCGTAGCGTTAGCAAAGCACTGGAACGTGTTGGTGCCGAAGTTGTTGTTACCA
ATGATCCGGAAGAACTGAAAGAAGCAGACGCACTGATTCTGCCTGGTGTGGGT
GCATTTGATGAAGCAATGAAAAATCTGCGTTCACGTGGTCTGGTTGAAGTGATT
AAAGAAGTGGATAAATTCAACCGTGTGGCGAAAGGTAAACCGCTGCTGGGTAT
TTGTCTGGGTATGCAGCTGCTGTTTGAAAGCAGCGAAGAAGGTGGCACCACCA
AAGGTCTGGGCATTATTCCGGGTCGTGTTGAACGTATTCGTAGCGAAGCAGCA
GAAGGTGATAATCTGAAAATTCCGCACATGGGTTGGAATCAGGTTAATGTTGTT
CGTGAAAGCCCTCTGCTGGAAGGTATTCCGGAAGGTAGCTATTTCTATTTTGTG
CACAGCTACTATGTTGTGTATCCGACCAATGAAGAACATATTGTTGCAACCACC
GAATACTATGGCCAGAAATACACCGCAGCAGTTGCACGTGGTAACATTTTTGG
CACCCAGTTTCATCCGGAAAAAAGCGGTAAAGCAGGTCTGAAACTGCTGAAAA
ACTTTCTGGAATGGGTGGAACGTGAAAATAATGCACGTCGCCTCGAG3’ 
 
Protein sequence 
MSKTMRVAIIDYGMGNLRSVSKALERVGAEVVVTNDPEELKEADALILPGVGAFD
EAMKNLRSRGLVEVIKEVDKFNRVAKGKPLLGICLGMQLLFESSEEGGTTKGLGIIP
GRVERIRSEAAEGDNLKIPHMGWNQVNVVRESPLLEGIPEGSYFYFVHSYYVVYPT
NEEHIVATTEYYGQKYTAAVARGNIFGTQFHPEKSGKAGLKLLKNFLEWVERENN
ARRLEHHHHHH 
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Anc1pa-HisF wt 
Nucleotide sequence 
5’CATATGCTGGCAAAACGTATTATTCCGTGTCTGGATGTTAAAGATGGTCGTG
TTGTTAAAGGCGTGAATTTTCAGAATCTGCGTGATGCCGGTGATCCGGTTGAAC
TGGCAGCACGTTATGAAGAAGAAGGCGCAGACGAAATTGTGTTTCTGGATATC
ACCGCAACACCGGAAGGTCGTGAAACCATGCTGGAAGTTGTTCGTCGTACCGC
AGAAGCAGTTAGCATTCCGCTGACCGTTGGTGGTGGTATTCGTAGCCTGGAAG
ATGTTGAAAAACTGCTGAAAGCCGGTGCAGATAAAGTGAGCATTAATACCGCA
GCAGTTAAAAATCCGCAGCTGATTACCGAAGCAGCAGAAGAATTTGGTAGCCA
GGCAGTTGTTGTTGCAATTGATGCAAAACGTGTGGGTGGTGGTTGGGAAGTTTT
TGTTCGTGGTGGTCGTAAACCGACCGGTCTGGATGCAGTTGAATGGGCAAAAA
AAGTTGAAGAACTGGGTGCCGGTGAAATTCTGCTGACCAGCATTGATCGTGAT
GGCACCAAAAATGGTTATGATCTGGAACTGACCCGTGCAGTTAGTGATGCCGTT
AAAATTCCGGTTATTGCAAGCGGTGGTGCGGGTGAACTGGAACATTTTTATGAA
GTGTTTAAACTGGAAGGTGCAGATGCAGCACTGGCAGCCAGCATTTTTCATTTT
GGTGTTCTGACCATTGGCGAAGTGAAAAAATACCTGCGTGAACGTGGTATTGA
AGTGCGTCTGTAACTCGAG3’  
 
Protein sequence 
MLAKRIIPCLDVKDGRVVKGVNFQNLRDAGDPVELAARYEEEGADEIVFLDITATP
EGRETMLEVVRRTAEAVSIPLTVGGGIRSLEDVEKLLKAGADKVSINTAAVKNPQL
ITEAAEEFGSQAVVVAIDAKRVGGGWEVFVRGGRKPTGLDAVEWAKKVEELGAG
EILLTSIDRDGTKNGYDLELTRAVSDAVKIPVIASGGAGELEHFYEVFKLEGADAAL
AASIFHFGVLTIGEVKKYLRERGIEVRL 
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Anc1pa-HisF* (including Trp to Tyr exchanges at positions 138 and 156) 
Nucleotide sequence 
5’CATATGCTGGCAAAACGTATTATTCCGTGTCTGGATGTTAAAGATGGTCGTG
TTGTTAAAGGCGTGAATTTTCAGAATCTGCGTGATGCCGGTGATCCGGTTGAAC
TGGCAGCACGTTATGATGAAGAGGGTGCAGATGAAATTGTGTTTCTGGATATC
ACCGCAACACCGGAAGGTCGTGAAACCATGCTGGAAGTTGTTGAACGTACCGC
AGAACAGGTTTTTATTCCGCTGACCGTTGGTGGTGGTATTCGTAGCCTGGAAGA
TGTGGAAAAACTGCTGCGTGCCGGTGCAGATAAAGTTAGCATTAATACCGCAG
CCGTTAAAAATCCGCAGCTGATTACCGAAGCAGCAGAAGAATTTGGTAGCCAG
GCAGTTGTTGTTGCAATTGATGCAAAACGTGTGGGTGGTGGTTATGAAGTTTTT
GTTCGTGGTGGTCGTAAACCGACCGGTCTGGATGCAGTTGAATATGCAAAAAA
AGTTGTGGAACTGGGTGCCGGTGAAATTCTGCTGACCAGCATTGATCGTGATGG
CACCAAAAATGGTTATGATCTGGAACTGACCCGTGCAGTTAGTGATGCAGTTA
GCGTTCCGGTTATTGCAAGCGGTGGTGCGGGTGAACTGGAACATTTTTATGAAG
TGTTTAAACTGGAAGGTGCCGATGCAGCACTGGCAGCCAGCATTTTTCATTTTG
GTGTTCTGACCATTGGCGAAGTGAAAAAATACCTGCGTGAACGTGGTATTGAA
GTGCGTTAACTCGAG3’ 
 
Protein sequence 
MLAKRIIPCLDVKDGRVVKGVNFQNLRDAGDPVELAARYDEEGADEIVFLDITATP
EGRETMLEVVERTAEQVFIPLTVGGGIRSLEDVEKLLRAGADKVSINTAAVKNPQLI
TEAAEEFGSQAVVVAIDAKRVGGGYEVFVRGGRKPTGLDAVEYAKKVVELGAGE
ILLTSIDRDGTKNGYDLELTRAVSDAVSVPVIASGGAGELEHFYEVFKLEGADAAL
AASIFHFGVLTIGEVKKYLRERGIEV 
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Anc1tm-HisF (including Trp to Tyr exchanges at positions 138 and 156) 
Nucleotide sequence 
5’CATATGCTGGCAAAACGTATTATTCCGTGTCTGGATGTTAAAGATGGTCGTG
TTGTTAAAGGCGTGAATTTTCAGAATCTGCGTGATGCCGGTGATCCGGTTGAAC
TGGCACGTCGTTATGATGAAGAGGGTGCAGATGAACTGGTTTTTCTGGATATCA
CCGCAACCCATGAAGGTCGTGAAACCATGCTGGAAGTTGTTCGTCGTACCGCA
GAACAGGTTTTTATTCCGCTGACCGTTGGTGGTGGTATTCGTAGCGTTGAAGAT
GTTAAAAAACTGCTGCGTGCCGGTGCAGATAAAGTTAGCATTAATACCGCAGC
CGTTAAAAACCCGGAACTGATTACCGAAGCAGCAGAAAAATTTGGTAGCCAGG
CAGTTGTTGTTGCAATTGATGCAAAACGTGTGGGTGGTGGTTATGAAGTTTTTA
CCCATGGTGGTCGTAAACCGACCGGTCTGGATGCAGTTGAATATGCAAAAAAA
GTTGAAGAACTGGGTGCCGGTGAAATTCTGCTGACCAGCATGGATCGTGATGG
CACCAAAAATGGTTATGATCTGGAACTGACCCGTGCAGTTAGTGATGCCGTTAG
CATTCCGGTTATTGCAAGCGGTGGTGCAGGTAATCTGGAACATTTTTATGAAGC
CTTTAAACTGGAAGGTGCCGATGCAGCACTGGCAGCAAGCATTTTTCATTTTGG
TGAACTGACCATTGGCGAAGTGAAAGAATATCTGCGCGAACGTGGTATTGAAG
TTCGTCTGTAACTCGAG3’ 
 
Protein sequence 
MLAKRIIPCLDVKDGRVVKGVNFQNLRDAGDPVELARRYDEEGADELVFLDITAT
HEGRETMLEVVRRTAEQVFIPLTVGGGIRSVEDVKKLLRAGADKVSINTAAVKNPE
LITEAAEKFGSQAVVVAIDAKRVGGGYEVFTHGGRKPTGLDAVEYAKKVEELGAG
EILLTSMDRDGTKNGYDLELTRAVSDAVSIPVIASGGAGNLEHFYEAFKLEGADAA
LAASIFHFGELTIGEVKEYLRERGIEVRL 
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Anc2tm-HisF (including Trp to Tyr exchange at position 156) 
Nucleotide sequence 
5’CATATGCTGGCAAAACGTATTATTCCGTGTCTGGATGTTAAAGATGGTCGTG
TTGTTAAAGGCGTGAACTTTGAAAATCTGCGTGATGCCGGTGATCCGGTTGAAC
TGGCACGCTTTTATAACGAAGAGGGTGCAGATGAACTGGTGTTTCTGGATATCA
CCGCAAGCCTGGAAGGTCGTAAAACCATGCTGGAAGTTGTTCGTAAAGTTGCC
GAACAGGTTTTTATTCCGCTGACCGTTGGTGGTGGTATTCGTAGCGTTGAAGAT
GCAAAAGAACTGCTGCTGCGTGGTGCAGATAAAGTTAGCATTAATACCGCAGC
AGTGAAAAACCCGGAACTGATTACCGAAATTGCCGAAAAATTTGGTAGCCAGG
CAGTTGTTGTTGCAATTGATGCAAAACGTGTGGGTGGTGGTTATGAAGTTTTTA
CCCATAGCGGTAAAAAACCGACCGGTCTGGATGCACTGGAATATGCAAAAAAA
GTTGAAGAACTGGGTGCCGGTGAAATTCTGCTGACCAGCATGGATCGTGATGG
CACCAAAAATGGTTATGATAATGAACTGATTCGTGCCGTTAGCACCGCAGTGA
GCATTCCGGTTATTGCAAGCGGTGGTGCAGGTAATCTGGAACATTTTTATGAAG
CCTTTAAACTGGAAGGTGCCGATGCAGCACTGGCAGCAAGCATTTTTCATTTTC
GTGAACTGACCATTCGCGAAGTGAAAGAATATCTGCGCGAACGTGGTATTGAA
GTTCGTCTGTAACTCGAG 3’ 
 
Protein sequence 
MLAKRIIPCLDVKDGRVVKGVNFENLRDAGDPVELARFYNEEGADELVFLDITASL
EGRKTMLEVVRKVAEQVFIPLTVGGGIRSVEDAKELLLRGADKVSINTAAVKNPEL
ITEIAEKFGSQAVVVAIDAKRVGGGYEVFTHSGKKPTGLDALEYAKKVEELGAGEI
LLTSMDRDGTKNGYDNELIRAVSTAVSIPVIASGGAGNLEHFYEAFKLEGADAALA
ASIFHFRELTIREVKEYLRERGIEVRL 
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8.3 Structural integrity of HisF variants used for interaction studies 
In order to rule out that weak complex formation of some HisF proteins with zmHisH is 
due to misfolding, the structural integrity of all investigated HisF proteins was analyzed by 
size exclusion chromatography (chapter 4.5.3) (Figure 37) and far-UV CD spectroscopy 
(chapter 4.5.4, Figure 38). 
 
 
Figure 37: Analytical size exclusion chromatography of HisF proteins used for fluorescence titration 
with zmHisH. 
Analytical size exclusion chromatography was performed with about 100 or 150 µM protein on an analytical 
Superdex 75 column that was equilibrated with 50 mM Tris/HCl, pH 7.5, 300 mM KCl. The proteins were 
eluted with a flow rate of 0.5 mL/min and the elution was observed at 280 nm. The elution profiles are 
indicative of a well-defined structure of homogeneous samples of proteins. 
 
For all HisF proteins the analytical Superdex 75 runs show symmetrical peaks, indicating 
homogeneous protein populations. The MWapp-values, calculated with the help of the 
calibration curve given in chapter 8.7 (Figure 45), are about 27 kDa. This value fits well to 
the MWcalc of HisF proteins, which is also about 27 kDa. 
132 Appendix 
 
 
 
Figure 38: Far-UV CD spectra of HisF used for fluorescence titration with zmHisH.  
Far-UV CD spectra were recorded with 20 or 30 µM protein in 10 mM potassium phosphate, pH 7.5, at 
25 °C. The shown curves are the result of five accumulations and were smoothed with the method of 
Savitzky-Golay (Savitzky & Golay, 1964). The CD spectra are indicative of a well-defined structure of the 
HisF variants. 
 
The CD spectra correspond to a integer (βα)8-barrel structure indicating that all HisF 
variants are correctly folded. Moreover, the HisF proteins that have a weak affinity to 
zmHisH tightly bind to tmHisH or paHisH with Kd-values < 50 nM, which suggests an 
intact tertiary structure. Thus, weak binding due to misfolding can be excluded. 
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8.4 Structural integrity of zmHisH mutants 
The structural integrity of zmHisH mutants was verified via size exclusion chromatography 
(chapter 4.5.3) and far-UV CD spectroscopy (chapter 4.5.4, Figure 39). 
 
Figure 39: Structural integrity of zmHisH-A28R, zmHisH-L202R and zmHisH-A28R+L202R in 
comparison with zmHisH wt.  
A) Analytical size exclusion chromatography was performed with about 50 or 100 µM protein on an 
analytical Superdex 75 column that was equilibrated with 50 mM Tris/HCl, pH 7.5, 300 mM KCl. The 
proteins were eluted with a flow rate of 0.5 mL/min and the elution was observed at 280 nm. B) Far-UV CD 
spectra were recorded with 30 µM protein in 10 mM potassium phosphate, pH 7.5, at 25 °C. The shown 
curves are the result of five accumulations and were smoothed with the method of Savitzky-Golay (Savitzky 
& Golay, 1964). The elution profiles and the CD spectra are indicative of a well-defined structure of 
homogeneous samples of the zmHisH mutants. 
 
The symmetric peaks observed in size exclusion chromatography analysis indicate a well-
folded protein population. The MWapp-values of 23 kDa, calculated with the help of the 
calibration curve given in chapter 8.7 (Figure 45), compare well to the MWcalc values, 
which are all around 23 kDa. The CD spectra are similar to the spectrum of the wild type 
protein and are indicative of an intact secondary structure. Overall, the structure of zmHisH 
is not perturbed by the introduction of the Arg residues. 
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8.5 Steady-state kinetic characterization of reconstructed and modern 
HisF and HisH proteins 
8.5.1 General remarks 
In order to find out if all reconstructed HisF proteins display catalytic activity, they were 
tested for ammonia-dependent cyclase activity (chapter 4.5.6.1), glutamine-dependent 
cyclase activity (chapter 4.5.6.2) and glutaminase activity with a present-day HisH subunit 
(chapter 4.5.6.3). Kinetic parameters for the contemporary native complexes 
tmHisF:tmHisH and paHisF:paHisH were determined, as well. 
The kinetic studies were conducted with the Trp-free HisF variants. In order to exclude that 
the Trp to Tyr exchanges affect the catalytic properties of the cyclase subunit, the kinetic 
parameters for LUCA-HisF wt, and for the contemporary enzymes paHisF wt and tmHisF 
wt were determined, as well.  
As PRFAR spontaneously hydrolyzes (Klem & Davisson, 1993), the more stable 
ProFAR is used in all measurements. In the case of ammonia-dependent cyclase activity 
and glutamine-dependent cyclase activity an excess of tmHisA is added to the reaction 
mixtures in order to convert ProFAR into PRFAR.  
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8.5.2 Ammonia-dependent cyclase activity 
The ammonia-dependent HisF reaction is the conversion of PRFAR into AICAR and ImGP 
in the presence of saturating concentrations of ammonia acetate (chapter 4.5.6.1). As 
KmPRFAR- values for the reconstructed HisF proteins seem to be far below 0.5 µM, initial 
velocities (vi) were only determined under saturating PRFAR concentrations. The maximal 
velocity (vmax) was defined as the mean value of these initial velocities. For the 
contemporary native complexes complete Michaelis-Menten curves were recorded. 
Ammonia-dependent cyclase activity was determined in the absence of HisH (Figure 40). 
 
Figure 40: Ammonia-dependent cyclase activity.  
Reactions were recorded at 25 °C in 50 mM Tris/Ac pH 8.5 in the presence of 100 mM NH4Ac and varying 
concentrations of ProFAR. ProFAR was converted in situ into PRFAR with 0.6 µM tmHisA. A) 0.1 µM 
paHisF were used to start the reaction. KmPRFAR and vmax were determined by fitting the data points with a 
hyperbolic equation. B) 0.05 µM Anc2tm-HisF were used to start the reaction. As Anc2tm-HisF has an 
immeasurably low KmPRFAR, only vmax was determined. 
 
The kinetic parameters of the reconstructed HisF proteins and those of contemporary HisF 
proteins are listed in Table 16. 
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Table 16: Kinetic parameters of the ammonia-dependent cyclase activity of isolated HisF proteins. 
The parameters were measured at 25 °C in 50 mM Tris/Ac pH 8.5 in the presence of 100 mM NH4Ac. If the 
KmPRFAR-values were too low to be determined accurately, initial velocities (vi) were recorded under saturating 
substrate concentrations. Vmax was then defined as the mean value of these vi values. Complete Michaelis-
Menten curves were fitted with the hyperbolic equation in order to determine KmPRFAR and kcat.  
 
 kcat (s-1) KmPRFAR (µM) kcat / KmPRFAR (M-1 s-1) 
tmHisF wt 3.6 3.9 9.2 · 105 
tmHisF wt1,2 1.2 3.6 3.3 · 105 
tmHisF wt3 2.2 1.7 1.3 · 106 
tmHisF 3.8 4.3 8.8 · 105 
paHisF wt 0.8 0.4 2 · 106 
paHisF wt4 1.0 0.9 1.1 · 106 
paHisF 1.1 0.8 1.4 · 106 
LUCA-HisF wt 0.3 < 0.5  
LUCA-HisF wt5 0.078 0.29 2.8 · 105 
LUCA-HisF 0.6 < 0.5  
Anc1pa-HisF 1.3 < 0.5  
Anc1tm-HisF 0.3 < 0.5  
Anc2tm-HisF 0.9 < 0.5  
1Catalytic parameters determined for tmHisF wt in complex with tmHisH, 
2(List et al., 2012), 3(Beismann-Driemeyer & Sterner, 2001), 4(Schmid, 2012), 
5(Reisinger et al., 2014),  
 
The kcat-value and, if determined, the KmPRFAR-value of the wild type enzymes resemble the 
value of the Trp-free variants, proving that the mutations do not alter the kinetic properties 
of the HisF enzymes. This result can be generalized for the other reconstructed HisF 
proteins as W138 and W156 that occur separately (tmHisF_W156; paHisF_W157) or in 
combination (LUCA-HisF_W138+W156) are conserved in the ancient HisF proteins.  
The kcat, KmPRFAR and kcat/ KmPRFAR of tmHisF wt do not differ significantly from the 
values for tmHisF wt published in List et al. (2012) and Beismann-Driemeyer and Sterner 
(2001). PaHisF wt exhibits catalytic parameters that fit well to the parameters of previous 
kinetic studies (Schmid, 2012). The kcat of LUCA-HisF wt deviates from the kcat published 
in Reisinger et al. (2014) by a factor of five. Concerning the fact, that the accurate 
determination of kcat for low substrate concentrations was difficult and that the data in 
Reisinger et al. (2014) were analyzed with the integrated form of the Michaelis−Menten 
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equation using the program COSY (Eberhard, 1990), deviations between these independent 
measurements may occur. 
All reconstructed HisF proteins displayed ammonia-dependent cyclase activity. It 
became evident in the course of the analysis that the initial part of the reaction curve 
slightly deviated from an ideal linear progression. On the basis of these observations, it may 
be hypothesized that the catalytic mechanism is affected by product inhibition. This 
phenomenon may be a by-product of the KmPRFAR-values that are apparently markedly low. 
However, this is speculative and a deeper understanding of the kinetic mechanism requires 
further investigations. In the range of 0.5 to 5 µM substrate concentration that was applied 
in the framework of these studies, kcat is constant. Moreover, variation of the enzyme 
concentration yielded similar kcat values, substantiating the validity of the results.  
 
8.5.3 Glutamine-dependent cyclase activity 
The glutamine-dependent activity is the physiological reaction of the HisF:HisH complex. 
Ammonia, which is produced via glutamine hydrolysis by HisH is channeled to the active 
site of HisF, where it reacts with PRFAR to AICAR and ImGP (chapter 4.5.6.2). 
In the course of this study, Anc1tm-HisF and Anc2tm-HisF turned out to form 
active complexes with zmHisH and Anc1pa-HisF with paHisH (Figure 41). 
 
Figure 41: Glutamine-dependent cyclase activity.  
Reactions were recorded at 25 °C in 50 mM Tris/Ac pH 8.0 in the presence of saturating concentrations of 
glutamine and varying concentrations of ProFAR. ProFAR was converted in situ into PRFAR with 0.6 µM 
tmHisA. A) The reaction contained 1 µM paHisH. 0.1 µM paHisF were used to start the reaction. KmPRFAR and 
vmax were determined by fitting the data points with a hyperbolic equation. B) The reaction contained 1 µM of 
zmHisH. 0.05 µM Anc2tm-HisF were used to start the reaction. As Anc2tm-HisF has an immeasurably low 
KmPRFAR, only vmax was determined. 
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The kinetic parameters of these and of various other HisF:HisH complexes are listed in 
Table 17. 
 
Table 17: Kinetic parameters of the glutamine-dependent cyclase activity of various HisF:HisH 
complexes. 
The parameters were measured at 25 °C in 50 mM Tris/Ac pH 8.0 in the presence of saturating concentrations 
of glutamine. If the KmPRFAR-values were too low to be determined accurately, initial velocities (vi) were 
recorded under saturating substrate concentrations. Vmax was then defined as the mean value of these vi 
values. Complete Michaelis-Menten curves were fitted with the hyperbolic equation in order to determine 
KmPRFAR and kcat.  
 
HisH HisF kcat (s-1) KmPRFAR (µM) kcat / KmPRFAR (M-1 s-1) 
tmHisH 
tmHisF wt 1.1 1.4 7.9 · 105 
tmHisF wt1 1.1 2.0 5.5 · 105 
tmHisF wt2 0.8 1.5 5.3 · 105 
tmHisF 1.2 1.8 6.7 · 105 
paHisH 
paHisF wt 0.6 < 0.3  
paHisF 0.5 0.6 8.3 · 105 
Anc1pa-HisF 0.3 < 0.5  
zmHisH 
LUCA-HisF wt 0.2 < 0.5  
LUCA-HisF wt3 0.058 0.36 1.6 · 105 
LUCA-HisF 0.3 < 0.5  
Anc1tm-HisF 0.05 < 0.5  
Anc2tm-HisF 0.3 < 0.5  
1(List et al., 2012), 2(Beismann-Driemeyer & Sterner, 2001), 3(Reisinger et al., 2014),  
 
The comparison of parameters of the wild type variants and parameters of Trp-free variants 
proves that the Trp to Tyr exchanges do not affect the kinetics. 
The kinetic parameters for tmHisF wt:tmHisH were well reproduced. Differences of 
the kcat determined for LUCA-HisF wt in this work and in (Reisinger et al., 2014) may be 
due to the same reasons outlined before. 
All reconstructed HisF proteins in combination with the present-day glutaminases 
zmHisH or paHisH displayed glutamine-dependent cyclase activity. For most of the HisF 
proteins the kcat are lower compared to the values of the ammonia-dependent cyclase 
activity. However, in the case of ammonia-dependent cyclase activity no HisH was present; 
thus the results cannot directly be compared. Overall, the outcome indicates that the 
reconstructed cyclase subunits can form functional glutaminase complexes with modern 
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glutaminase subunits and effectively channel ammonia from the active site of HisH to the 
PRFAR binding site. For Anc1tm-HisF, however, a kcat that is on average six times lower 
than the kcat values of the other reconstructed HisFs was determined. As Anc1tm-HisF is a 
structurally integer enzyme that displays realistic kinetic parameters for ammonia-
dependent cyclase activity and glutaminase activity the reason for this low value is not 
clear.  
 
8.5.4 Glutaminase activity 
The ability of the reconstructed HisF proteins to allosterically stimulate glutaminase 
activity was tested in a NAD+-dependent glutaminase assay (chapter 4.5.6.3). As 
measurable glutaminase activity can only be detected if an activating ligand is bound to 
HisF, ProFAR was added in saturating concentrations to the reaction mixture (Figure 42). 
 
Figure 42: Glutaminase activity.  
Reactions were recorded 25 °C in 50 mM Tricine/KOH pH 8.0 in the presence of 40 µM ProFAR, 1 mg/mL 
glutamate dehydrogenase, 10 mM NAD+, and variable concentrations of glutamine at 25 °C. The reaction was 
started with the addition of HisF resulting in an increase in absorption at 340 nm. (A) The reaction contained 
1 µM paHisH . 2 µM paHisF were used to start the reaction. (B) The reaction contained 0.01 µM zmHisH. 1 
µM Anc2tm-HisF was used to start the reaction. For all reactions KmGln and vmax were determined by fitting 
the data points with a hyperbolic equation. 
 
The parameters determined for various HisF:HisH complexes are listed in Table 18. 
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Table 18: Kinetic parameters of the glutaminase activity of various HisF:HisH complexes. 
The parameters were measured at 25 °C in 50 mM Tricine/KOH pH 8.0 in the presence of saturating 
concentrations of ProFAR. Michaelis-Menten curves were fitted with the hyperbolic equation in order to 
determine KmGln and kcat.  
 
HisH HisF kcat (s-1) KmGln (mM) kcat / KmGln (M-1 s-1) 
tmHisH 
tmHisF wt 0.07 0.7 1 · 102 
tmHisF wt1 0.1 0.8 1.3 · 102 
tmHisF w2 0.1 n.d. n.d. 
tmHisF 0.08 0.8 1 · 102 
paHisH 
paHisF wt 0.3 1.9 1.6 · 102 
paHisF 0.3 2.0 1.5 · 102 
Anc1pa-HisF 0.7 16 4.4 · 10 
zmHisH 
LUCA-HisF wt 4.5 2.2 2.0 · 103 
LUCA-HisF wt3 0.21 1.9 1.2 · 102 
LUCA-HisF 4.6 2.1 2.2 · 103 
Anc1tm-HisF 9.0 0.9 1.0 · 104 
Anc2tm-HisF 9.0 2.2 4.1 · 103 
1(List et al., 2012), 2(Beismann-Driemeyer & Sterner, 2001), 3(Reisinger et al., 2014) 
 
Like before, the kinetic parameters of wild type and Trp-free variants are similar, indicating 
that the Trp-Tyr exchanges do not influence the allosteric mechanism of glutaminase 
stimulation. 
The kinetic parameters for tmHisF wt:tmHisH compare well with the activity of 
tmHisF wt:tmHisH from List et al. (2012) and Beismann-Driemeyer and Sterner (2001). 
The kcat of LUCA-HisF wt:zmHisH published in Reisinger et al. (2014) and the kcat 
determined in the course of this work deviate by a factor of 21. As newly purified zmHisH 
was used for the measurements presented here, deviations might result – among other 
factors – from that. 
The results confirm that Anc1tm-HisF, Anc2tm-HisF and Anc1pa-HisF are able to 
allosterically stimulate the glutaminase activity of the present-day glutaminases zmHisH 
and paHisH, respectively. In fact, LUCA-HisF:zmHisH, Anc1tm-HisF:zmHisH and 
Anc2tm-HisF:zmHisH displayed kcat values that are on average higher by a factor of 15 to 
129 compared with the native present–day complexes tmHisF:tmHisH and paHisF:paHisH.  
However, the strikingly high differences are due to the comparison between 
complexes with glutaminase subunits from thermophilic and mesophilic organisms 
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(Benschoter & Ingram, 1986). The comparison of kinetic data between the complexes 
comprising a reconstructed HisF and zmHisH and the native present-day complex 
zmHisF:zmHisH would be more substantive. However, as zmHisF is not stable, no kinetic 
parameters for the glutaminase activity of the native complex zmHisF:zmHisH could be 
determined. Interestingly, kinetic studies on ImGPS from mesophilic E.coli and S. cervisiae 
(Klem & Davisson, 1993; Chittur et al., 2000) provide kcat-values of 2.6 s-1 and 5 s-1 at 
30 °C, respectively. Because of this, it can be speculated that zmHisF:zmHisH exhibits 
similar turnover numbers at 25 °C and thus the kcat-values determined for the artificial 
complexes in this work would be similar to those of modern mesophilic ImGPS. In 
accordance with this, Anc1pa-HisF:paHisH exhibits a kcat-value that differs by a factor of 
ten from tmHisF:tmHisH and only by a factor of two from paHisF:paHisH.  
In summary, the results of these kinetic studies prove that the reconstructed HisFs 
are functional enzymes that can form allosterically active complexes with contemporary 
glutaminases. 
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8.6 Structural integrity of Anc2tm-HisF_A2 
In order to rule out that the amino acid mutations introduced into Anc2tm-HisF in order to 
generate Anc2tm-HisF_A2 resulted in structural perturbations that negatively affect protein 
activity, the structural integrity was assayed via analytical size exclusion chromatography 
(chapter 4.5.3) and far-UV CD spectroscopy (chapter 4.5.4, Figure 43) and the cyclase 
activity was tested in the presence of saturating concentrations of ammonia acetate (chapter 
4.5.6.1). 
 
Figure 43: Structural integrity of Anc2tm-HisF_A2.  
A) Analytical size exclusion chromatography was performed with about 100 µM protein on an analytical 
Superdex 75 column that was equilibrated with 50 mM Tris/HCl pH 7.5, 300 mM KCl. The protein was 
eluted with a flow rate of 0.5 mL/min and the elution was observed at 280 nm. B) The far-UV CD spectrum 
was recorded with about 30 µM Anc2tm-HisF_A2 (green) in 10 mM potassium phosphate pH 7.5 at 25°C. 
The shown curve is the result of five accumulations and was smoothed with the method of Savitzky-Golay 
(Savitzky & Golay, 1964). For comparison, the far UV-CD spectrum of Anc2tm-HisF is shown. The elution 
profile and the CD spectrum are indicative of a well-defined structure of a homogeneous sample of Anc2tm-
HisH_A2. 
 
Size exclusion chromatography revealed that part of the protein forms aggregates. The 
protein that elutes at about 9.6 mL has a MWapp = 60.0 kDa, which represents a dimer. The 
dominant peak at 11.5 mL represents a monomer with 28.0 kDa, which fits well to MWcalc 
= 27.6 kDa. Despite partial aggregation, both the symmetrical peak in the elution profile 
and the CD spectrum are indicative of portions of properly folded protein. In accordance 
with that, Anc2tmHisF_A2 displayed ammonia-dependent cyclase activity. 
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8.7 Calibration curves 
Calibration of analytic Superdex 75 10/300 GL (GE HEALTHCARE, 23.56 mL) was done 
in 50 mM Tris/HCl pH 7.5, 300 mM KCl (Figure 44 & Figure 45).  
Calibration curve I 
 
Figure 44: Calibration of analytic Superdex 75 in 50 mM Tris/HCl pH 7.5, 300 mM KCl for 
determination of MWapp of LUCA-HisH and LUCA-HisH mutants. 
 
Calibration was done with the following proteins (Table 19). 
 
Table 19: Proteins used for calibration of analytical Superdex 75. 
Protein MW (Da) log MW V (mL) 
Ribonuclease A 13700 4.14 13.76 
Carbonic Anhydrase 29000 4.46 12.27 
Ovalbumin 44000 4.64 11.15 
Conalbumin 75000 4.88 10.29 
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Calibration curve II 
 
Figure 45: Calibration of analytic Superdex 75 in 50 mM Tris/HCl pH 7.5, 300 mM KCl. 
 
Calibration was done with the following proteins (Table 20). 
 
Table 20: Proteins used for calibration of analytical Superdex 75. 
Protein MW (Da) log MW V (mL)
Aprotein 6500 3.81 15.20 
Ribonuclease A 13700 4.14 13.11 
Carbonic Anhydrase 29000 4.46 11.42 
Ovalbumin 44000 4.64 10.22 
Conalbumin 75000 4.88 9.27 
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8.8 Data collection and refinements statistics 
LUCA-HisF wt:tmHisH with bound glutamine 
Table 21: Crystal structure determination for glutamine bound LUCA-HisF wt:tmHisH. 
Resolution range 48.2 - 2.419 (2.506 - 2.419) 
Space group P 1 21 1 
Unit cell (Å) a=43.114 b=195.708 c=55.608 α=90 β=95.211 γ=90 
Unique reflections 34778 (3391) 
Completeness (%) 1.00 
Reflections 
used  
in refinement 34772 (3391) 
for Rfree 1740 (169) 
Rwork / Rfree (%) 0.2068 (0.2343) / 0.2810 (0.3449) 
Average B-factor (Å2) 27.10 
Number of 
non-hydrogen atoms 7218 
macromolecules  6935 
ligands 20 
solvents 263 
Protein residues 898 
RMS bonds (Å) 0.008 angles (°) 0.94 
Ramachandran 
favorable (%) 95 
allowed (%) 3.7 
outliers (%) 1 
Rotamer outliers (%) 0.14 
Clashscore 6.93 
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apo LUCA-HisF wt:tmHisH 
Table 22: Crystal structure determination for LUCA-HisF wt:tmHisH. 
Resolution range 39.23 - 2.17 (2.248 - 2.17) 
Space group P 1 21 1 
Unit cell a=43.058 b=194.812 c=55.518 α=90 β=95.463 β=90 
Unique reflections 47542 (4472) 
Completeness (%) 0.99 
Reflections used in refinement 47531 (4472) 
Reflections used for R-free 2379 (224) 
Rwork / Rfree (%) 0.2050 (0.2957) / 0.2547 (0.3775) 
Average B-factor (Å2) 33.75 
Number of 
non-hydrogen atoms 7492 
macromolecules  6936 
solvents 556 
Protein residues 898 
RMS bonds (Å) 0.009 angles (°) 1.07 
Ramachandran 
favorable (%) 96 
allowed (%) 3 
outliers (%) 0.67 
Rotamer outliers (%) 0.55 
Clashscore 10.92 
Number of TLS groups 22 
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